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Abstract 
Synthetic peptides offer enormous potential to encode the assembly of molecular 
electronic components, provided that the complex range of interactions is distilled 
into simple design rules. Herein is reported a spectroscopic investigation of 
aggregation in an extensive series of peptide-perylene imide conjugates designed to 
interrogate the effect of structural variations. Throughout the course of this study, 
the self-assembly and photophysical properties of the compounds are explored to 
better understand the behavior and application of these materials. Three principal 
avenues of inquiry are applied: (1) the evaluation of structure-property relationships 
from a thermodynamic perspective, (2) the examination of peptide chiral effects 
upon properties and self-assembly, and (3) an application of the understanding 
gained from rationally designed systems to effectively utilize naturally optimized 
peptides in bio-organic electronics. 
By fitting different contributions to temperature-dependent optical absorption 
spectra, this study quantifies both the thermodynamics and the nature of 
aggregation for peptides with incrementally varying hydrophobicity, charge density, 
length, amphiphilic substitution with a hexyl chain, and stereocenter inversion. 
Coarse effects like hydrophobicity and hexyl substitution are seen to have the 
greatest impact on binding thermodynamics, which are evaluated separately as 
enthalpic and entropic contributions. Moreover, significant peptide packing effects 
are resolved via stereocenter inversion studies, particularly when examining the 
nature of aggregates formed and the coupling between π-electronic orbitals. 
Peptide chirality overall is seen to influence the self-assembly of the perylene imide 
cores into chiral nanofibers, and peptide stereogenic positions, stereochemical 
configurations, amphiphilic substitution, and perylene core modification are 
evaluated with respect to chiral assembly. Stereocenters in peptide residue positions 
proximal to the perylene core (1-5 units) are seen to impart helical chirality to the 
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perylene core, while stereocenters in more distal residue positions do not exert a 
chiral influence. Diastereomers involving stereocenter inversions within the 
proximal residues consequently manifest spectroscopically as pseudo-enantiomers. 
Increased side-chain steric demand in the proximal positions gives a similar chiral 
influence but exhibits diminished Cotton Effect intensity with additional longer 
wavelength features attributed to interchain excimers. Amphiphilic substitution of a 
peptide with an alkyl chain disrupts chiral self-assembly, while an amphiphilic 
structure achieved through the modification of the perylene imide core with a 
bisester moiety prompts strongly exciton-coupled, chiral, solvent-responsive self-
assembly into long nanofilaments. 
Informed by rationally designed sequences, and capitalizing upon the optimization 
seen in many natural systems, specific peptide sequences designed by inspection of 
protein-protein interfaces have been identified and used as tectons in hybrid 
functional materials. An 8-mer peptide derived from an interface of the 
peroxiredoxin family of self-assembling proteins is exploited to encode the assembly 
of perylene imide-based organic semiconductor building blocks. By augmenting the 
peptide with additional functionality to trigger aggregation and manipulate the 
directionality of peptide-semiconductor coupling, a series of hybrid materials based 
on the natural peptide interface is presented. Using spectroscopic probes, the mode 
of self-assembly and the electronic coupling between neighboring perylene units is 
shown to be strongly affected by the number of peptides attached, and by their 
backbone directionality. The disubstituted material with peptides extending in the 
N-C direction away from the perylene core exhibits strong coupling and long-range 
order, which are both attractive properties for electronic device applications. A bio-
organic field-effect transistor is fabricated using this material, highlighting the 
possibilities of exploiting natural peptide tectons to encode self-assembly in other 
functional materials and devices. 
These results advance the development of a quantitative framework for establishing 
structure-function relationships that will underpin the design of self-assembling 
peptide electronic materials. The results further advance a model for adapting 
natural peptide sequences resident in β-continuous interfaces as tectons for bio-
organic electronics. 
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Chapter 1 
Introduction 
1.1 Building from a Molecular Foundation 
In distinction to molecular synthesis which is employed to alter the covalently 
bonded atomic architecture of molecular structures, molecular self-assembly 
involves the spontaneous, unaided self-organization of molecules themselves into 
larger, ordered supramolecular architectures that are formed and cohere via 
noncovalent interactions.1 Because the innate features of a molecular structure 
determine the nature of any ensembles resulting from molecular self-assembly, 
molecular synthesis can, therefore, be used to produce molecular structures with 
particular features designed to encode specific assembly interactions toward desired 
supramolecular self-assembly goals. Successful self-assembly by a molecular system 
is determined by five principal system characteristics:1 (1) structural components, (2) 
system interactions, (3) interactive adjustability, (4) the assembly environment, and 
(5) mass transport. For self-assembly, the structural components are simply the 
homo- or heteromolecular units (or macromolecular segments) interacting during 
the process. During the process, the system interactions are just the balancing of 
repulsive and attractive noncovalent forces driving self-assembly. As self-assembly 
occurs, the nature of the interactions must be sufficiently reversible (not 
permanently affixed) to allow molecular units to have adjustable positioning within 
the supramolecular architecture while self-assembly proceeds. Irreversible processes 
leading to rigid bonding states would not accommodate the development of an 
evolving assembly as it forms. The molecular environment must then also be 
2 
 
supportive of the self-assembly process by permitting sufficient motion and mass 
transport of the self-assembling units (such as in solution or at an interface). If 
molecular structural units possessing complementary forms and mutually 
supportive noncovalent interactions are placed in an appropriately conducive 
environment, elaborate self-assembly can be achieved from relatively simple 
molecular building blocks as illustrated in Figure 1.1. 
 
 
Figure 1.1 Schematic illustration for the self-assembling behavior of the dimers 
of β-cyclodextrin (β-CD) threaded by one dodecane molecule via a host-guest 
inclusion. The dimer is a supramolecular building block of dodecane@2β-CD. 
(Figure adapted for review from Zhou et al.2 with permission of  NPG.) 
For the system shown in Figure 1.1, each of the previously discussed aspects 
underpinning self-assembly are seen to be present. Structurally, the doughnut ring-
like form of the β-cyclodextrin molecule and the thread-like structure of the 
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dodecane molecule mutually facilitated a host-guest interaction. Interactively, the 
structures are driven together by noncovalent hydrophobic/hydrophilic influences 
wherein the mutual attraction of the hydrophobic dodecane molecule to the 
hydrophobic cavity of the β-cyclodextrin prompts self-assembly of dodecane within 
the interior of two β-cyclodextrin units such that the hydrophobic aspects of all 
molecules involved are shielded by a shell of the β-cyclodextrin hydrophilic exterior. 
This dynamic also is derived from the innate molecular structural features of the 
respective molecules. Environmentally, the aqueous solution provided a medium to 
make the assembly favored and facilitated the motion and mass transport of the 
molecular units. Through such scenarios molecular self-assembly is easily achieved. 
 
Informed by these principles of self-assembly, the focus of the work described in the 
subsequent chapters of this study is that of the self-assembly of organic 
semiconductors — in particular, perylene imide semiconductors. Extending from 
this focus, the goal of this study is to use the diverse, adaptable structures of 
peptides to encode the self-assembly of the semiconductor moieties to ultimately 
create macroscopically conductive devices. 
1.2 Why Self-Assembly? 
Electronic delocalization, which is an intrinsic characteristic in organic molecules 
containing conjugated π-orbital systems, can facilitate the movement of charge 
carriers as electrons or electron vacancies (holes) through a conjugated network.3,4 
This property, together with an accessible material band-gap, permits many π-
functional organic molecules, oligomers, and polymers to exhibit semiconducting 
properties.3 Developing such compounds into organic semiconducting materials has 
received considerable interest since organic semiconductors may potentially 
provide several advantages over traditional inorganic materials. 
 
Organic semiconducting materials have desirable mechanical properties (flexibility 
and durability) and can be processed at lower temperatures (using less energy) by 
industrial methods such as vacuum evaporation, solution casting, inkjet printing, 
stamping, etc., which are already in use for semiconductor fabrication.3 
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Additionally, organic synthesis, which is governed by functional group interactions, 
provides an added dimension of molecular-scale structural control not always 
present with inorganic materials, and this additional control becomes an 
increasingly important advantage as cost-effective improvements to silicon-based 
device performance reaches a limit.3 The molecular-scale control provided by 
organic synthesis may allow the production of electronically-tuned organic 
semiconductors that facilitate the construction of high density, extremely 
miniaturized, inexpensive, low power electronic components and devices.5 To 
realize the potential of these organic semiconductors, however, a further level of 
structural control is needed — supramolecular control. An example of this 
molecule-up approach to self-assembly is shown in a timed molecular assembly 
progression in Figure 1.2. 
 
 
 
Figure 1.2 (a) Schematic depiction of the phase transition observed in the Boc-
Phe-Phe system over time. (b) Schematic molecular structure of Boc-Phe-Phe. (c-e) 
Microscopy images of aliquots of Boc-Phe-Phe in 10% ethanol/water solution were 
collected and left to dry on glass slides at 2, 40 and 60 min. from initial mixing. 
(Figure adapted  for review from Levin et al.6 with permission from NPG.)  
For organic semiconductors, self-assembly into nanostructures like those shown in 
Figure 1.2 can greatly improve the material properties needed for electronic 
applications. Since organic π-functional materials are primarily two-dimensional 
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semiconductors, interchain electronic coupling highly impacts the performance of 
devices employing them.7 This is because conduction within such materials requires 
that the two-dimensionally semiconducting π-functional units electronically interact 
three-dimensionally. To enhance the interchain electronic coupling and charge 
transfer needed for this, the formation of crystalline-like mono-domains is desirable; 
however, this can be difficult to achieve beyond that of a few hundred nanometers 
in size.7 When making the transition from molecular properties to macroscopic, 
bulk material properties, a combination of chemical synthesis and process controls 
can be employed to alter material morphology and optimize material performance. 
Beyond this, however, applying supramolecular self-assembly design affords a 
means to directly facilitate the formation of fundamental nano-architectural arrays 
within the material across larger length-scales to promote order and enhance bulk 
material performance.7 
1.3 How to Assess Self-Assembly? 
Given the goal of using self-assembly to enhance interchain electronic coupling, 
charge transfer, and conduction in organic semiconductors for improved material 
function, a simple means to assess the effectiveness of a self-assembly strategy 
toward material performance is desirable. For π-functional materials, this is easily 
achieved since changes in the conductive properties are reflected in the 
photophysical properties of the materials. The conjugated π-bond networks of π-
functional molecules give them characteristically strong absorption features. 
Moreover, π-stacking becomes important, wherein noncovalent aromatic-aromatic 
electrostatic attractions between the p-orbitals of two separate aromatic rings 
produce a stacked p-orbital alignment of electrostatic potential between the two 
rings. Due to π-stacking by the molecules, the individual chromophores exhibit 
sensitivity to the local electronic environment induced by their mutual orientations. 
This sensitivity, in turn, is manifest spectroscopically by the chromophores. 
Because self-assembly changes the orientation of π-functional molecules, prompting 
a change in the local electronic environments of the chromophores that is expressed 
photophysically, spectroscopy may be used as a convenient tool for assessment. 
Spectroscopic evaluations in solution offer a simple means of evaluating a self-
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assembly strategy (and any refinements to it) before progressing to more involved 
solid-state examinations of nano-architectures. 
 
Following from the spectroscopic assessments, once indications of the successful 
formation of the desired nano-architectures are obtained in solution, solid-state 
microscopy methods such as transmission electron microscopy (TEM), scanning 
electron microscopy (SEM), and atomic force microscopy (AFM) can be used to 
image the actual nanostructures formed (as previously exemplified in Figure 1.2). 
In addition to providing verification of the presence of the nanostructures indicated 
by spectroscopy, microscopy can show and easily distinguish the exact 
morphologies of the nanostructures obtained. Moreover, microscopy has value in 
showing the topographical detail and material distribution of nanostructures 
applied to surfaces, which can be helpful during material device fabrication. 
 
As a final means of assessing self-assembly (from an applied perspective) once the 
microscopy imaging reveals favorable morphologies, the construction of devices 
from the material can be undertaken to measure the actual solid-state 
semiconducting characteristics of the nanostructures.  
1.4 How to Self-Assemble? 
Self-assembly of molecular units into ordered supramolecular groups of molecules, 
in general, is achieved using weak noncovalent interactions such as Coulombic, 
ion-dipole, or dipole-dipole attractions, amphiphilic associations, hydrogen 
bonding, and π-π interactions.7 Hydrogen bonding and π-π interactions (π-stacking) 
are particularly important and are often used to prompt self-assembly of small 
molecular units and some oligomers, whereas supramolecular ordering of polymers 
is often achieved through more complex block copolymer-solvent methodologies.7 
Often, more than one type of noncovalent interaction is employed simultaneously 
within a system to effect self-assembly. The structures employed as substituents (or 
scaffolds) to prompt self-assembly are diverse. While some are the result of clever, 
rational design, others are inspired by (or adapted from) natural systems. Bio-
inspired structures used for self-assembly include small molecules (Watson-Crick 
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base pairs), nucleic acids, peptides, proteins, and even viruses.8 Yet despite the 
structural diversity of the moieties used as agents of self-assembly, in general, the 
same simple, noncovalent interactions can be seen to underpin the architectures 
formed. Figures 1.3-1.5 provide three examples of self-assembled systems reported 
in the literature which illustrate common noncovalent self-assembly methodologies. 
 
 
 
Figure 1.3  (a) A self-complementary hydrogen-bonding strategy for self-
assembly of an organic semiconductor, enabling the formation of mixed dimers and 
mixed aggregates. (b) Photoluminescence spectra for mixtures in dodecane solution: 
(top panel) 0-30 mol % OPV 4 at 80 °C, (lower panel) 0-1.2 mol % OPV 4 at 10 °C. 
(c) Inside the mixed stacks efficient energy transfer is observed from OPV 3 to OPV 
4. (Figure adapted for review from Hoeben et al.9 with permission from Wiley.) 
In addition to providing an example of the use of hydrogen-bonding to effect self-
assembly, the system shown in Figure 1.3 also demonstrates how self-assembly can 
achieve advantageous supramolecular architectures that enhance the primary 
molecular structural features of the individual units forming it. Other systems, 
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however, need not use hydrogen-bonding due to the presence of significant π-π 
interactions, as shown in Figures 1.4-1.5. The system shown in Figure 1.4 also 
demonstrates that hydrophobic-hydrophilic interactions are often an important 
factor in supramolecular self-assembly. The π-stacking interactions of this system 
are shepherded by hydrophobic-hydrophilic interactions, wherein the hydrophilic 
oligo(ethyleneoxide) dendrons preferentially associate while the hydrophobic 
phenylene faces undergo π-stacking. While the π-stacking assures that the 
hydrophobic association is not disordered, it does not provide a definite orientation 
for molecules within the aggregate, meaning both parallel and radial π-stacking 
arrangements (or a mixture) might be possible. The amphiphilicity and molecular 
packing efficiency, therefore, drive the shape of the self-assembly. Beyond 
shepherding self-assembly behavior, strong hydrophobic-hydrophilic interactions 
can also improve the robustness of supramolecular architectures, which can be 
fragile due to the weak nature of the forces driving their assembly.10  
 
 
Figure 1.4  An example of a π-π interactions and amphiphilic influences in 
supramolecular self-assembly. (Figure adapted for review from Yoo et al.11 with 
permission from ACS.) 
For the system depicted in Figure 1.5, additional influences from both structural 
design and from electrostatic interactions are seen to guide the π-stacking 
associations. Variable length helical spine segments act as modular spacers for the 
π-stacking aromatic layers. Self-assembly occurs at the connecting points on the 
helix branches via amine salt formation between the substituents of the two 
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components of the block co-polymer. The helical spine segments and the aromatic 
plates are held together both by electrostatic attraction from the amine salt moieties 
as well as by the π-stacking interactions of the aromatic layers. 
 
Figure 1.5  An example of supramolecular self-assembly in a block co-polymer. 
(Figure adapted for review from Thünemann et al.12 with permission from ACS.) 
1.5 Why Peptides? 
Among the many possible moieties which may be employed to impart the 
noncovalent interactions which drive self-assembly, peptides hold great potential 
and versatility. Peptides are known to innately exhibit self-assembly into secondary 
structures such as β-sheets (parallel or anti-parallel), β-turns, helical forms,13,14 
supramolecular gels,15 nanosheets,16 and nanofibres.17 Moreover, peptide interfaces 
are known to underpin and drive protein homodimer assembly.18 Incorporating 
peptides with their demonstrated innate propensity toward self-assembly within 
larger molecular structures offers a tunable means of guiding the self-assembly of 
other attached moieties. The self-assembly of the peptide sequences can be 
influenced (enhanced or disrupted) by many factors such as electrostatic effects,19 
hydrogen-bonding influences,20 side-chain hydrophobicity,20–22 pH,23 π-π 
interactions of attached moieties,15,24 and solvent effects. These extrinsic and 
intrinsic characteristics and behaviors resulting from the structure of the peptide 
sequence all influence which type of supramolecular structure may result. Since the 
properties of a peptide are sequence-dependent, a wealth of possible amino acid 
permutations is possible, which may be used to tune the overall self-assembly of an 
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appended moiety of interest. Accordingly, several studies applying peptide 
sequences for material development have been undertaken. 
 
Even peptides of relatively short length can often provide remarkable results in self-
assembly endeavors. For example, native phenylalanine dipeptide (Phe-Phe) 
strands have been shown to form extensive nanotubes,25 highlighting that peptide 
length is simply one more useful variation within peptide diversity. In fact, the 
formation of conjugated hydrogels has been achieved with a simple dipeptide. One 
such reported hydrogel was constituted using an Fmoc-dipeptide appended to a 
naphthalene diimide semiconductor  as shown in Figure 1.6).15  
 
 
Figure 1.6  Self-assembly of an Fmoc-Lys-Lys dipeptide naphthalene diimide 
semiconductor: (a) Self-assembly in water produces a hydrogel from a network of 
nanobelts; (b) Key molecular structural aspects, (inset: photo of hydrogel formed at 
1.5 wt%); (c) TEM image (negatively stained) of hydrogel fibers (scale bar = 100 
nm); (d) AFM image (tapping mode), showing segments with regular height. 
(Figure adapted for review from  Shao et al.15 with permission from RSC.) 
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The hydrogel in Figure 1.6 was found to be composed of uniform micrometer-sized 
nanobelts (Figure 1.6c,d). The model proposed for the nanobelts based on the data 
collected (Figure 1.6a) suggested an interior structure with a significant extent of π-
π interactions. Notably, these results were achieved simply by the inclusion of a 
dipeptide as a moiety within the rational design for the material (Figure 1.6b). 
 
Longer peptides may also be used effectively to prompt chromophore self-assembly, 
resulting in additional chromophore interactions that impact the expressed 
photophysics. The use of peptide self-assembly to modify fluorophore photophysics 
has been demonstrated by a peptide (amino acid residues 105-115 from the protein 
transthyretin) functionalized with a fluorene moiety (Figure 1.7a),24 wherein 
peptide β–sheet formation was found to coordinate the fluorene moieties into an 
ordered π-stacking arrangement (Figure 1.7b) which altered the photophysical 
response of the fluorene fluorophores. 
 
 
Figure 1.7  Self-assembly of a peptide-fluorophore conjugate: (a) Peptide 
sequence with appended fluorophore; (b) Peptide self-assembly into stacked β–
sheets orients the attached fluorene fluorophore into an ordered π-stacking 
arrangement; (c) TEM image of fibrils resulting from self-assembly (scale bar = 500 
nm); (d) Wide-angle X-ray fiber diffraction pattern of a partially aligned, dried stalk 
produced from the compound gel. (Figure adapted for review from Channon et al.24 
with permission from ACS.) 
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Transmission electron microscopy (TEM) imaging of the gel found it to contain an 
array of self-assembled fibrils throughout (Figure 1.7c), and a dried stalk produced 
from the gel was also found to produce an X-ray diffraction pattern (Figure 1.7d). 
Beyond the self-assembly demonstrated by this system, the study also highlights the 
opportunity to use self-assembly as a means to tune the photophysical response 
from a moiety of interest. 
 
In a similar scheme, but using an alternating glycine-alanine peptide sequence 
inspired by silk (such as in spider silk26), an oligo(p-phenylenevinylene)-peptide 
(OPV-peptide) conjugate was produced for a self-assembly study (shown in Figure 
1.8).27 The alternating GAGAG motif of the peptide sequence used (which is 
common in silk) has been shown to be important in β-sheet formation, and was 
found to behave in a similar fashion in the self-assembly of the OPV-peptide 
conjugate material. 
 
 
Figure 1.8  (a) Illustration of the hydrogen-bonding anti-parallel peptide β-sheet 
formation leading to the self-assembly of a peptide-substituted π-functional moiety. 
(b, c) STM images of the self-assembled architectures of the compound shown in 
panel (a). (d) Magnified view of image from panel (c) with a superimposed 
molecular model. (Figure adapted for review from Matmour et al.27 with 
permission from ACS) 
13 
 
The β-sheets formed by the extensive hydrogen-bonding of the peptide (depicted in 
Figure 1.8a) provided an organizing influence leading to ordered assemblies of 
OPV-peptide stacks and lamellar-like domains within the material as shown in the 
scanning tunneling microscopy (STM) image in Figure 1.8b,c. The order achieved 
in the material (as evidenced by the STM images) was of sufficient quality to 
propose a model for the self-assembled, stacked arrays as shown in Figure 1.8d. 
 
The structural design of the OPV-peptides shown in Figure 1.8 immediately signals 
the potential for a modular, analogous approach of applying a similar design using 
various other chromophores which might be targeted for self-assembly. Moreover, 
these reported OPV-peptide structures also underscore the underexplored potential 
of other peptide sequences. In fact, the silk peptide motif applied in the OPV-
peptide study is only one of many potential natural motifs which may be 
advantageously applied in self-assembly. 
 
Yet peptides can offer more than simply enhancing self-assembly. Peptide-driven 
hierarchical self-assembly can also impact other material aspects such as 
thermomechanical properties. A study conducted by Croisier et al. reported a 
mixture of oligopeptide-terminated polymers of different lengths, in which the 
oligopeptide-polymer strands selectively self-assembled into small aggregates and 
nanofibrils in a length-dependent, self-sorting manner, resulting in a self-assembled 
bulk material with intermingled, distinctive nanostructural domains together 
yielding elastomeric character.28 Moreover, the thermomechanical properties of the 
bulk material were observed to vary with the oligopeptide-polymer structures and 
blend ratios. Accordingly, adjusting the oligopeptide-polymer structure and blend 
to alter the relative numbers of cross-linking, hydrogen-bonding aggregates, single 
β-sheet tapes, and stacked β-sheet nanofibrils formed during self-assembly, yielded 
elastomers which could be tailored to express a broad range of thermomechanical 
properties. Illustrations for this material approach are shown in Figure 1.9. The 
material structural dynamic in these elastomers is reminiscent or natural systems 
such as silk, wherein the mechanical traits of various types of silk arise from the 
combined contributions of three types of nanostructural domains:28 (1) well-ordered 
β-sheet nanofibrils (for reinforcement),29,30 (2) short β-sheet tapes (aiding energy 
dissipation during stretching),29,31–33 and (3) amorphous regions (for elasticity).30,34 
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Figure 1.9    Schematic illustration of the selective self-assembly and self-sorting co-
assembly processes for oligopeptide-polymer strands. Depending on the 
oligopeptide length, compounds M0–M5 (n=0–5; x≈20) and the corresponding 
derivatives D0–D5 (n=0–5; x≈20) self-organize into (a) small H-bonded aggregates 
or (b) stacked β-sheet fibrils, accompanied by single β-sheet tapes. Coexistence of 
these nanostructures in blends of molecules with different oligopeptide termini 
results in (c) inherently reinforced thermoplastic elastomers, or (d) interpenetrating 
supramolecular networks. (Figure adapted for review from Croisier et al.28 with 
permission from NPG.) 
The selected examples discussed in this section (and the references noted) 
underscore the versatility and diverse potential of peptides for application in 
supramolecular self-assembly. Peptides themselves are highly prone to self-
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assembly and may be appended to other moieties to drive or guide the formation of 
nano-architectures of those moieties. Peptides offer an array of variations which 
can be used to tune material responses as expressed in both the Nano architectural 
form assembled and, by extension, in the optical properties observed. Yet whether 
alone or appended to a chromophore, peptides themselves remain highly responsive 
to the solvent environment experienced. Accordingly, this quality may be invoked 
through solution media changes to trigger nanostructure formation or to prompt 
nanostructural rearrangements, adding yet another layer to the use of peptides as 
agents of self-assembly. The selected examples discussed in this section (and the 
references noted) underscore the versatility and diverse potential of peptides for 
application in supramolecular self-assembly. Peptides themselves are highly prone 
to self-assembly and may be appended to other moieties to drive or guide the 
formation of nano-architectures of those moieties. Peptides offer an array of 
variations which can be used to tune material responses as expressed in both the 
Nano architectural form assembled and, by extension, in the optical properties 
observed. Yet whether alone or appended to a chromophore, peptides themselves 
remain highly responsive to the solvent environment experienced. Accordingly, this 
quality may be invoked through solution media changes to trigger nanostructure 
formation or to prompt nanostructural rearrangements, adding yet another layer to 
the use of peptides as agents of self-assembly. 
1.6 Why Perylene Imides? 
Perylene imides have attracted considerable attention as organic semiconducting 
materials since these compounds exhibit good n-type properties when 
functionalized as diimides or dianhydrides.35 The high electron affinity of perylene 
diimides makes these molecules among the best n-type organic semiconductors 
known.36–38 Perylene diimides also have a high fluorescence quantum yield and 
photostability,39 making them some of the best fluorophores for single molecule 
spectroscopy with a quantum yield often near unity.40,41 The stability and unique 
properties of perylene imides and perylene derivatives have led to the exploration of 
perylene imides in numerous applications including pigments (paint, automotive 
coatings, etc.), organic field effect transistors, xerographic photoreceptors and 
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photovoltaics, fluorescent dyes, laser dyes, fluorescent light collectors, and light-
induced energy and electron transfer processes.3,39  
 
Extending from the interest in capitalizing on the properties of perylene imides, a 
multitude of studies have been reported related to the self-assembly and application 
of perylene imide nanostructures. The extensive, reported variety of self-assembled 
perylene imide nano-architectures include: conductive nanofibers,42,43 
photofunctional supramolecular fibers,44 long polymer fibers built upon 
polyisocyanide scaffolds,45 semiconducting columnar assemblies,46,47 light-
harvesting crystalline nanosheets,48 chiral helical assemblies,49 chiral lactose-
functionalized, multivalent glycoclusters,50 fluorescent, thermotropic columnar 
mesophases,51 hairpin linkers or end-capping groups for DNA duplexes used in 
DNA photonics,52 and DNA-based oligomeric stacks.53,54 In order to give an 
appropriate research context and to provide illustrations, selected examples of 
reported perylene diimides (PDIs) and their applications will be highlighted here 
with an emphasis toward organic electronic aspects. 
 
Due to the highly fluorescent nature of the PDI chromophore, PDIs are often used 
as emitters for spectroscopy. The fluorescence spectra of PDIs often resemble a 
mirror image of the vibronically-structured absorbance band of an isolated, 
monomeric chromophore which exhibits three distinct vibronic peaks within the 
band; however, concentration effects can impact the observed spectral profiles (as 
seen in Figure 1.10). This effect is caused by a strong tendency of the PDI units to 
aggregate (co-facially π-stack) in solution, which is intensified as concentration 
increases. Upon aggregation, the distinctive vibronic peaks of the absorption band 
redistribute in position and intensity (Figure 1.10a), and the corresponding 
fluorescence emission spectral profiles lose vibronic structure and shift position to 
longer wavelengths (as seen in Figure 1.10b). 
 
It is important to note here that this tendency of PDIs toward self-aggregation and 
the subsequent changes observed in the spectral profiles can together be exploited to 
invoke, detect, and monitor PDI self-assembly. The shift in the fluorescence band 
with increasing concentration also highlights the potential value of this for tuning 
PDI material properties through self-assembly. More immediately, the prospect of 
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tuning fluorescent emission via concentration is also evident; however, for many 
PDI compounds, the strongly aggregating tendency of PDIs leads to poor solubility 
which prevents achieving the range of concentration required to observe 
concentration-dependent effects like those exemplified in Figure 1.10.          
 
Figure 1.10    (a) Concentration-dependent UV-vis absorption spectra of a dialkyl 
PDI (2.0×10−7 to 1.0×10−3 M) in methylcyclohexane (MCH). Arrows indicate 
spectral changes upon increasing concentration. Blue line: UV-vis spectrum of a 
spin-coated film of the PDI after annealing at 150 °C for 3 h. (b) Normalized 
concentration-dependent fluorescence spectra (excitation at 469 nm) of the PDI 
(2.1×10−7 to 2.1×10−4 M) in MCH solution and of a spin-coated thin film (blue line). 
Inset: Color photographs of MCH solutions of the PDI with increasing 
concentration (left to right) and a thin film. Red lines indicate spectra for a 
concentrated 1.0×10−3 M solution.  (Figure adapted for review from Chen et al.55 
with permission of Wiley-VCH.) 
One such example which utilized self-assembly of a PDI material to achieve 
desirable fluorescent properties potentially suitable for application in a solid-state 
red light emitter was reported by Refiker and Icil (Figure 1.11).56 Chiral imide 
substituents (selected to impart tunable chiral amphiphilicity to the overall 
molecule) achieved controlled PDI self-assembly through intermolecular hydrogen-
bonding. This hydrogen-bonding was found to impact the fluorescent properties of 
the material, causing the excited state of the chiral dye to decay in the solid-state 
exclusively by fluorescing red light.56 Accordingly, the material has been proposed 
for use in solid-state lighting technologies and solid-state dye-sensitized solar cells.56 
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Figure 1.11     Chiral amphiphilic LPPDI dye with potential for solid-state lighting 
technologies: (a) Chemical structure of the dye; (b) Absorption and emission 
spectra of LPPDI in solid-state and chloroform (excitation wavelength = 485 nm). 
(Figure adapted for review from Refiker and Icil.56 with permission from Tübitak.)  
Changes in PDI fluorescence can also be used in fluorescence sensing, as shown in 
the example in Figure 1.12.57 For this system, a PDI sensing agent was synthesized 
with imide substituents capable of forming complexes with metal ions (Figure 
1.12a). Upon complexation, photoinduced electron transfer could occur, prompting 
enhanced fluorescent emission with particularly distinctive responses observed for 
Cu+2 and Fe+3 (Figure 1.12b), highlighting a responsive selectivity for those ions.   
 
Figure 1.12    Fluorescence sensing based on photoinduced electron transfer using 
a novel perylene diimide sensing agent: (a) PDI fluorescence sensing compound 
structure; (b) Effect of the metal cations (2 μM concentrations) on the fluorescence 
of PDI sensing agent (1 μM concentration) in DMF solution. (Figure adapted for 
review from Giorgiev et al.57 with permission from Elsevier.)  
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A more qualitative example of fluorescence sensing reported for the detection of 
organic compounds is seen in Figure 1.13.58 Here, a PDI cyclophane (Figure 1.13a) 
is employed as the fluorescence sensing agent by utilizing host-guest interactions 
with other smaller  aromatic  molecules  to  be detected.  In this scheme, the smaller 
organic molecules are drawn to π-stack as guests within the PDI cyclophane host 
cavity. 
 
Figure 1.13      PDI Cyclophane host-guest interactions: (a) PDI cyclophane 
chemical structure; (b) Schematic illustration of the fluorescence “turn-on” and 
“turn-off” process of PDI cyclophane upon complexation with electron-poor and 
electron-rich aromatic guests (top) with the respective photographs; (c) A plot of the 
fluorescence quantum yields of the host-guest complexes. (Inset) A schematic 
illustration for the fluorescence quenching mechanism via charge transfer (CT) 
from electron-rich guests. Structures of selected electron-poor (red) and electron-
rich (blue) guest molecules are shown. (Figure adapted for review from Spenst and 
Würthner.58 with permission from Wiley-VCH.)  
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Formation of the host-guest complex with an electron-poor aromatic molecule 
results in a high increase in fluorescence and “turns on” the PDI cyclophane; 
whereas formation of the host-guest complex with an electron-rich aromatic 
molecule quenches fluorescence and “turns off” the PDI cyclophane (Figure 
1.13b,c). This on/off response by the PDI cyclophane which permits distinguishing 
between electron-poor and electron-rich aromatic guest molecules can be explained 
by charge transfer. The electron-withdrawing imide substituents on the perylene 
cores of the PDI units produce an electron-deficient character. If guest molecules 
with a similar electron-deficient character reside in the host-guest complex, the 
electron deficient nature of the PDI core is enhanced and promotes fluorescence. 
Conversely, electron-rich guest molecules can provide charge transfer to the 
electron-deficient PDI core which quenches the fluorescence (Figure 1.13c). 
 
Beyond fluorescence characteristics, the hydrogen-bonding and π-stacking 
aggregation behaviors noted for the fluorescent dye in Figure 1.11 have been 
exploited to form self-assembled fibers and gels comprised of PDI stacks as 
illustrated in Figure 1.14. Here, hydrogen-bonding orientationally directs the 
inherent π-stacking behavior of the perylene cores within each PDI monomer unit, 
thus producing a helical stacked assembly propagated in one dimension. 
 
 
Figure 1.14    (a) Concept for self-assembly of PDI F114 supported by side-chain 
amide-amide hydrogen-bonding interactions. The dodecyl groups are simplified as 
R. Right part depicts a schematic representation of face-to-face stacks of 
rotationally displaced PDI cores. (b) Toluene organogel of F114 formed at 1.5 mM. 
(c) AFM height image of an aggregate sample spin-coated from diluted gel solution 
of F114 in toluene onto mica; scale bar = 200 nm. (Figure adapted for review from 
Li et al.59 with permission from RSC.)  
F114 
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Alternatively, helical π-stacked PDI assemblies have been formed using polymer 
scaffolds such as polyisocyanide (as shown in Figure 1.15). Using this approach, 
the structural order of the underlying scaffold directs the assembly of the individual 
PDI units. For the example in Figure 1.15, the ordered, helical structure of the 
polyisocyanide is functionalized with amino acid linkers (Figure 1.15b) which serve 
as hydrogen-bonding tethers for the PDI units (Figure 1.15a) and prompt PDI 
assembly into a four-strand, helical array (Figure 1.15c). Using this material as an 
organic semiconductor blended with polymers such as poly(3-hexylthiophene) 
(P3HT), organic photovoltaic devices60–63 were successfully fabricated, displaying 
photocurrent and voltage bias output such as that shown in the plot in Figure 1.15d. 
 
 
Figure 1.15    (a) Molecular structure of PDI-substituted polyisocyanide F115. (b) 
Illustration of the hydrogen-bonding between the nth and (n + 4)th monomeric units 
within the polymer. (c) Cartoon showing the complete helical structure. The dashed 
arrow indicates a stack of PDI units running along the central polyisocyanide 
backbone. (d) Semi-logarithmic J–V plots in darkness (blue) and under illumination 
(red) for a 1:1 P3HT/F115 photovoltaic cell. (Figure adapted for review from 
Palermo et al.63 with permission from ACS.)  
F115 
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Other PDI photovoltaic devices have been reported which do not use the scaffold 
approach of Figure 1.15. Instead, a PDI organogelator which forms nanowires 
during gelation (such as F116 in Figure 1.16a) can be blended with a suitable 
conducting polymer (such as pvDMTPD) and used to fabricate a photovoltaic 
device (as illustrated in Figure 1.16b) with output shown in Figure 1.16c. 
 
 
 
Figure 1.16    (a) Molecular structures of PDI F116 and pvDMTPD. (b) Device 
architecture with inverted cell configuration. FTO=fluorine-doped tin oxide, 
PEDOT=poly(3,4-ethylenedioxythiophene), PSS=poly(styrene sulfonate). (c) J–V 
plots under illumination with white light (AM 1.5 spectral conditions, 100 mW 
cm−2) for photovoltaic devices constructed from a PDI xerogel/pvDMTPD blend 
with an additional pvDMTPD layer. The compositions for the devices B1, B2, and 
B3 are 3:1, 1:1 and 1:3 (PDI:pvDMTPD wt%), respectively. (Figure adapted for 
review from Wicklein et al.64 with permission from ACS.)  
PDIs which self-assemble (but are not organogelators) have also been used to 
fabricate devices. One such example is shown in Figure 1.16 which shows the 
fabrication of an organic inverter device consisting of two organic field-effect 
transistors made from self-assembled nanowires. For this device, nanowires of 
N,N'-dioctyl perylene diimide (F117) were grown by carefully layering a volume of 
methanol onto an aliquot of a chloroform solution of F117 (monomers) without 
mixing the layers. Over the course of 25-30 minutes, mixing of the methanol and 
F116 
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chloroform layers by diffusion induced self-assembly of the monomers into 
nanowires (Figure 1.17a). The resulting nanowires were then applied across pre-
fabricated gold electrode junctions (Figure 1.17b) arrayed in an interdigitated 
fashion on top of a doped silicon wafer with silicon dioxide dielectric layer (Figure 
1.17c). For the device, PDI F117 served as an n-type material (electrons generated 
as charge carriers), while hexathiapentacene (applied in similar fashion to F117) 
served as a p-type material (electron vacancies generated as charge carriers). 
Together the joint n-type and p-type transistors formed the inverter device (Figure 
1.17c) with output characteristics as shown in Figure 1.17d.     
 
 
Figure 1.17    (a) A series of optical photographs detailing the interfacial self-
assembly of PDI F117 nanostructures. The top layer of the vial is methanol, and 
bottom layer is F117 dissolved in chloroform (~1.5 mg/mL). The last picture frame 
illustrates a 500 mL flask containing a large quantity of PDI F117 nanowires that 
were also synthesized in ~25 min. (b) A colorized SEM image of a network of PDI 
F117 nanowires drop-cast across the gold electrodes from a methanol suspension. 
(c) Schematic of an inverter with p- and n-type nanowire networks covering 
interdigitated source-drain electrodes. (d) Output characteristics of field-effect 
transistors fabricated from nanowires of n-type PDI F117 (red) and p-type 
hexathiapentacene (green). (Figure adapted for review from Briseno et al.65 with 
permission from ACS.)  
F117 
R = C8H17 
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For each of the examples highlighted in this section, self-assembly and/or 
morphology play a crucial role in the PDI material application. Often, 
manipulation of the solvent environment for a PDI solution is used to invoke 
solvophobic/solvophilic interactions to trigger and drive self-assembly. For many 
perylene imides, low solubility is a common feature, which introduces solution 
concentration limitations and may complicate material processing, but these 
potential limitations can be mediated through the selection of appended 
substituents. Moreover, the strong aggregation and solvophobic characteristics 
associated with the low solubility of many PDI compounds, can, in fact, provide an 
enhanced robustness to self-assembled perylene imide nanostructures.10 The 
interplay between solvophobic and solvophilic interactions modulated 
appropriately by suitable perylene imide substituents can yield compounds such as 
stimuli-responsive perylene imide gels that are responsive to changes in ionic 
charging, solvent environment, and temperature.66 Consequently, the innately low 
solubility of many perylene imides joined in tandem with appropriate substituents 
can become an advantageously solvent-responsive trait impacting self-assembly and 
its associated morphology.67,68 
 
With regard to the possibility of achieving tunable, responsive self-assembly and 
morphology from perylene imide compounds by balancing the influences from the 
perylene core and its substituents, a highly illustrative example was reported from a 
study by Zhang and co-workers.68 In the study, a detailed evaluation of 
morphological controls was examined based on fine-tuning the secondary forces 
acting upon an amphiphilic perylene imide compound (Figure 1.18a). The sensitive 
and nuanced response to the solvent environment by the compound yielded a 
variety of distinctive morphological outcomes (Figure 1.18b,c) and permitted the 
construction of phase diagrams for the compound in the solvent systems examined 
(Figure 1.18b,c and Figure 1.19). As seen from Figure 1.18, both the acidic and the 
acid-free solvent environments induce a morphological response in the perylene 
imide dye. In the acid-free solvent series, solvophobic/solvophilic influences are 
primarily driving the changes observed in the morphology. In the acidic solvent 
series, however, acid-base ionization interactions are at work in addition to the 
solvophobic/solvophilic influences.  
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Figure 1.18  SEM/TEM images showing changes in self-assembled nanostructure 
morphology of a perylene diimide dye: (a) Dynamic protonation among dyes 
F118a, F118b, and F118c; (b,c) The 1D phase diagram shows morphologies 
formed either from (b) proton-free dye F118a or (c) from doubly protonated dye 
F118c equilibrating with mono-protonated dye F118b and F118a at [HCl] = 0.03 M 
controlled by the volume fraction of water (Rw), where Rw = Vwater/(Vwater+Vmethanol). 
For all samples, [dye] = 1×10
−3
 M. Unlabeled scale bars = 2 μm. (Figure adapted 
for review from Zhang et al.68 with permission from Wiley-VCH.) 
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Figure 1.19  The 2D phase diagram showing the various self-assembled 
nanostructures formed by the interplay of dyes F118a, F118b, and/or F118c (from 
Figure 1.18), where the volume fraction of water (Rw) and [HCl] both control the 
morphological transitions. Open plot shapes represent the starting concentration of 
hydrochloric acid and the transformation from one morphology to the binary 
mesophases. The filled plot shapes represent the final acid concentration and the 
transition from the binary phases to the single phase again. Panel (b) is an enlarged 
view of panel (a) for [HCl] = 0 to 0.9 M. (Figure adapted for review from Zhang et 
al.68 with permission from Wiley-VCH.) 
As seen from Figure 1.18 and Figure 1.19, multiple influences in the solvent 
environment can impact the self-assembly and morphology of perylene imide 
compounds. When it is possible to independently adjust these various influences, 
they may be advantageously tailored as a part of the morphological tuning. Thus, 
perylene imide compounds are attractive candidates for supramolecular material 
design for three principal reasons. First, they have desirable electronic properties. 
Second, their strong solvophobic/solvophilic responses to the solvent environment 
may be utilized to enhance the robustness of the nanostructures formed. Third, the 
morphology of their self-assembly can be tuned through substituent and solvent 
environment selections. Accordingly, appropriate selection of the substituent 
moieties employed for these interactions is underscored here. 
(a) (b) 
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1.7 Why Peptides and Perylene Imides Together? 
Peptides and perylene imides each demonstrate respective innate tendencies to self-
assemble. By the simple means of hydrogen-bonding, peptides exhibit a diversity of 
self-assembly outcomes, which display strong, innate, versatile, sequence-
dependent, and functional behavior (as discussed in Section 1.5). Likewise, by 
simply π-stacking, perylene imides form a variety of self-assembled morphologies 
which yield a diverse expression of the desirable optoelectronic properties which 
these compounds possess (as discussed in Section 1.6). For both peptides and 
perylene imides, the orientational aspects of the self-assembled architectures impact 
the properties expressed. Accordingly, joining the perylene imide and peptide 
moieties together into a single molecular unit holds promise of a synthesis of self-
assembly characteristics toward advantageous nano-architectures. 
 
Since peptides are comprised of amino acids, an initial examination of amino acids 
as N-substituents for perylene imides provides an appropriate beginning in the 
consideration of peptides as N-substituents. A recent review of amino acid 
derivatized arylenediimides, which covered both naphthalene diimides (NDIs) and 
perylene diimides, has highlighted numerous arylenediimides with amino acid N-
substituents.69 Although NDIs have important differences to PDIs, the two groups 
do share some similarities; therefore, amino acid derivatized NDIs may be 
instructive to PDIs. Many NDIs with amino acid N-substituents expressing 
fascinating self-assembling outcomes have been studied.69 Among the reported 
nano-architectures are: nanospheres, particles, nanobelts, fibers, and fractals 
assembled from tryptophan-appended NDIs architectures,70 highly crystalline 
nanosheets with large lateral dimensions assembled from enantiomers of 
phenylalanine methyl ester appended NDIs,71 cylindrical microstructures assembled 
from bolaamphiphiles constructed with a hydrophobic core of NDI and hydrophilic 
ends of glycine or β-alanine,72 and encapsulation of single-walled carbon nanotubes 
(via surface functionalization) by self-assembled stacks of (L-4-iodophenylalanine) 
derivatized NDI.73 Likewise, PDIs with amino acid N-substituents have also shown 
good self-assembly behavior and a few examples are worth noting. As shown in 
Figure 1.20, a tetrachloroperylene diimide with carboxybenzyl-protected L-lysine 
N-substituents (Figure 1.20a) has been reported which exhibited concentration-
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dependent self-assembly outcomes.74 As the concentration was increased prior to 
self-assembly, the resulting nanostructures transitioned from nanowires (Figure 
1.20c), to nanobelts (Figure 1.20d), to nanosheets (Figure 1.20e), and then to 
nanotubes (Figure 1.20f), leading to the proposal of the self-assembly pathway 
shown in Figure 1.20b.   
 
 
Figure 1.20   (a) Chemical structure of tetrachloroperylene diimide F120 with 
carboxybenzyl-protected L-lysine N-substituents. (b) Proposed self-assembly 
pathway for PDI F120 toward different nanostructures. (c-f) SEM images of 
nanostructures assembled from PDI F120 in 45% H2O/acetone mixture at different 
concentration: (c) 100 μM, (d) 300 μM, (e) 800 μM, and (f) 1 mM. (Figure adapted 
for review from Sun et al.74 with permission from ACS.)  
Resulting from fibrous nanostructural formations, other PDIs with amino acid N-
substituents have been found to be organogelators, including PDIs with N-
substituents of alanine, histidine, phenylalanine, and valine.75 Gels have also been 
demonstrated using tryptophan.76 Of particular interest among the PDIs gels are 
those which show photoconductivity. One notable example of this is the alanine 
PDI derivative F121, which is shown in Figure 1.21, wherein a gel of F121 (Figure 
1.21a) is formed from a solution of F121. The gel and the solution were deposited 
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(Figure 1.21e,f) and were both found to be air-stable and photoconductive films.  
This was further supported by indications following irradiation of the deposited 
samples with 365 nm light.  Upon irradiation,  the samples changed color and  then  
 
 
 
Figure 1.21   (a) Photograph of a gel formed on acidification of a solution of 
N,N'-dialaninyl PDI F121 (5 mg/mL). (b) SEM image of structures formed on 
drying the gel. (c) Photograph of a solution of PDI F121 (5 mg/mL) at pH 10. (d) 
SEM image of structures formed on drying the solution. (e) On irradiation with 365 
nm light, a xerogel of PDI F121 (left) changes color (middle). After the light is 
turned off, the original color slowly returns (right), photograph after 18 hours. (f) A 
similar effect is observed for the dried solution. (g) UV-Vis-NIR spectra for a 
xerogel of PDI F121 (—), and for the same film 1 minute after irradiation with 365 
nm light (- - -). (h) UV-Vis-NIR spectra for a dried solution of PDI F121 (—), and 
for the same film 1 minute after irradiation with 365 nm light (- - -). (Figures 
adapted for review from Draper et al.75 with permission from RSC.)  
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slowly returned to the original color over several hours (Figure 1.21e,f). 
Spectroscopic investigations of color this transition indicated spectral features 
consistent with the formation of the radical anion and the dianion PDI species 
within the samples upon irradiation with the 365 nm light (Figure 1.21g,h).75 
 
Another gel formed by a N-substituted PDI coupled with tryptophan (via the 
primary amino end) was also found to be photoconductive (as shown in Figure 
1.22).76 For this compound, current on the microamp scale was observed upon 
irradiation with both visible and white light (Figure 1.22a). Clear evidence of 
photo-switching can be seen in the current over time as the light source is turned on 
and off (Figure 1.22b). Similar results with photo-switching behavior were seen for 
a gel made from a bolaamphiphile amino acid comprised of a tyrosine moiety 
tethered to the PDI core by a hydrophobic 11-carbon alkyl linker.77 
 
 
Figure 1.22   (a) Plots of I–V curves of a simple conductor device made of N,N'-
dityrosinyl PDI xerogel in darkness (purple line), visible light (orange line), and 
white light (blue line). Inset: A schematic representation of the layout of the circuit 
diagram for I–V measurements. (b) Transient photo-response by turning on/off 
white light illumination of a representative conductor device made of the N,N'-
dityrosinyl PDI xerogel. (Figures adapted for review from Roy et al.76 with 
permission from RSC.)  
Following from the examples of good self-assembly and gel formation observed for 
PDI compounds employing single amino acids as imide substituents, an 
examination of longer peptide segments is of interest. Accordingly, since peptides 
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with two amino acid residues are the next step in size from single amino acids, the 
peptide-PDIs in Figure 1.23 merit consideration. For these compounds, the 
peptides form a glycine link to the perylene core which then connects to either a 
tyrosine or an aspartic acid residue. Both compounds were found to be gelators, but 
 
Figure 1.23   (a) Self-assembly of PDI-[GY]2 and PDI-[GD]2 to chiral fibrous and 
spherical structures in different polar solvents: PDI-[GY]2 forms fibers in buffer 
solution (pH 10.8), DMSO, DMF, THF, and acetone. PDI-[GD]2 forms fibers in 
DMF and spheres in water and DMSO. Inset photographs are PDI-[GY]2 gels in 
buffer solution (pH 10.8) and DMF, solutions in DMSO, acetone, and THF. PDI-
[GD]2 gels in DMF and DMSO, and solution in buffer solution (pH 10.8). (b) AFM 
images of structures of PDI-[GY]2 assembled in DMSO, DMF, THF, and acetone 
at a concentration of 1×10−4 M. All scale bars = 500 nm. Insets are optical 
photographs showing the different fluorescence emissions of PDI-[GY]2 in DMSO, 
DMF, THF, and acetone under a UV lamp (365 nm) at the same concentration. 
(Figures adapted for review from Bai et al.78 with permission from ACS.)  
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both compounds were also seen to be highly sensitive to the solvent environment. 
This sensitivity was seen to prompt different modes of self-assembly in different 
solvents which was evidenced both by the different nanostructures obtained from 
the solutions (Figure 1.23b) as well as by the corresponding change in the 
fluorescence emission observed (at the same concentration) from the solutions. 
 
Given the solvent-responsiveness invoked by the short peptide substituents used for 
the compounds in Figure 1.23, peptide of even greater length may hold further 
possibilities for tuning self-assembly. Longer peptide segments provide an extended 
hydrogen-bonding interface via the accompanying longer polyamide backbone. The 
added residue positions also increase the capacity for additional combined 
structural functionalities. Moreover, longer peptides allow for the formation of 
interface-type segments (like those found in proteins) in which factors such as the 
segment size, the charge, and the overall interface shape, etc., can be relevant in 
ways not applicable to shorter peptides or to single amino acids. 
 
Given the need for appropriately balanced substituent influences to modulate 
perylene imide morphology (as demonstrated in Figures 1.18, 1.23), highly tunable 
substituents (such as longer peptides) may hold added value for modulating the 
supramolecular self-assembly of perylene imide compounds. As an example of this, 
research published by Gallaher, et al.79 has described the development of peptide-
substituted perylene diimides (peptide-PDIs) using longer peptides and has reported 
many characteristics of these compounds and their aggregates. The published 
spectroscopy from the study demonstrated that the peptide-PDIs form aggregates as 
a result of competing hydrophobic/hydrophilic interactions between the peptide 
substituents and the perylene core (Figure 1.24a), making the peptide-PDIs very 
sensitive to the solvent environment and readily influenced by solvent composition 
(Figure 1.24b). The peptide substituents employed (which were comprised of 5-7 
amino acid residues containing a glycine linking unit, three central hydrophobic 
alanine or leucine residues, and 1-3 terminal hydrophilic glutamic acid residues) 
elucidated several properties which could be exploited to tune the PDIs. Firstly, the 
ionizable glutamic acid residues in the peptide sequences were seen to provide 
sensitivity to pH, allowing pH-triggered aggregation and the exploitation of 
electrostatic interactions to adjust the orientation of PDI monomers in aggregation 
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(Figure 1.24c,d). Secondly, the charged glutamic acid residues were seen to act as 
ligands toward metal cations, providing modulation of the orientation of PDI 
monomers in aggregation via cation binding or charge screening (Figure  1.24c,d).   
  
 
Figure 1.24  A composite of selected results for peptide-PDIs: (a) UV-vis spectra 
of a monomeric reference dialkyl-PDI and two peptide-PDIs in selected solvents 
with the vibronic peaks labeled. The inset shows the CD spectrum of the N,N'-di[-
Gly-(Ala)3-(Glu)3]PDI. (b) UV-vis spectra of the N,N'-di[-Gly-(Ala)3-(Glu)3]PDI in 
varying water/acetonitrile solvent compositions. (c) A plot of the    0-1/0-0 vibronic 
absorption peak ratio versus ionic strength of various salts in aqueous solutions for 
the N,N'-di[-Gly-(Ala)3-(Glu)3]PDI. The inset shows spectra of the same solutions 
(salt ionic strength = 6.8 × 10−4 M), as well as the spectra of the N,N'-di[-Gly-(Ala)3-
(Glu)3]PDI in water and in DMSO (without salt) for comparison. (d) Models 
showing transitions in the relative orientations of the N,N'-di[-Gly-(Ala)3-
(Glu)3]PDI monomers in an aggregate upon (i) moving from CH3CN to a 
CH3CN/H2O mix, (ii) changing solvent composition to a high water content, and 
(iii) adding cross-linking dications. (Figure adapted for review from Gallaher et al.79 
with permission from RSC.) 
(a) (b) 
(c) (d) 
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Thirdly, the three central hydrophobic amino acid residues were found to impart 
chirality to the supramolecular structure of the aggregates formed (suggesting helix 
formation) as indicated by circular dichroism (CD) spectroscopy (inset Figure 
1.24a). These results spectroscopically demonstrate the use of longer peptides to 
easily modulate the self-assembly of PDIs through small changes in the solvent 
environment. In later research conducted by Marty et al.,80 a hybrid peptide-PDI 
system was investigated in which the perylene imide substituent consisted of a -Gly-
(Ala)4 peptide with a 19-mer polyisobutylene polymer appended to the peptide’s 
carboxyl terminus (Figure 1.25a).  Like the system reported  by Gallaher  et al.,  the  
 
 
Figure 1.25  Self-assembly of oligo(L-alanine)-poly(isobutylene)-substituted 
PDI: (a) Molecular structure of the compound; (b) Synergistic aggregation 
enhanced by  β-sheet-like hydrogen-bonding (of the oligopeptide segments) and π-π 
stacking (of the central chromophores); (c) Molecular chirality and polymer 
attachment suppress lateral aggregation in solution, giving curled (helical) or 
twisted tapes formed from single stacks of the chromophores; (d) Hierarchically 
structured microfibers comprised of highly aligned arrays of the randomly close-
packed nanofibrils with helical grooves filled by collapsed, appended polymer; (e,f) 
AFM height and phase images (respectively) showing the formation long single 
nanofibrils; (g,h) SEM images of microfibers comprised of highly aligned 
microfibrils constituted of smaller protofibrils. (Figure adapted for review from 
Marty et al.80 with permission from ACS.) 
(a) 
(b) (c) (d) 
(e) (g) (h) (f) 
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hybrid peptide-PDI reported by Marty et al. exhibited spectral profiles consistent 
with self-assembly induced by the solvent environment. Likewise, the CD spectra 
also were consistent with that of chiral assemblies. Additionally, the system studied 
by Marty et al. was verified by microscopy methods to form helical fibers or twisted 
tapes (Figure 1.25e-h) supporting the expectations for the system studied by 
Gallaher et al. 
1.8 Focus of This Study 
Being informed by the numerous aforementioned studies employing amino acids 
and peptides for self-assembly, and arising from pioneering work with peptide-PDIs 
reported by Gallaher, et al. and the subsequent work by Marty, et al., this study 
seeks to further investigate several aspects related to the self-assembly of peptide-
PDI systems. These aspects may be broadly grouped into three overarching queries: 
(1) What is the impact of specific peptide structural changes on the self-assembly of 
peptide-PDIs? (2) What impact do peptide chiral centers (and their relative 
positions) within longer peptides have on the self-assembly of peptide-PDIs and 
their material function? (3) Can peptide-PDI systems — particularly those involving 
natural peptide sequences — be applied to advantageously assemble organic 
semiconductors within organic electronic devices?  
 
While peptides have been shown to successfully aid in self-assembly, a limited 
quantitative understanding of the balance of competing aggregation forces has 
thwarted efforts to deterministically encode assembly of electronically active units 
via peptide sequences. This study achieves a systematic investigation of how 
specific modifications to short (4-7 residue) peptide sequences affect the binding 
thermodynamics of peptide-PDI molecules toward an understanding of rational 
design principles. 
 
Peptide stereocenters have been shown to impart a chiral sense to the 
supramolecular architectures formed by several reported systems, but how does this 
chiral sense impact material performance? While no difference in material 
performance would be anticipated between supramolecular assemblies resulting 
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from enantiomers, what impact (if any) might be seen in supramolecular assemblies 
resulting from diastereomers generated from selectively inverted peptide 
stereocenters along a short (4-7 residues) peptide chain? This study investigates 
chiral modes of self-assembly to assess the impact of chiral supramolecular 
arrangements on material behavior. 
 
Natural peptide interfaces within proteins often exhibit highly refined self-assembly 
during protein folding, but these interfaces have yet to be exploited in electronic 
devices. This study capitalizes on the exquisite self-assembly characteristics of a 
natural peptide and applies it in an organic electronic device.  
1.9 Topical Overview 
Following from the various aspects which have been discussed in this chapter, and 
leading on from the areas of further interest highlighted in the last section, the 
chapters ahead present a detailed study of the peptide-directed self-assembly of N-
substituted perylene imide compounds using a variety of peptide sequence 
variations. 
 
In the next chapter, a discussion of the rational design, synthetic approaches, and 
analytical methods used for the compounds studied will be presented. Particular 
emphasis will be given to the theoretical spectroscopic framework applied for the 
interpretation of the data obtained from the analytical methods used throughout 
this study. 
 
In Chapter 3, an examination of the impact of specific peptide structural changes 
will be explored from a thermodynamic perspective using temperature-dependent 
UV-vis spectroscopy and spectral data-fitting to ascertain peptide structure-to-
property relationships as they relate to supramolecular self-assembly. 
 
In Chapter 4, an evaluation of the effect of chiral amino residues on the internal 
architectures of self-assembled nanofibers will be explored via circular dichroism 
spectroscopy and by spectral data-fitting models. 
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In Chapter 5, an exploration of the use of natural peptide sequences for the self-
assembly of organic semiconductors will be presented, culminating in a proof-of-
concept solid-state organic field-effect device. 
 
Chapters 6 and 7 enumerate the conclusions and ideas for future work, respectively, 
which were prompted out of this work. 
 
Chapter 8 provides full experimental details for reference with additional 
supporting information given in the appendices. 
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Chapter 2 
Synthesis and Analytical Strategy 
2.1  Introduction 
The use of peptides as moieties to guide supramolecular self-assembly brings with it 
a wealth of possible amino acid sequential variations which may be used to tune the 
structural properties and behavior impacting self-assembly. To effectively use this 
wealth of sequential possibilities, a consideration of peptide structure is warranted. 
A peptide varies principally in the type and order of the side-chain groups 
(represented by R1, R2, R3, and Ri in Figure 2.1) attached at the alpha carbon 
positions of the amino acid residues and incorporated along the polyamide 
backbone of the peptide. It is these side-chain groups which not only give the amino  
 
Region #1                      Region #2                      Region #3
H N CH
R1
O
N CH
R2
O
N CH
R3
N
OH H H
CH
O
OH
H
Ri
x1 x2 x3
Regions #4 to N
xi
index:  i = 4 to N
Figure 2.1 A general peptide structure showing the polyamide backbone for a 
peptide of unspecified length with N regions. Variable side-chain groups within 
each region are noted as R1, R2, R3, and Ri. Regions vary in size by the number of 
monomers contained in each (unspecified sizes noted as x1, x2, x3, and xi). 
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acid building blocks a distinctive identity and distinctive properties, but it is also 
these groups  which,  when  taken  together, largely determine the  overall 
properties of  a peptide. 
 
From the twenty-one natural amino acids, these side-chain groups are diverse and 
classified as hydrophilic, hydrophobic, charged, uncharged, polar, nonpolar, etc. 
Accordingly, the polyamide strand of a peptide, which is comprised of amino acid 
monomers, may be divided into regions defined as a block of one or more 
consecutive amino acid monomers of the same type. Each region will share 
properties similar to those of its corresponding amino acid, and the size of a region 
depends upon the number of amino acid residues it contains. Many different 
regions can be found in a single peptide, and a similar (or identical) region 
occurring in one position along the peptide chain may recur at another position 
elsewhere along the peptide chain. In addition to underscoring the high number of 
sequential permutations possible in such polymeric structures where subunit order 
is relevant, recognizing that region block placements along the peptide also matter 
serves to further underscore the importance of the specific amino acid sequence 
order. This takes on an added dimension when considering peptide units for use as 
moieties to aid in self-assembly. Upon chemically bonding a peptide sequence with 
a moiety for self-assembly, the specific regions within the sequence will have a 
relative position to the bound moiety based upon the point of attachment. For 
peptide-guided supramolecular self-assembly, sequence variations change the 
proximity of particular regions in a peptide relative to the appended moiety to be 
guided in self-assembly. As a result, the specific amino acid sequence, length, 
regions, and regional properties of a peptide must be taken into account when 
selecting a peptide sequence to use as a substituent. 
 
Secondary structures formed by peptides add another dimension to sequence and 
structural considerations. Most basically, for example, intramolecular hydrogen-
bonding between adjacent carbonyl and amide-NH groups causes these units to 
tend toward co-planarity with the side-chain groups projecting from either side of 
the polyamide plane. Other intramolecular and intermolecular interactions within a 
specific peptide sequence (with specific sequentially positioned regions) can 
produce a molecule which becomes structurally more than the sum of its parts, 
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leading to the formation of secondary structures such as β-sheets (parallel or anti-
parallel), β-turns, and α-helices (or other helical forms). Selecting (or rationally 
designing) sequences with a propensity toward forming a particular secondary 
structure can facilitate the inclusion of these secondary structural tendencies into a 
larger self-assembly scheme. Yet whether rationally designed or naturally occurring 
sequences are selected, a means to acquire sufficient amounts of the peptide 
material must be possible.  Moreover, once the peptides are synthetically applied 
for self-assembly by incorporating them with another moiety into a larger structure, 
a means to assess the self-assembly (and the impact of particular peptide sequence 
differences on that self-assembly) must be possible. Some avenues applied to 
address these issues are examined in this chapter.   
2.2  Solid-Phase Peptide Synthesis 
To reliably obtain significant quantities of peptides with high sequential and 
chemical purity without reliance on isolation from natural sources, solid-phase 
peptide synthesis (SPPS) delivers markedly. Since its initial development by 
Merrifield,81 SPPS has now become the preferred method for a majority of peptide 
syntheses due to several advantages over solution-phase methods.82 Chief among 
these advantages is a simplified separation of the desired peptide product from 
unreacted starting materials and side-products. In SPPS, a solid support (such as 
cross-linked divinyl benzene resin beads) is employed to which a loading of amino 
acid moieties are chemically bound (generally through the carboxyl group of the 
amino acid via a linker). These amino acid moieties on the resin become the 
reaction sites to start peptide formation, and these moieties are incorporated as the 
C-terminal residue of the peptide. As such, the selection of the moiety used in the 
resin loading must be deliberate since the amino acid on the resin becomes the first 
residue incorporated into the peptide. Over the course of the SPPS processes, the 
peptide essentially “grows” on the resin support. Because SPPS is performed on a 
solid support, purification is greatly simplified, in that, the peptide product remains 
attached to the resin; excess reagents and some side-products are simply removed 
by washing and filtration without the need to transfer any resin material from the 
reaction column throughout the various steps. This solid-phase approach also 
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avoids difficulties related to the changing solubility properties of the peptide with 
each step as it is produced. A further striking advantage of SPPS is that it can be 
automated and performed by machines programmed with specific parameters to 
generate desired peptide sequences according to a pre-designed synthetic strategy.82 
One common SPPS protocol employs the 9-fluorenylmethoxycarbonyl (Fmoc) 
protecting group with a Wang resin solid support. An overview of a general 
synthetic scheme is given in Scheme 2.1, which illustrates standard Fmoc-based 
SPPS protocols.81 
 
 
Scheme 2.1 An overview of the solid-phase peptide synthesis procedures. 
Functionalized resin beads are employed in a repeated Fmoc-deprotection/amino 
acid coupling cycle until the desired peptide sequence is obtained. Each full cycle 
introduces one additional Fmoc-protected amino acid link into the peptide chain. 
The completed peptide is subsequently removed from the resin. 
A central feature of the SPPS process is the deprotection/coupling cycle shown in 
Scheme 2.1. This cycle is repeated for each amino acid residue to be incorporated 
into the peptide and continues until the end of the peptide sequence. The principal 
change occurring in the cycle involves the introduction of the different amino acids 
(in the necessary order) to produce the desired peptide. Each full cycle adds one 
amino acid link to the peptide chain via the formation of a new amide bond 
through a reaction between the terminal amino group of the growing peptide and 
the activated carboxylic acid group of the amino acid introduced. To enhance the 
formation of the amide linkage, a high excess of the amino acids used during 
coupling is supplied to drive the coupling reaction to completion, and the 
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carboxylic acid moiety is activated with agents such as O-benzotriazole-N,N,N',N'-
tetramethyluronium hexafluorophosphate (HBTU) along with a small amount of 
the non-nucleophilic base N,N-diisopropylethylamine (DIPEA). The amino acids 
used in SPPS processes incorporate protecting groups such as Fmoc to ensure that 
only the amine functionality on the growing peptide is available to react during the 
coupling reaction. Additional protecting groups (such as tert-butyl groups, noted 
generally in Scheme 2.1 as Zi) are used for sensitive functional groups in the amino 
acid residue side-chains (noted in Scheme 2.1 as Ri). Protecting groups used for the 
side chains are selected to be stable under the conditions used during the SPPS 
deprotection/coupling cycle but to be unstable and easily removed under the final 
conditions applied to cleave the peptide from the resin and conclude the SPPS 
protocol. This feature of protecting group orthogonal behavior is a key aspect 
affording the success of the SPPS protocols. In Scheme 2.1, the side-chain 
protecting groups and resin link are stable under  the basic conditions used,  but  the  
 
 
 
 
Scheme 2.2 Reaction mechanism for the Fmoc deprotection of the amino 
terminus of a resin-bound peptide during SPPS. 
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Scheme 2.3 Reaction mechanism for the coupling of an HBTU activated 
carboxyl group of an Fmoc-protected amino acid with the amino terminus of a 
resin-bound peptide forming during SPPS. 
Fmoc group is cleaved from the growing peptide with an appropriate base. In the 
final step, the resin link and the side-chain protecting groups are unstable are 
removed under the acidic conditions applied. Mechanisms for the deprotection and 
coupling reactions are given in Schemes 2.2 and 2.3, respectively. 
2.2.1 Synthesis of Protected Peptide Products  
In some cases, it may be desired to retain one or more of the SPPS protecting 
groups in the final peptide product. For example, retaining specific protecting 
groups may shield certain side-chain moieties during subsequent reactions between 
the peptide and another compound during a targeted synthesis. Although the 
general SPPS protocol previously outlined is designed for the removal of all side-
chain protecting groups upon cleavage of the completed peptide from the resin, it 
can be adapted easily to obtain peptides which have some (or all) of the side-chains 
protected. In fact, if carefully planned, adaptations can often be made to 
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simultaneously apply multiple strategies, thus allowing a staged, selective 
deprotection of certain amino acid residues. Three main types of adaptations are 
made to the standard protocol to effect selective deprotection during resin cleavage. 
These are: (1) Change the reaction cleavage solution; (2) Change the type of 
support resin used; (3) Change the specific protecting groups used on one or more 
amino acids incorporated into the peptide during SPPS. Often changes of more 
than one of these parameters may be needed for the desired outcome. 
 
The first approach is to change the reaction cleavage conditions. Some protecting 
groups are more labile than others. As a result, in some instances, lowering the 
trifluoroacetic acid (TFA) concentration in the cleavage solution below a certain 
threshold or switching to a solvent such as 1,1,1,3,3,3-hexafluoroisopropanol 
(HFIP) can permit the removal of the more acid-labile protecting groups while 
retaining the less acid-labile protecting groups. This method, however, is often 
limited by the types of protecting groups (in conjunction with others on the peptide) 
which are removed by this strategy.  
 
The second approach is to change the type of support resin used. Although Wang 
resins are standard in the Fmoc SPPS protocol discussed here, other more acid 
labile resins such as 2-chloro-trityl resins are also used. Perhaps the simplest 
protected peptide to achieve is one in which all side-chain protecting groups are 
retained. This is accomplished by changing both the support resin and the cleavage 
solution of the standard Fmoc protocol. Using a 2-chloro-trityl resin to perform the 
SPPS, and then cleaving from the resin using HFIP gives a scenario in which the 
HFIP is acidic enough to cleave the highly acid-labile 2-chloro-trityl resin but too 
weak to remove the side-chain protecting groups normally removed by TFA.83 
When considering an alternative resin, however, it is important to evaluate the 
loading of reactive sites in the resin network. Some solid supports not specifically 
for SPPS may have a loading which is detrimental to the synthesis, since a loading 
which is too high may introduce steric crowding or promote aggregation between 
neighboring peptide strands and hinder reaction completion, necessitating more 
repeated coupling cycles and longer coupling times. For shorter peptides (11 
residues or less), a loading of 0.35-0.60 mmol/g is usually desirable, but in general, 
the longer the sequence, the more the loading may need decreased.  
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The third approach is to change the protecting groups applied to the amino acid 
side-chains. Numerous protecting groups have been developed which are removed 
under specific conditions.84 Some available protecting groups employ removal 
conditions very different to the solvent environments encountered in SPPS84 such as 
N2H2·H2O in DMF, Zn in acetic acid, or photolysis. Protecting groups with very 
specific removal conditions outside of the SPPS regime may thus be selected where 
required. 
2.2.2 Other Specialized Resins 
Although most pre-loaded resins are loaded with an amino acid derivative, a small 
number of resins are available which are loaded with other linker moieties such as 
ethylenediamine (or other diamine alkyl chains). Alternatively, unloaded resins 
may be purchased for custom loading with other moieties. In the case of the 
ethylenediamine-loaded resin, one amino end is tethered to the solid support while 
the other amino group is free to bond with an amino acid during SPPS. The end 
result upon resin cleavage is a peptide with an ethylamino group appended to its 
carboxyl terminus. This outcome demonstrates the potential use of specialized 
resins to introduce customized linkers during the SPPS, which affords a much more 
reliable approach with a higher yield than trying to form an amide linkage via a 
solution protocol after the peptide is synthesized. 
 
In similar fashion, special resins may be applied to “cap” the carboxyl end of the 
peptide against further reaction upon completion of the synthesis. This is 
accomplished via resins such as Rink resins which produce an amidated carboxyl 
terminus upon resin cleavage. 
2.2.3 The Kaiser Test 
Regardless of the resin employed, during the SPPS protocol, after each new amino 
acid coupling reaction is done, verification must be obtained that the reaction has 
gone to completion and that all amino acids at the ends of the peptide chains have 
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added the new amino acid unit. This is done by testing for free primary or 
secondary amines via the Kaiser test.85 The test involves exposing a small amount 
of the SPPS active resin to a mixture of three drops of ninhydrin solution (5 g in 
100 mL ethanol), three drops of phenol solution (80 g in 20 mL ethanol), and three 
drops of a KCN solution (2 mL 0.001 M aqueous KCN in 98 mL pyridine) and 
then heating near 95-100 ˚C for about 5 minutes.  Overheating should be avoided 
since deprotection of the amino acids can occur resulting in false-positive test 
results. If free, unbound primary or secondary amino groups are present (presumed 
to be those of unreacted amino acids on the ends of the peptide), a color change 
will result from the reaction of the ninhydrin with the amino functionality as 
outlined in Scheme 2.4. The Kaiser test is obvious for primary amino groups, 
releasing a strong, distinctive blue chromophore into the yellow solution. 
Consequently, a blue color change indicates that an amino acid coupling reaction is  
 
O
O
O
NH2
R OH
O
O
O
OH
OH
O
O
NH
OH
R
OH
O
O
O
N
R
OH
O
H
2
O—
H
2
O—
O
O
N
R
CO
2
decarboxylation
—
O
O
N
R
H
2
O+
O
O
NH2
+
H
R
O
O
O
OH
OH
O
O
N
O O
  
Scheme 2.4 Reaction pathway for the reaction of an amino acid primary amine 
with ninhydrin, generating a chromophore having a dark blue color indicative of a 
positive Kaiser test result, which signals an incomplete coupling reaction during 
SPPS. A photo (inset) shows a positive and negative result.  
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incomplete and needs repeated. The Kaiser test is less suited to secondary amines 
(such as methylated amino acids), however, since it produces a weaker brownish-
red color which may be difficult to distinguish in the solution. 
2.3 Peptide-Perylene Imide Synthesis 
Although solid-phase peptide synthesis makes a wealth of peptide sequences 
accessible in sufficient quantities, the peptide materials obtained still require a 
synthetic strategy to couple the sequences to a moiety selected for peptide-mediated 
self-assembly. While reactions with functional groups on the peptide side-chain is 
possible, for self-assembly this may be undesirable since bonding through the side-
chains could disrupt the inter-chain and intra-chain interactions present in peptide 
self-assembly. Bonding through the peptide termini, therefore, may be more 
desirable since this leaves the lateral aspects of the chain free to associate as occurs 
in proteins. The carboxyl terminus, while available to synthetic transformations, 
holds less intrinsic reactivity and presents the associated challenges of this. In 
distinction, the amino terminus of a peptide is ideally suited as a resident 
functionality which can facilitate a variety of synthetic options adaptable to the 
moiety chosen for self-assembly. A target molecule functionalized to be responsive 
toward amine chemistry can provide a way to attach a peptide sequence to a target 
moiety provided that the reaction employed is compatible with the other portions of 
the structures involved. For self-assembling perylene moieties, the formation of 
perylene imides is ideal and is easily accomplished via an amine condensation 
reaction with an anhydride functionalized chromophore.  
 
The methods used to synthesize the N-substituted peptide-perylene imides in this 
study were based on amine condensation with perylene anhydrides using methods 
previously reported for the synthesis of symmetric perylene diimide derivatives.86 
Using these reactions (or adaptations) as a synthetic framework, several symmetric 
and non-symmetric perylene imide compounds with significant structural variations 
were synthesized as outlined in Scheme 2.5. (Synthesis of appropriate perylene 
anhydride precursors for the general amine condensation reaction drew upon 
additional synthetic methodologies87,88 noted in Chapter 8.) While the mechanism 
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for the amine condensation with perylene anhydride is not fully understood, it is 
thought to proceed by a radical initiated pathway.89 The reaction is often performed 
in molten imidazole as the solvent in part to address solubility limitations of 
perylene compounds in other solvents; however, DMSO, DMF, or N-methyl-2-
pyrrolidone (NMP) can alternatively be used in some perylene imide reaction 
protocols. Using solvents other than molten imidazole may, in fact, be 
advantageous in some cases. In this study, it was observed that reactions involving 
the perylene bisester anhydride in imidazole would result in some cleavage of ester 
groups, reducing the yield of the desired product obtained.      
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Scheme 2.5 General perylene imide synthesis reaction performed. 
2.4 Rational Design of the Peptide-Perylene Imides 
Synthesized  
Having recognized peptides as a promising, versatile substituent for self-assembly, 
and having identified synthetic pathways to produce desired peptides and 
subsequently incorporate them into perylene imides, a selection of appropriate 
peptide sequences must still be made. Here, previously published studies of peptide 
amphiphiles are instructive. Peptide amphiphiles consist of a long hydrophobic 
alkyl chain appended to the terminus of a peptide, thus producing molecules with 
segments having strongly competing hydrophobic and hydrophilic character. These 
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features prompt peptide amphiphile to self-assemble into highly ordered 
nanostructures such as rod-like nanofibers. Emerging from pioneering work with 
peptide amphiphiles by Stupp et al.,17,23,90–95 it was found that successful self-
assembly by peptide amphiphiles into functional nano-architectures requires the 
inclusion of four essential structural regions, as illustrated in Figure 2.2a. These 
regions are: (1) a hydrophobic tail to produce hydrophobic interactions and 
engender amphiphilicity, (2) a peptide sequence capable of intermolecular 
hydrogen-bonding to aid self-assembly and the impartation of interfacial curvature 
in the self-assembled structure, (3) charged amino acids (for solubility), and (4) a 
functional (such as a biologically-active) peptide epitope.96,97 (Appropriately placed 
linkers or spacers such glycine or alkyl chains may also be added with these 
regions.17) Upon triggering self-assembly, the hydrophobic tails orient away from 
the aqueous environment to form a hydrophobic core, while the more hydrophilic 
peptide segment orient toward the aqueous environment and begin to associate 
(through hydrogen-bonding) into β-sheets. These interactions produce a radial 
curvature around a 1D assembly directionality, resulting in a rod-like nanofiber 
formation (as shown in Figure 2.2b). 
 
Based on the synthetic strategies discussed in Section 2.2 and the peptide 
amphilphile considerations outlined here, a small library of peptide-perylene imides 
was synthesized primarily employing peptide sequences with three regions as 
outlined in Scheme 2.6. The three regions were: (1) a glycine unit to serve as a low 
steric demand linking unit for condensation with perylene anhydride precursors, (2) 
a central region (3-7 amino acid residues) to serve as a structural variable and the 
central assembly interface for investigating steric, chiral, and hydrogen-bonding 
influences, and (3) a terminal glutamic acid region (1-3 amino acid residues) to 
influence solubility and to investigate the impact of charged groups. This structural 
design in Scheme 2.6 shares some similarity with that of the peptide amphiphile in 
Figure 2.2a (notably regions 2 and 3), but two important differences are also present. 
First, rather than utilizing a hydrophobic tail like the peptide amphiphile, Scheme 
2.6 achieves amphiphilicity by replacing the tail with the hydrophobic, π-stacking 
perylene imide moiety. This serves both to impart amphiphilicity as well as to 
achieve π-stacking self-assembly of the perylene core. Additionally, no biologically 
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active peptide segment is included in Scheme 2.6, since the functional goal of the 
self-assembly resides with the perylene imide moiety. 
 
 
Figure 2.2 An example of peptide amphiphile self-assembly. (a) Four essential 
structural regions are required for self-assembly into a functional system. 
Constituents in these regions may be altered to influence nanostructural and self-
assembly properties (b) Model of a cylindrical nanofiber formed as a result of the 
aggregation of individual peptide amphiphile molecules with an IKVAV peptide 
terminal group. (Figure adapted for review  from Hamley et al.97 with permission 
from John Wiley & Sons, Ltd.) 
Due to the proximity of the central variable region to the perylene core, amino acid 
residues in this region were expected to impart a much greater impact with regard 
to steric effects, chiral effects, and hydrogen-bonding during aggregation than the 
amino acid residues more distal on the peptide chain. As a result, changes in this 
region were investigated to alter aggregate associations and impact supramolecular 
assembly. Since the more distal glutamic acid residues on the chain are not held as 
closely to the perylene core and can diverge more easily during aggregation, these 
were not expected to impact aggregate trends as strongly and were incorporated 
into the structure to aid in solubility and to enable pH-triggered aggregation. 
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Scheme 2.6 An overview of the structural variations employed in the peptide-
PDI synthesis. Three structural regions were modified in the peptide along with 
three perylene core variations to investigate the influence of specific structural 
effects. 
In addition to the peptide variations explored, both symmetric and non-symmetric 
peptide-PDIs were investigated by substituting a hexylimide moiety in place of a 
peptide in some structures. Additionally, two variations of the perylene 
chromophore were examined by substituting a bisester moiety in place of an imide 
group in other structures. Two exceptions to the structural design depicted in 
Scheme 2.6 were also examined. In the first exception, the linking unit was 
attached to the carboxyl end of the peptide to allow a reversed mode of peptide 
attachment. In the second exception, Lysine residues were used in place of glutamic 
acid in the charged region of the peptide. Following from the variations outlined 
here and those depicted in Scheme 2.6, a summary of the synthesized peptide-
perylene imides studied is given in Scheme 2.7. 
 
The compounds summarized in Scheme 2.7 were selectively synthesized to provide 
structures permitting specific comparisons which evaluate the impact of particular 
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structural features on self-assembly. Firstly, compounds 1-8, and 1H-5H allow the 
examination of peptide steric effects, ionizable groups, chiral centers, and 
hydrophobicity. These comparisons are discussed in Chapter 3 from a 
thermodynamic perspective. Secondly, diastereomer and enantiomer sets 
represented by compound sets 3/3E/4, 3H/3HE, and 7/8 along with glycine-rich 1 
and meso 3M (as control compounds) permit an examination of the effects of chiral 
centers in close proximity to the perylene imide core. Implications of these chiral 
effects are discussed in Chapter 4. Thirdly, compounds 9-11 provide test structures 
involving lysine-terminated peptides, to be noted in Chapter 7. Lastly, an assortment 
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1 R1 -Gly-(Gly)3-(Glu)3   1H R2 -Gly-(Gly)3-(Glu)3 
2 R1 -Gly-(Ala)3-Glu   2H R2 -Gly-(Ala)3-Glu 
3 R1 -Gly-(Ala)3-(Glu)3   3H R2 -Gly-(Ala)3-(Glu)3 
3E R1 -Gly-(D-Ala)3-(D-Glu)3 3HE R2 -Gly-(D-Ala)3-(D-Glu)3 
3M R1 -Gly-(D/L-Ala)3-(D/L-Glu)3     
4 R1 -Gly-(D-Ala)3-(Glu)3   4H R2 -Gly-(D-Ala)3-(Glu)3 
5 R1 -Gly-(Glu)3   5H R2 -Gly-(Glu)3 
6 R1 -Gly-(Phe)3-(Glu)3         
7 R1 -Gly-(Leu)3-(Glu)3      
8 R1 -Gly-(D-Leu)3-(Glu)3   10 R2 -Lys(-R2)-(Ala)3-(Glu)3 
9 R1 -Gly-(Ala)3-(Lys)3   11 R3 -Lys(-R3)-(Ala)3-(Glu)3 
           
12 R1 Ac-IK(-yl)HLSVN-NH2   12H R2 Ac-IK(-yl)HLSVN-NH2 
           
13 R1 -GIRHLSVNEEE   15 R3 -GIRHLSVNEEE 
14 R1 Ac-EEEIRHLSVN-ethyl- 16 R3 Ac-EEEIRHLSVN-ethyl- 
 
Scheme 2.7 Summary of N-peptide perylene imides synthesized, arranged by 
structural similarity. 
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of compounds incorporating a natural peptide sequence (12, 12H, 13-16) enables 
an examination of the application of natural peptide sequences optimized in nature. 
This topic is discussed in Chapter 5. To make these comparisons and evaluate 
crucial differences, informative methods are needed which can probe and 
discriminate the subtle differences produced by the various structural aspects; these 
methods will be discussed in the next section. 
 
Before discussing the analytical methods useful for investigating the compounds in 
Scheme 2.7, it is worth briefly mentioning four compounds which are not included 
in the list due to unsuccessful (or partially unsuccessful) synthetic attempts to 
produce them. These syntheses are summarized by Scheme 2.8. 
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Scheme 2.8 Unsuccessful (or incomplete) synthetic pathways explored. 
Syntheses of compounds U1 and U2 (Scheme 2.8) were attempted with the 
intention of generating a set of compounds (3, U1, and U2) for the investigation of 
H-bonding effects on self-assembly. Comparison of the N-methylated alanine 
(MeAla) derivative U1 with the non-methylated PDI 3, was desired to examine the 
effect of H-bonding originating along the polyamide peptide backbone during PDI 
self-assembly, while comparison of 3 and serine derivative U2 was desired to 
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examine the effect of H-bonding originating from peptide side-chains. Attempts to 
synthesize the N-methylated peptide for U1 failed to produce a peptide precipitate 
during SPPS, and no peptide material could be isolated from the solution. It was 
suspected that the MeAla couplings did not proceed even with two or more 
attempted coupling attempts lasting 3 hours or longer. Synthesis of the serine 
peptide for U2 was successful; however the reaction with perylene dianhydride to 
form U2 did not proceed. No traces matching those expected for U2 could be 
confirmed. The serine hydroxyl side-chains were suspected to have generated some 
interfering side-reaction during the attempted PDI formation. 
 
Syntheses of U3 and U4 were attempted as part of early investigations using natural 
peptides in PDIs (to be discussed later in Chapter 5). The respective peptides used 
as precursors for both U3 and U4 were both successfully synthesized. Likewise, the 
reaction to form U3 was also accomplished; however, the reaction methodology to 
form U4 was not fully effective. Both compounds were difficult to purify due to 
very poor solubility. During purification on HP20ss resin, the compounds were 
found to be difficult to elute. This difficulty was compounded for U4 since the 
reaction mixture utilized during synthesis was difficult to fully remove. An atypical 
reaction solvent mixture was employed for U4 due to the competing solubility 
characteristics of the reagents. The unusual selection of 1-chloronaphthalene was 
made to provide an aromatic liquid with the ability to partially solvate some 
aromatic compounds that have low solubility. The reaction proceeded, but the yield 
was also very low due to the unfavorable equilibrium toward amide coupling, 
necessitating a higher molar excess of peptide to shift the equilibrium toward the 
amide formation. This solution-phase amide coupling was ultimately abandoned in 
favor of an SPPS methodology which employed a resin-bound linker on which to 
form the peptide directly. This SPPS method was seen to be superior for joining the 
peptide and the linker since it did not require excess peptide for a coupling with an 
ethylenediamino PDI precursor. Accordingly, more of the peptide with the 
appended linker (made via SPPS) could be carried forward to a reaction to produce 
the final desired peptide-PDI. Therefore, this SPPS methodology was adopted for 
the subsequent syntheses of PDI 14 and PIBE 16 (studied in Chapter 5). Since U3 
and U4 were not fully purified, these and the synthesized diethylendiamino PDI 
precursor Q057 are not reported in this thesis.           
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2.5 Synthetic Characterization Methods 
Following the synthesis of the compounds, several techniques were applied to 
verify that the correct synthetic conversions were achieved in high purity. Although 
these methods will not be discussed in detail, for context, these techniques are 
mentioned in this section in relation to the primary indications sought from each 
analysis. Specific experimental details for these methods are given for reference in 
the experimental Chapter 8. 
2.5.1 Nuclear Magnetic Resonance (NMR) Spectroscopy 
Spectra for the 1H and 13C nuclei were of primary interest for the compounds 
studied. Spectra of both nuclei were collected for the synthesized peptide precursors 
and were examined in detail to verify sequence production and to check for the 
presence of aberrant sequence impurities. Due to the low solubility of the peptide-
perylene imide conjugates, however, 13C spectra could only be obtained for the 
unbound peptide precursors (not for their perylene imide conjugates), making 
comparison of the 1H spectra of a free peptide with that of its respective perylene 
imide conjugate useful for verification of the synthesis of the conjugate. In such 
comparisons, resonance peak groups seen in the peptide spectrum were analogously 
seen in the conjugate spectrum along with the inclusion of the perylene aryl 
resonance at highest chemical shift in the spectrum. 
2.5.2 High Resolution Mass Spectrometry (HRMS) 
Synthesized peptides were screened by HRMS from solution using electrospray 
ionization (ESI) to verify that the material samples exhibited primary ions having 
mass-to-charge ratios (m/z) consistent with that theoretically expected for the 
desired products. The HRMS spectra were further evaluated for possible aberrant 
species such as deletion sequences. Due to poor solubility in the preferred solvents 
used for HRMS instrumental analysis from solution, the peptide-perylene imide 
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conjugates were instead screened in a solid-state matrix via MALDI mass 
spectrometry. 
2.5.3 Matrix-Assisted Laser Desorption Ionization (MALDI) 
 Mass Spectrometry 
Synthesized peptide-perylene imide conjugates were screened from solid-state 
samples via MALDI time-of-flight (TOF) mass spectrometry to verify that the 
samples displayed spectral features consistent with that theoretically expected for 
the desired product and to check for indications of starting materials or side-
products. Since poor solubility of the perylene imide conjugates did not permit the 
collection of 13C NMR spectra, MALDI was also applied further to collect ion 
fragmentation spectra for ion fragment assignment. Assigned ion fragmentation 
spectra were supplied, when possible, as data verifying the expected molecular 
carbon frame in place of the unavailable 13C NMR spectra. 
2.5.4 Fourier-Transform Infrared (FT-IR) Spectroscopy 
Following the synthesis of the peptide-perylene imide conjugates, samples of the 
compounds were screened via FT-IR spectroscopy to verify the complete 
conversion of the anhydride functionality to the imide functionality. This 
conversion manifested as a distinct shift of the associated carbonyl stretch band to 
lower frequency. Accordingly, mixtures of anhydride and imide functionalities are 
easily detected, making FT-IR a simple synthetic conversion screening tool. 
 
FT-IR amide band analysis is often performed for peptides and proteins to ascertain 
secondary structural features and modes of assembly adopted by such 
compounds,.98–101 Briefly stated, this band analysis method examines the amide 
absorbance bands as a composite of several contributing bands which are 
computationally resolved. The evaluated contributing bands are then assigned to 
specific secondary structural features based on band correlations determined 
through protein structure studies. Due to interferences from the carbonyl stretches 
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of the perylene imides such band analyses were not applied in this study for the 
evaluation of the modes of peptide self-assembly apart from selected cases which 
will be discussed later in Chapter 5. Due to the limited use of amide band analysis 
in this study, it will not be discussed in detail.      
2.6 Nanostructure Analysis Methods 
Although the application of many analytical techniques is limited by the low 
solubility of the synthesized perylene imide compounds, both microscopy and 
spectroscopy are well suited for the analysis of nanostructures formed by the 
compounds in dilute solutions. These two types of techniques also firmly address 
two essential goals in the analysis of self-assembled nanostructures: (1) To prove 
that ordered nanostructures have indeed formed (rather than simple disordered 
aggregates), and (2) To probe the internal architectures of the nanostructures to 
discriminate differences in self-assembly between compounds for informing 
structure-property correlations. Microscopy can provide valuable nanoscale 
imaging of the morphological character of aggregates formed in solution, and 
supply proof of the type of nanostructures resident. While microscopy can also 
supply clues about the internal architectures of the nanostructures in some instances, 
often these clues are limited. Spectroscopy, however, is sensitive toward differences 
in the local electronic environment between chromophores within supramolecular 
assemblies and is well suited to discriminate packing differences in the internal 
architectures of perylene imide nanostructures. Specifically, ultraviolet-visible (UV-
vis) and circular dichroism (CD) spectroscopy are particularly useful in evaluating 
nanostructure architectures. Herein is presented a discussion of the theoretical 
framework applied from these methods to evaluate the self-assembled 
nanostructure architectures of the perylene imides from this study. 
2.6.1 Microscopy Methods for Nanostructure Analysis 
Beyond supplying proof of the formation of ordered nanostructure architectures, 
microscopy techniques can inform the application of those nanostructures from 
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solution to solid-state applications such as device fabrication. Identification and 
characterization of any supramolecular assemblies forming from the compounds 
synthesized in this study was facilitated primarily by atomic force microscopy 
(AFM) and cryogenic transmission electron microscopy (cryo-TEM). Microscopy 
images reported in this study were collected via collaborations with technique 
specialists at the University of New South Wales (Sydney, Australia) for AFM and 
the Weizmann Institute of Science (Rehovot, Israel) for cryo-TEM. In this study, 
cryo-TEM and AFM were used primarily in a supportive role to provide additional 
evidence of nanostructure formation and were not the main analytical emphasis of 
this study. Due to its supportive role, analyses and theory associated with these 
techniques are not discussed at length, but some brief method details and associated 
examples are included here for context.  
2.6.1.1 Atomic Force Microscopy (AFM) 
AFM works on the basis of interactions between surface atoms and the atoms of a 
probe tip which is attached to a cantilever, as illustrated in Figure 2.3a.102 Attractive 
or repulsive forces between the surface and the tip cause  a deflection of the position  
    
 
Figure 2.3  (a) AFM instrumental diagram representing the tip and detector 
setup, (b) AFM image of the adsorption of 1.8 mM cetyl trimethylammonium 
bromide (CTAB) on mica in the presence of 10 mM KBr showing the formation of 
cylindrical rows. (c) A model of the cylindrical structure of adsorbed CTAB. A 
cross-section of the cylinder on the right shows the interior of the cylinder. (Figure 
adapted for review from Thordarson et al.102 with permission from CSIRO.) 
(a) (b) 
(c) 
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of the cantilever corresponding to changes in the topography of the surface. The 
changes in the position of the cantilever are monitored by a laser reflected from a 
point on the cantilever to a position-sensitive photo detector. Scanning in a raster 
pattern along the x- and y-directions across the surface allows the monitored 
changes in the cantilever position to be translated into z-direction contrasts in order 
to construct an image of the surface scanned. In this way, objects on the surface 
(such as deposited supramolecular structures) can be imaged. An example AFM 
image is shown in Figure 2.3b. Such images allow the visualization and 
measurement of fine structures which facilitates efforts to ascertain or support 
proposed models of supramolecular assembly (see Figure 2.3b,c). 
2.6.1.2 Cryogenic Transmission Electron Microscopy (cryo-TEM) 
Cryo-TEM can be superior to other microscopy methods for visualizing fine 
structures. The true shape and structure of supramolecular aggregates formed in 
solution may be difficult to observe by dry microscopy methods since fine structures 
may collect together into indistinguishable masses when drying solution samples 
onto the microscope substrate. Cryo-TEM overcomes this limitation by flash 
cooling (avoiding ice crystal formation) to vitrify a solution and capture any 
dissolved nanostructures it may contain in their native form within the solution. 
Slow sublimation of the vitrified media gently reveals fine structures which then be 
visualized by electron microscopy.  A general process used in cryo-TEM is as 
follows:103 (1) The analyte solution is applied to a support film such as holey carbon 
affixed to an EM copper grid; (2) The prepared sample is quickly plunged into 
liquid ethane at the temperature of liquid nitrogen; (3) The sample is then 
transferred to a cryo holder and placed in the electron microscope; (4) Images of 
fine structures revealed as the sublimation process occurs are recorded under low 
dose conditions via a CCD camera. Images collected by cryo-TEM may then be 
used to measure and model the supramolecular structures observed. Examples of 
some cryo-TEM images of a self-assembling polyethyleneglycol-PDI (PEG-PDI) 
monomer along with measurements and proposed models for its self-assembly into 
nanofibers are shown in Figure 2.4.10,44 
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Figure 2.4 (a) Molecular structure of a self-assembling PEG-PDI monomer.10,44 
(b) Cryo-TEM image showing segmented nanofibers formed by the self-assembly of 
the PEG-PDI monomers in water. (c) Cryo-TEM image showing the disruption of 
the nanofibers into spherical assemblies following reduction. The nanofibers were 
seen to reform upon oxidation. (d) Proposed models of the self-assembly and the 
supramolecular structures observed by cryo-TEM. (e) Measurements for the 
proposed models taken from the cryo-TEM images. (Figures adapted for review 
from Krieg et al.10  and Baram et al.44 with permission from Wiley and ACS.)  
2.6.2 UV-vis Spectroscopy for Aggregate Analysis 
In spite of solubility limiting spectroscopic investigations to micromolar 
concentrations, peptide-perylene imide solutions display UV-vis spectra with rich 
behavioral detail. This is due to the sensitivity of the perylene chromophore to 
changes in the local electronic environment associated with perylene π-stacking 
interactions. The response of the perylene chromophore to these changes can be 
detected spectroscopically and used to discriminate packing differences in the 
internal architectures of perylene imide nanostructures. 
 
(b) (c) (a) 
(e) (d) 
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As a solid-state example of these factors, a comparison of the crystal structures of 
N,N'-disubstituted perylene diimides has shown that the alignment of π-stacking 
interactions between two neighboring molecules within the crystal unit cell is 
shifted longitudinally or transversely as the imide substituents are changed.39,104 As 
a result, intermolecular charge transfer through π-stacking interactions is impacted 
solely by crystal packing, leading to crystallochromic changes in these 
compounds.39 These effects are illustrated by the crystal structure packing (and the 
associated color change) in red, maroon, and black perylene diimide-based 
pigments, as shown in Figure 2.5.39,105–107 
 
 
 
Figure 2.5 Three commonly used perylene diimide-based pigments. The colors 
of the pigments are seen to result from changes in the perylene core packing 
arrangement, which is influenced by the imide substituents. (Figure adapted for 
review from Würthner39 with pigment images from Liaoning Liangang Pigment 
and Dyestuff Chemicals Co., Ltd.107 and permission from RSC.)   
The crystallochromic effects observed can be attributed directly to changes in the 
local electronic environment of intermolecular π-stacking interactions rather than to 
direct imide substituent electronic interactions because of the presence of a node at 
each of the imide nitrogen atom positions in the calculated HOMO and LUMO 
molecular orbitals shown in Figure 2.6.108 Consequently, the imide nodal position 
also means that changes observed in the PDI spectral profile in solution can 
similarly be attributed directly to supramolecular self-assembly interactions and not 
to any inductive substituent effects produced by the imide peptides acting on the 
molecular orbital of the perylene core. 
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Figure 2.6 DFT calculations of the HOMO and LUMO orbitals of N,N'-
dimethyl-PDI as a simple model PDI. No HOMO or LUMO density is seen on the 
marked imide nitrogen atoms. (Figure adapted for review from Huang et al.108 with 
permission from ACS.) 
Conjugated π-functional molecules give strong π→π* electronic transitions during 
electronic excitation. Coupling of an electronic excitation to a vibrational mode 
results in a vibronic progression being displayed in the UV-vis spectrum of the 
molecule (Figure 2.7a,b). In the case of an isolated PDI chromophore, the vibronic 
progression shown in Figure 2.7b is seen to result from the coupling of a π→π* 
electronic  transition  to  the  principal  PDI  vibrational  mode  (a C=C stretch near  
 
 
Figure 2.7 Illustrations related to the vibronic progression seen in the UV-vis 
spectra of organic molecules: (a) Absorption (blue) of a photon gives an electronic 
transition from the ground state (S0) to one of the vibrational levels in the excited 
(S1) with emission (red) following relaxation (green). (b) The absorption and 
emission spectra displaying a vibronic progression for an isolated PDI molecules in 
toluene. (Figures adapted for review from Spano109 and Huang et al.,108 respectively, 
with permission from ACS.)  
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1400 cm−1). Changes to this vibronic progression may be taken as indications of 
PDI aggregation (PDIs which are no longer isolated). In the notation used to 
specify the electronic transitions, the first number gives the vibrational level of the 
initial state, and the second number gives the vibrational level of the state following 
the transition. For example, in Figure 2.7a, the 0-2 absorption transition is shown 
by the longest solid blue line, and the 0-2 emission transition is shown by the 
shortest dashed red line. The spectral features corresponding to these transitions are 
labeled in Figure 2.7b. 
 
For molecules which participate in π-stacking, the extent and orientation of the π-
stacking between two neighboring molecules is dependent upon the nature of the 
aggregation. Aggregation changes the electronic and dipolar interactions of 
neighboring molecules which gives rise to specific spectroscopic signatures from the 
aggregates which are different to those of an isolated (monomeric) molecule. These 
distinct spectroscopic traits can be identified and utilized to evaluate the mode of 
supramolecular assembly. Two important modes of assembly are H-aggregates and 
J-aggregates. H-aggregates occur when the monomer molecular dipoles are in 
predominantly “side-by-side” orientations in the aggregates; J-aggregates occur 
when the monomer molecular dipoles are predominantly in “head-to-tail” 
orientations in the aggregates.109 Distinguishing H- and J-aggregates 
spectroscopically can be accomplished by evaluating changes in the vibronic 
absorption peaks relative to those of the monomer spectrum. A comparison of the 
spectroscopic differences between H- and J-aggregates using computational 
modeling is shown in Figure 2.8. 
 
Broadly stated, in H-aggregates, the main absorption peak tends to blueshift to 
higher energies and fluorescence is quenched, but for J-aggregates the main 
absorption peak tends to redshift to lower energies and fluorescent emission may be 
observed.109–111 Relative to the monomer absorbance spectrum, in H-aggregates the   
0-0 peak of the absorbance spectrum decreases while the 0-2 peak increases relative 
to the 0-1 peak.109 The opposite trends are seen for J-aggregates. Although seen to a 
greater extent in H-aggregates, in both H- and J-aggregates, the vibronic peaks 
become irregularly spaced as the aggregate bands develop.109  
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Figure 2.8 Comparisons of calculated spectra for the absorption (blue) and 
emission (red) of H- and J-aggregates compared to the spectrum of a non-
aggregated free molecule (grey) and its associated monomer emission (red dashed). 
(a) Calculated spectra for an H-aggregate compared to that of a free molecule. (b) 
Calculated spectra for a J-aggregate compared to that of a free molecule. (Figure 
adapted for review from Spano109 with permission from ACS.)  
To explain these spectroscopic changes produced by aggregation, an application of 
some aspects of exciton theory can be made. An exciton, which can be generated 
during electronic excitation, is an electron-hole pair in a bound state via a mutual 
electrostatic Coulomb force attraction. Excitation by an incoming photon of 
sufficient energy can produce electronic transitions between states. These electronic 
transitions involve interactions with the oscillating displacement of an electron.112 
Because the distribution of electron density between the ground state and the 
excited state is different, an electronic transition dipole moment (μ) with a specific 
magnitude (intensity) and orientation (direction of displacement) is produced.112 
Oscillations of μ in a chromophore may be represented by a double-headed arrow 
which simultaneously depicts both phases of the oscillation along an axis of 
polarization (generally the long axis of a chromophore).113 In the case of PDIs, the 
symmetry seen in the DFT calculations of the HOMO and LUMO orbitals (recall 
Figure 2.6) means that PDIs are polarized along an axis running between the 
nitrogen atoms as illustrated in Figure  2.9. 
 
When two or more chromophores are associated closely together (as in aggregation 
or as with ligands bound to a metal center, etc.), the chromophores may become 
exciton coupled, wherein an electronic excitation in one chromophore is 
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delocalized across one or more additional chromophores in the associated group.112 
A consequence of exciton coupling between two degenerate chromophores is the 
generation of two non-degenerate excited states (S1 and S2) arising from the in-phase 
and out-of-phase interactions of the electronic transition dipole moments of the 
chromophores as illustrated in Figure 2.10. 
 
 
 
Figure 2.9 An illustration of the oscillations of the electronic transition dipole 
moment, μ, across the long axis of a PDI molecule. 
 
Figure 2.10 Energy diagrams for exciton coupled aggregate dimers comprised of 
degenerate chromophores: (a) Comparison of J- and H-aggregates, showing the 
emergence of two non-degenerate excited states (S1 and S2); (b) Energy diagram for 
an H-aggregate with a rotational displacement, showing a forbidden 0-0 transition 
and a weakly allowed 0-1 transition via coupling to a vibrational mode. 
(b) (a) 
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As seen from Figure 2.10a, the in-phase and out-of-phase interactions of the electronic 
transition dipole moments of the chromophores gives differences in the allowed and 
forbidden electronic transitions of each type of aggregate based upon the relative 
orientations of the dipoles. For a strongly coupled H-aggregate without any 
rotational displacement between co-facial chromophores, the lower energy 
transition is forbidden since there is no net dipole for the transition. But in cases of 
a weakly coupled H-aggregate with some rotational offset between chromophores 
(Figure 2.10b), the 0-1 transition can become partially allowed through an increase 
in oscillator strength resulting from coupling to a vibrational mode.109 Accordingly, 
in the case of a weakly coupled H-aggregate, a redistribution of oscillator strength 
to higher energy occurs, resulting in a diminished intensity of the 0-0 vibronic peak 
and an increased intensity in the 0-1 vibronic peak compared to the vibronic 
spectrum of monomer (recall Figure 2.8a).  The opposite scenario is seen from the 
energy diagram for a J-aggregate, leading to a vibronic redistribution to lower 
energy as previously shown in Figure 2.8b. These vibronic changes can be used to 
indicate aggregate formation, to identify the type of aggregates formed, and to 
identify changes in the mode of aggregation produced by structural or solvent 
environment effects. 
 
Although UV-vis spectroscopy serves as a powerful technique to probe aggregate 
systems, it cannot examine the aspects of chirality which factor strongly in peptide 
structures. For evaluating the impact of chirality, a second type of spectroscopy is 
needed which is sensitive to chiral systems.  
2.6.3 CD Spectroscopy to Detect Chiral Self-Assembly 
Circular dichroism (CD) spectroscopy can be used to detect the presence of chiral 
supramolecular assemblies formed from the self-assembly of perylene imide 
monomers. CD spectroscopy is sensitive to the absolute configuration and 
conformation of a molecule114 and only gives a signal for chiral, non-racemic 
molecules which are either intrinsically chiral, or which are achiral but part of a 
larger chiral supramolecular group.115 In CD spectroscopy, a solution is exposed to 
circularly polarized light. The generation of circularly polarized light proceeds by 
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using prisms and filters to cause the electric field associated with a light wave to 
oscillate,14 producing a helical electromagnetic waveform along the axis of 
propagation. When the helical wave of the circularly polarized light is viewed on 
end with the direction of propagation, and perpendicular to its central axis, the 
oscillating wave can be seen as the resultant vector of two component vectors of 
equal magnitude which each sweep out rotating circles with one moving in a 
counter-clockwise (left-handed, EL) direction and the other moving in a clockwise 
(right-handed, ER) direction.
14,115 As such, the circularly polarized light consists of 
two circularly polarized component waves which are of opposite rotation and 
ninety degrees out of phase.14,115 Non-symmetric, chiral molecules interact with and 
absorb the left-handed and right-handed components of circularly polarized light to 
different extents, causing an unequal change in EL and ER which produces an 
elliptical polarization in the resultant vector.14,115 Illustrations of circularly polarized 
light and its interactions with chiral and achiral media are shown in Figure 2.11. 
 
 
Figure 2.11 Illustration of the left- and right-handed components of circularly 
polarized light. Interactions of circularly polarized light with chiral media produce 
a differential absorption between left- and right-handed components causing the 
light to become elliptically polarized. No differential absorption with achiral media. 
(Figure partially based on illustrations by Kelly et al.115) 
During electronic excitation of a chiral molecule, the helical waveform produces a 
helical electron displacement which manifests as a difference in extinction 
coefficient for left and right circularly polarized light (Equation 2.1).116 The 
69 
 
measurement of a CD signal by CD spectrometers is typically accomplished by 
measuring the differential absorbance of the left and right circularly polarized light 
by the sample (Equation 2.2) using polarization modulation and phase-locked 
detection techniques for signal enhancement.116 As a result, the cell path length (b) 
and molar concentration (c) must be reliably known to determine Δε, according to 
the Beer-Lambert Law (Equation 2.3),14,116 or alternatively, to express in as molar 
ellipticity  by Equation 2.4. Examples of a CD spectrum are given in Figure 2.12. 
 
  Δε  =  εL − εR     (2.1) 
  ΔA =  AL − AR     (2.2) 
  A   =  εbc      (2.3) 
  [θ]  =  3298.2Δε     (2.4) 
 
 
Figure 2.12 Overlaid CD spectra of peptides and proteins with representative 
secondary structure profiles: (a) CD spectra of poly-L-lysine and collagen under 
various conditions, and (b) CD spectra of selected proteins. (Figure adapted for 
review from Greenfield14 with permission from NIH.) 
Because CD spectroscopy is sensitive to the conformation of a molecule, the 
spectral profiles seen in a CD spectrum can frequently be used to identify some 
(a) (b) 
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types of secondary structures which molecules may adopt. This is particularly true 
for proteins, polypeptides, and some shorter peptides, for which the UV region of 
the CD spectrum can be used to detect the presence of secondary structures such as 
helices, β-sheets, β-turns, and random coils.14,115,117,118 Examples of these common 
diagnostic CD spectral profiles are shown in Figure 2.12 for some selected 
polypeptides and proteins.14 
 
For molecules containing chromophores, conformational configurations or 
supramolecular assembly can produce a CD signal in the visible region of the 
spectrum. The CD response in the visible region arises exclusively from chirally 
arranged chromophores and does not contain contributions from individual 
monomeric chromophores. A CD response in the visible can be advantageous in 
cases where the UV region contains many CD active moieties. Numerous studies 
using CD spectroscopy for analysis of chiral perylene supramolecular assemblies 
have been reported. Among these are: the ionic self-assembly of perylene-chiral 
surfactant complexes,119 the hydrogen-bond-directed formation of chiral, helically-
stacked PDI-melamine assemblies,120 and the co-self-organization of oligo(p-
phenylene vinylene) and PDI dyes.121 In these examples, the achiral perylene core is 
incorporated into a chiral  arrangement  or  environment  by  substituent  influences 
 
 
Figure 2.13 (a) Overlaid CD spectra of a chiral enantiomeric perylene diimide 
pair measured in toluene solution with an inversion of the CD couplet observed 
between the enantiomers. (b) The PDI structures differ only in the stereocenter (*) 
configurations adjacent to the perylene core. (Figure adapted for review from 
Schmidt et al.122 with permission from Wiley-VCH.) 
(a) (b) 
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invoking self-assembly. In a simple case, chiral centers in moieties near the perylene 
core can impart a chiral sense upon π-stacking as illustrated in Figure 2.13.122 An 
inversion of the chiral centers causes the sign of the CD spectrum to switch. 
 
A more in-depth discussion of CD spectroscopy as a diagnostic tool in analyzing 
chiral chromophore self-assembly will be made in Chapter 4; however, the 
distinctive, diagnostic CD spectral profiles associated with peptide β-sheets (Figure 
2.12) and with chiral chromophore assemblies (Figure 2.13) will feature in various 
instances throughout this work and are noted here in advance. 
2.6.4 Chiral Aggregate Modeling 
Calculations based on the exciton (coupled oscillator) model for optical activity 
may be applicable along with CD spectra to provide non-empirical determinations 
of structural configurations of both organic and inorganic molecules.123 CD 
spectroscopy has been used in relation to exciton coupling to study 
oligothiophenes,124 coordination compounds,112 dissymmetric pseudo-tetragonal 
metal complexes,125 and perylene diimides.126 Using structural and spectroscopic 
clues to model the supramolecular structures formed, CD spectra potentially can 
provide additional information, permitting the derivation of geometric models of 
the ordered, chiral aggregate structures detected. A discussion of these calculations 
follows from the illustrations given in Figure 2.14.114 
 
For the derivation of geometric models using CD spectra, helical supramolecular 
assemblies yield immediate clues regarding configuration. For such helical 
assemblies, the presence of a Cotton Effect couplet indicates a left-handed, counter-
clockwise (M) helical arrangement or a right-handed, clockwise (P) helical 
arrangement of the transition dipoles.119 Upon confirmation of a helical assembly, 
calculations pertaining to exciton coupling may allow estimates of the torsion angle 
between two chromophores around the central axis leading to modeling of the 
helix.121 Accomplishing such calculations, however, requires either an assessment 
of the associated parameters or some simplifying assumptions. 
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Figure 2.14 Illustrations relating chiral geometry, exciton coupling, and CD 
spectra: (a) Splitting of the excited states of two degenerate exciton coupled 
chromophores; (b) Illustration of the geometrical parameters relating two exciton 
coupled chromophores; (c, d) Theoretical absorbance and CD spectra, respectively, 
resulting with exciton splitting. Component spectral curves are given in blue/red; 
resultant spectra are shown in violet. (Figure adapted for review from Berova et 
al.114 with permission from RSC.) 
As previously discussed, when two or more chromophores are associated closely 
together, they may become exciton coupled, causing the excited states of the 
chromophores to split into two levels as shown in Figure 2.14a. The interval 
between these levels (known as Davydov splitting) has an energy difference equal to 
twice the exciton splitting energy, J, which is defined from exciton theory by 
Equation 2.5,126 where μ1 and μ2 are the magnitudes of the electronic transition 
dipole moments of the two chromophores (in isolation), r is the center-to-center 
separation distance between the chromophores, θ is the rotational offset, and α1 and 
α2 are the angles between the dipole vectors and the r vector. These parameters are 
illustrated in Figure 2.14b. 
 
                 (2.5) 𝐽 =
𝜇1𝜇2
𝑟3
 𝑐𝑜𝑠 𝜃 − 3 𝑐𝑜𝑠 𝛼1 𝑐𝑜𝑠 𝛼2   
(a) 
(b) 
(c) 
(d) 
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The exciton splitting energy depends upon both the magnitudes of the electric 
transition dipole moments as well as their mutual orientation and proximity. For 
cases where the chromophores are degenerate, μ1 = μ2 which simplifies these terms 
in Equation 2.5 to μ2. Evaluation of μ2 can be accomplished by integrating the 
absorption band of the chromophore according to Equation 2.6,127 where ε(ṽ) is the 
molar extinction coefficient as a function of wavenumbers, c is the speed of light, h 
is Planck’s constant, ε0 is the permittivity, and NA is Avogadro’s number. 
 
 
                 (2.6) 
 
Two parameters associated with an exciton-coupled helix may be immediately 
assessed via spectroscopy. First, the exciton splitting energy itself may be evaluated 
from a well-defined positive and negative peak couplet (Cotton effect) within a CD 
spectrum (purple line in Figure 2.14d), where J is equal to half of the difference in 
energy associated with the Davydov splitting (Figure 2.14a,d). Second, a value for μ 
can be evaluated from the integrated absorption spectrum. Proceeding with a model 
from this point requires more information or simplifying assumptions. One such 
possibility is to assign a separation distance for r based on known PDI crystal 
structures. Computational assessments of the chromophore orientation angles θ, α1 
and α2 might then be possible. During this study, however, such attempts were not 
successful given the numerous value combinations possible which can result in the 
same value of exciton splitting, J. Accordingly, simple data fitting was found to be 
an inappropriate computational approach. Further attempts at such analyses would 
be expected to be improved through the use of statistical methods such as a Markov 
Chain Monte Carlo methodology,128 which might successfully evaluate multiple 
permutations of interdependent variables across a range of values in a probabilistic 
manner. Such efforts might arrive to a set of likely variable values which could be 
applied to the aggregate models.   
2.7 Summary 
The topics discussed in detail in this chapter enumerate several crucial aspects 
which enable the development of peptide-substituted perylene imides. Solid-phase 
𝜇2 =
3ℎ𝑐𝜀0 ln 10
2π2𝑁𝐴
 
𝜀 𝜈  
𝜈 
𝑑𝜈 
𝜈 2
𝜈 1
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peptide synthesis enables access to a wealth of peptide sequential variations which 
may be used to enhance, guide, and tune guide supramolecular self-assembly. 
Peptide termini (particularly the amino terminus), present resident moieties which 
can facilitate incorporation of the peptide into a molecule of interest for self-
assembly, and synthesis of N-substituted peptide-perylene imides can be easily 
achieved via amine condensation reactions, permitting the synthesis of a small 
library of peptide-perylene imides employing peptide sequences with three key 
regions relevant to rational self-assembly design.  
 
Both microscopy and spectroscopy are well suited for the analysis of peptide 
perylene imide nanostructures formed in dilute solutions, and these techniques 
firmly address two essential goals of proving the formation of ordered 
nanostructures and probing the internal architectures of any nanostructures formed. 
Cryo-TEM allows superior visualization of fine nanostructures in solution, while 
AFM provides evaluation of the nanostructure morphology in solid-state. Even at 
micromolar concentrations, UV-vis spectroscopy is sensitive to changes in the local 
electronic environment associated with perylene π-stacking interactions, supplying 
rich behavioral detail which can be attributed exclusively to chromophore stacking 
due to the imide nodal positions. Enhancing this rich behavioral detail further, CD 
spectroscopy can be used in the visible region of the CD spectrum to detect the 
presence of chiral assemblies formed from the self-assembly of perylene imide 
monomers, while the UV region of the CD spectrum can be used to detect the 
presence of secondary structures formed by the peptide. 
 
Taken together, the information gathered from the clues these techniques provide 
facilitates the evaluation of structural features impacting self-assembly and 
nanostructure morphology. Consequently, underlying thermodynamic factors as 
well as chiral influences may be evaluated toward the goal of applying self-
assembling peptide-substituted organic semiconductors into organic electronic 
devices. 
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Chapter 3 
Thermodynamic Factors 
Impacting the Peptide-Driven 
Self-Assembly of Perylene 
Diimide Nanofibers 
3.1 Introduction 
Nature has a refined, exquisite self-assembly toolbox, which is illustrated in 
proteins whose precise three dimensional folding and interaction with other 
elements is encoded by the sequence of amino acids.129–131 Protein subunits can be 
bound in specific configurations via relatively short (<10 residue) sequences that 
have very high affinities driven by a balance of charge interactions, hydrogen 
bonding, hydrophobicity, and shape.18,130 
 
Inspired by self-assembly in natural systems, synthetic peptides have gained 
significant interest as a powerful new class of molecular self-assembly agents.17,18,20,24 
Peptide amphiphiles, generated via the attachment of a long alkyl chain to a peptide 
headgroup, have been shown to exhibit sequence dependent self-assembly into well-
defined fibers,132 sheets,16 vesicles,133 micelles,134 and sacs.135 These self-assembled 
nanostructures have been explored for use as small molecule encapsulation and 
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delivery assemblies,22,136 mineralization templates,17 magnetic resonance imaging 
contrast agents,137 and support networks for regenerative medicine.96 
 
π-conjugated molecular semiconductors have also been incorporated into peptide 
amphiphile type molecules, raising new possibilities in molecular electronics 
applications.138 Here, tethered peptides could fulfill the requirement for building 
blocks to be deposited from an ink and assembled over macroscopic length scales 
with finely tuned electronic coupling between neighboring molecules. π-conjugated 
molecules also exhibit optical absorption and emission signatures that are sensitive 
to their immediate environment and the nature of coupling with their neighbors, 
providing an incisive probe of their assembly. Several studies have undertaken 
spectroscopic investigations of short peptides attached to π-conjugated units, 
including perylene diimides (PDIs),74,79,122,139,140 naphthalene diimides,15 
oligophenylene vinylenes,141 1,4-distyryl benzene,142 pyrene,22 fluorene,24 and 
naphthalene.143 PDIs are particularly attractive, owing to their excellent 
performance as n-type semiconductors in field effect transistors37,38,65,144,145 and 
photovoltaic devices,121,146–148 excellent photostability,37,39 and their synthetic 
accessibility. Moreover, the electronic properties of PDIs exhibit strong 
spectroscopic sensitivity to the orientation of neighboring PDI units.39 By tethering 
substituents to the imide position of PDIs, it is possible to alter the type of assembly, 
while ensuring that spectroscopic perturbation relates only to aggregate structures, 
since imide substituents are not directly coupled to the frontier molecular orbitals 
responsible for the visible absorption in the PDI chromophore.39,108 Non-peptide 
imide substituents have previously been used to control the formation and 
morphology of PDI nanofibers and demonstrate their potential for use in nanoscale 
devices.43,65,149 However, limited quantitative understanding of the balance of 
competing aggregation forces has thwarted efforts to deterministically encode 
assembly of electronically active units via peptide sequences. 
 
Herein is presented a systematic investigation of how incremental changes to short 
peptide sequences affect the binding thermodynamics of peptide-PDI molecules. By 
spectroscopically parameterizing the type and degree of aggregation as a function of 
temperature, it is possible to decouple enthalpic and entropic contributions to 
aggregation and link them to structural features of the peptides. In this chapter most 
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of the measurements presented were undertaken in water, which can itself can act 
as a self-assembly “matrix”,150 and leads to pronounced sensitivity to the peptide 
hydrophobicity. Other factors whose significance we quantify include; asymmetric 
substitution with hexyl chains, peptide charge density, steric bulk, and isomeric 
substitution. Collectively, it was found that coarse parameters like hydrophobicity 
and hexyl substitution play the biggest role in driving aggregation, however the 
nature of interactions between neighboring PDI units can be finely tuned via more 
subtle effects like the peptide’s three dimensional shape. 
3.2 Results and Discussion 
To investigate the effect of peptide sequence on the self-assembly of peptide-PDI 
conjugates, a set of conjugates with widely varied structural features was 
synthesized consisting of the following three strategic peptide regions highlighted in 
Scheme 3.1. i) a glycine unit presents a reactive terminal amine and low steric 
demand efficiently condensing with perylene anhydride; ii) a central sequence of 
three amino acids; and iii) a terminal glutamic acid region introduces charge that 
engenders solubility and hydrophilic character. Coupling peptides via an imide 
ensures that we can spectroscopically isolate their effect on assembly rather than 
directly modulating the electronic structure of the chromophore, because PDI does 
not have frontier orbital density in this position. 
 
 
Scheme 3.1     General structure of the peptide-PDIs explored in this study. 
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Based on this strategy, the specific peptide sequences shown in Scheme 3.2 were 
synthesized in order to probe the effects of incremental structural variations on the 
multifaceted interactions that govern peptide-driven PDI assembly. This modular 
synthetic strategy, detailed in Chapter 2, relies on standard solid-phase peptide 
synthesis, followed by condensation of cleaved peptides with perylene dianhydride 
to deliver peptide-PDI conjugates in high yield. In addition to the dipeptide-PDI 
series 1-8, conjugates 1H-5H featured PDIs with a hydrophobic hexyl chain in 
place of one of the peptides to engender pronounced amphiphilic character.96 The 
effect of different amino acids may be considered relative to glycine rich references 
PDI 1 (for dipeptide-PDIs 1-8) and PDI 1H (for hexyl-PDIs 1H-5H). The impact of 
increasing the peptide hydrophobicity and the steric demand can be evaluated by 
comparing PDIs 1-8, while the effect of replacing one peptide with a hexyl chain is 
revealed by comparing dipeptide-PDIs 1-5 with their hexyl-PDI counterparts 1H-
5H. The effect of charge density can be examined by comparing PDI pairs 2/3 and 
2H/3H, and the effect of peptide length is probed by comparison of 1 and 5. 
Additionally, the diastereomer pairs 3/4, 7/8, and 3H/4H provide an opportunity 
to examine the role of stereocenters and specific structure within the peptides. 
 
 
Scheme 3.2     Synthesis of peptide-substituted perylene diimides. 
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3.2.1 Solution Preparation 
Concentrated stock solutions were prepared by dissolving 1.3-1.8 mg samples of the 
PDI compounds into 1 mL of water containing a small amount of an added base, 
thus producing 800 μM stock solutions. This approach utilized the ionizable 
glutamic acid residues built into the three-region peptide design (Scheme 3.1) to 
engender aqueous solubility. Although many possible bases are available which 
might be used for the stock solutions, prolonged exposure to strongly nucleophilic 
bases such as sodium hydroxide and primary amines was avoided to prevent 
potentially destabilizing the imide moieties of the compounds. For example, during 
initial solubility investigations using PDI 6, high concentrations of primary amines 
such as 1-hexylamine and ethylenediamine were found spectroscopically to slowly 
degrade the PDI material over time. Additionally, bases such as sodium hydroxide 
were avoided to minimize potential charge-screening by introduced ions and salts, 
which had been shown in previously published studies of peptide-PDIs to impact 
their aggregation.79 To minimize potential issues with strongly nucleophilic bases 
and introduced ions and salts, pyridine was selected as the base for use in the stock 
solutions used for spectroscopy and was added at a concentration of 200 μL per 10 
mL of water. Pyridine was also anticipated to provide some small enhancement to 
peptide-PDI solubility through π-stacking while also being easily removable as a 
volatile organic base. It should be noted here, however, that while pyridine was 
used for the stock solutions diluted for spectroscopy, it was avoided (due to toxicity) 
in the stock solutions prepared for AFM imaging, since these samples did not 
require extended exposure to the basic solution during preparation, and since 
charge-screening was not relevant to the solid-state imaging. 
 
Solutions for the spectroscopic analyses were prepared by diluting (injecting) small 
volumes (20-40 μL) of the aqueous stock solutions of the PDI materials (described 
above) into 5 mL of the dilution solvents of interest, thus producing 3-6 μM 
solutions for spectroscopic analysis. At this stage, the resulting solution could be 
designed to leave either a slight residual of base or a slight residual of acid. For 
example, if the stock solution (described above) is injected into distilled water, a 
solution with some residual base is produced, but if the stock solution is injected 
into 0.1 M HCl, a solution with some residual acid is obtained instead. Thus, the 
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final pH of the solvent environment can be adjusted to influence the extent of 
equilibrium exchange between the self-assembled aggregates and the solution. 
 
For the studies presented in this chapter, solutions having residual base were 
chosen since these solutions were found to exhibit UV-vis spectra with a greater 
temperature-dependence than those spectra examined for solutions with residual 
acid (which displayed minimal temperature-dependence). The negligible 
temperature-dependence for the spectra of the residual acid solutions suggested 
strongly aggregated assemblies with little or no self-assembly equilibrium in the 
solvent, while the greater temperature-dependence for the spectra of the solutions 
with residual base indicated the presence of some extent of a self-assembly 
equilibrium which was crucial for the application of the temperature-dependent 
analyses presented in this chapter. 
 
The use of the aqueous stock solutions described earlier presupposes a dilution 
solvent which is miscible with water; however, this method may be modified by 
making the stock solutions in acidic solvents such as TFA or HFIP. These solvents 
effectively dissolve the peptide-PDI materials due to the disruption of hydrogen-
bonding and the protonation of many sites on the molecules. Care must be taken 
when diluting such stock solutions to ensure dilution solvent compatibility, and the 
acids must be appropriately neutralized within the dilution solvent (if necessary) to 
ensure the desired pH in the resulting solution. 
3.2.2 Self-Assembly Process 
Self-assembly of the peptide-PDI materials was simultaneously achieved with 
solution preparation. During the solution preparation, the final dilution step of the 
aqueous stock solution into the solvent of interest also served as the process to 
induce self-assembly. Accordingly, upon injecting, diluting, and mixing the stock 
solution aliquot into the solvent of interest, a change in pH and/or a change in 
solvent environment for the peptide-PDI units occurs. With this change, the 
ionizable glutamic acid region of the peptide no longer moderates the strong 
solvophobic/solvophilic interactions, which consequently triggers the peptide-PDI 
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units to self-assemble during the process. This employed self-assembly process is 
specified here, since the process employed (not just the particular molecular units 
undergoing self-assembly) has been shown to be relevant to self-assembly outcomes, 
such that different processes (for the same molecular units) sometimes produce 
different self-assembly results.151 This can arise from the fact that molecular self-
assembly units with strong solvophobic/solvophilic influences may assemble by 
kinetic control in favor of the most direct mode of assembly which alleviates the 
solvophobic/solvophilic tensions without necessarily arriving to the most 
thermodynamically favorable self-assembly state. Accordingly, kinetically 
controlled self-assembly processes may produce assemblies which are effectively 
trapped states that are energetically above some thermodynamic minimum. As a 
result, different processes may be either kinetically or thermodynamically 
controlled and may access different states. In this study, the term “thermodynamic 
factors” is used to indicate thermodynamic properties measured for the 
nanostructural outcomes (states) achieved by the self-assembly process described 
here. The term “thermodynamic factors” is not used with regard to kinetically 
versus thermodynamically controlled self-assembly process distinctions which this 
study does not directly address.         
 3.2.3 Nanostructure Formation from Peptide-PDIs 
To verify that the peptide-PDIs self-assembled into ordered nanostructures, samples 
were analyzed by atomic force microscopy (AFM), transmission electron 
microscopy (TEM), and circular dichroism (CD) spectroscopy. AFM imaging of 
samples dropcast and dried onto mica from solutions with PDI concentrations near 
saturation were observed to produce particulate formations (Figure 3.1). 
 
AFM imaging of samples dropcast and dried onto mica from solutions with lower 
PDI concentrations plus some residual base (NaOH) were also observed to produce 
larger aggregated deposits, but these deposits did not display a particulate 
morphology. In one instance, morphologies resembling crystalline deposits or 
aligned fibrous bundles were observed (Figure 3.2a). In most cases, only irregular 
clusters were seen, but fiber-like  strands  could  be  seen to  be  forming  among  the  
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Figure 3.1    AFM images shown in height mode (top row) and deflection mode 
(bottom row) of deposits of PDI 3 (dropcast from 1000 μM solution in 0.1 M HCl, 
solution aged 2 minutes), showing particulate formations in three views (a,b,c). 
 
Figure 3.2    AFM images shown in height mode (top row) and deflection mode 
(bottom row) of deposits of PDI 3 (dropcast from 50 μM aqueous solution with 
residual base, aged 4 days): (a) Crystalline formations or aligned fibrous bundles; 
(b,c) Fiber-like strands seen between larger deposits. 
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clusters (Figure 3.2b,c). However, imaging of samples dropcast from solutions in 
dilute acid (to fully pH-trigger self-assembly) displayed abundant fibers (Figure 3.3). 
 
Here it is important to make some comments about solution aging. In a few 
instances, aging the solution prior to dropcasting samples onto the mica substrate 
initially appeared to impact the quality and number of the fibers, as illustrated when 
comparing Figure 3.3a,b (fibers from solutions aged 3 days) to Figure 3.3c (fibers 
from a freshly prepared solution aged 2 minutes). Usually, however, the onset of 
extensive aggregation and fiber formation was observed to occur rapidly and 
completely. Further investigation of solution aging (using solutions of the same 
concentration and solvent environment), however, revealed no conclusive evidence 
that aging impacted the nature or extent of the self-assembled nanostructures. 
Instead, the earlier perceived differences were found to be most likely attributed to 
mass distribution differences on the mica substrate surface. Nevertheless, the 
solution ages associated with the selected AFM images shown in this chapter are 
included for completeness along with the other reported experimental conditions. 
 
 
Figure 3.3    AFM images shown in height mode (top row) and deflection mode 
(bottom row) of deposits of PDI 3 (dropcast from 50 μM solution in 0.1 M HCl): (a) 
Fibrous formations surrounding larger aggregates (aged 3 days); (b) Magnified view 
of interlaced fibers (aged 3 days); (c) Isolated fibers (solution aged 2 minutes). 
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Figure 3.4    AFM images shown in height mode (top row) and deflection mode 
(bottom row) of deposits of PDI 4 (dropcast from 50 μM solution in 0.1 M HCl, 
aged 3 days): (a) Fibrous formations surrounding larger aggregates; (b) Magnified 
view of matted fibers; (c) Magnified view of interlaced fibers. 
Figure 3.5    AFM images shown in height mode (top row) and deflection mode 
(bottom row) of deposits (dropcast from 50 μM solution in 0.1 M HCl): (a) PDI 3 
(aged 3 days); (b) PDI 3H (aged 1 day); (c) PDI 3H (aged 1 day). 
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Figure 3.6    AFM images shown in height mode (top row) and deflection mode 
(bottom row) of deposits (dropcast from 50 μM solution in 0.1 M HCl): (a) PDI 2 
(aged 3 days); (b) PDI 5 (aged 4 days); and (c) PDI 5H (aged 1 day). 
 
Of the samples imaged, PDIs 3 and 4 were both observed to most readily form 
fibrous nanostructures and both gave similar morphologies; however PDI 4 was 
found to produce masses of fibers with a denser, matted appearance in all cases 
observed. The fibrous networks generally appeared less diffusive (Figure 3.4a,b), 
while individual fibers also appeared shorter (Figure 3.4c). 
 
To further investigate the internal architectures of the nanostructures of PDIs 3 and 
4 confirmed by AFM, TEM microscopy and CD spectroscopy analyses were 
undertaken. As shown in Figure 3.7a,b, well solvated monomers of PDIs 3 and 4 in 
DMSO lack CD features in the visible region because the solvated chiral amino 
acids do not affect the PDI chromophore. However, aqueous solutions of PDIs 3 
and 4 exhibited a CD couplet in the visible region (as did other aggregated 
compounds), indicating exciton coupling between ordered PDI chromophores in a 
chiral supramolecular assembly.119 These chiral aspects provide significant insight 
about the internal structure of the fibers and will be addressed in detail (along with 
relevant comments about dynode voltage data) in Chapter 4. Strong light 
absorption  from  the  residual  pyridine  in  the  solutions  obscured  the  UV  range,  
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Figure 3.7    Detection of PDI nanostructure self-assembly as exemplified by 3 and 
4: (a) Circular dichroism spectra of 3 and 4 showing chiral supramolecular 
assembly in aqueous solutions. Reference spectra are shown for DMSO solutions, 
where molecules exist as monomers (all solutions 3 μM). Cryo-TEM image of 
nanofibers captured in vitrified aqueous solution of (b) 3 and (c) 4. TEM image of 
an air-dried deposit of nanofibers of (d) 3 cast from a 50 μM aqueous solution at pH 
5, and (e) 4 cast from a 50 μM solution in 10% DMSO/water at pH 5. AFM 
deflection (error) mode image of dry 72 h aged nanofibers deposited on mica from a 
50 μM solution in aqueous hydrochloric acid (0.1 M) of (f) 3 and (g) 4. (Figure 
adapted from Eakins et al.88 with permission from ACS.) 
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preventing inspection of any peptide CD response; however, the visible region of 
the spectrum was of primary interest as proof of chirally assembled achiral 
chromophores. 
 
Cryogenic TEM images of PDIs 3 and 4 (Figure 3.7c,d) provided further detail on 
the nature of the supramolecular aggregates captured in vitrified solution, verifying 
the formation of nanofibers. Closer magnification of PDI 4 (Figure 3.7d) shows a 
ribbon-like architecture comprised of aligned, interacting fibers, where the dark 
lines correspond to hydrophobic fiber interiors comprised of π-stacked perylene 
cores of individual PDI units and the lighter-contrast areas correspond to interfiber 
regions comprised of the hydrated peptides. Nanofiber deposits of PDI 3 and 4 
shown in the dry TEM images (Figure 3.7e,f) exhibited extensive fibers or fiber 
bundles with an average width of the bundles of PDI 3 being around 13 nm. 
  
By comparison, AFM measurements of the nanofiber deposits from solutions of 
PDIs 3 and 4 found that the nanofibers formed from PDI 3 (Figure 3.7g) also 
tended to be present in more diffusive bundles with heights of 15-20 nm (along with 
some isolated fibers), while the nanofibers formed from PDI 4 (Figure 3.7h) tended 
to be present in matted bundles with heights of 30-45 nm. These matted fiber 
bundles were a common feature seen by AFM as previously discussed. 
   
3.2.4 UV-vis Spectroscopy and Data Fitting Analyses 
Having confirmed that peptide-PDIs self-assemble into nanofibers in solution, a 
spectroscopic examination of their assembly was performed. UV-vis spectroscopy is 
ideally suited to probe the local electronic environment of the PDI core because 
small differences in the extent, nature, or orientation of coupling between 
neighboring chromophores result in spectral shifts. The spectra shown in Figure 
3.8a illustrate three important representative spectral profiles that dominate all of 
the spectra we measured: monomer, H-aggregate, and π-aggregate. The absorption 
spectrum of 3 in DMSO exhibits a well-defined vibronic progression with ~1400 
cm−1 splitting and diminishing intensity for higher energy transitions, consistent 
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with isolated (monomeric) PDI units. This was further verified by comparison with 
an N,N′-dialkyl PDI reference compound in a dilute chloroform solution. The 
spectrum of 3 in water, however, exhibits a relatively diminished 0-0 transition, 
which is a clear signature of a weakly coupled H-aggregate. In a strongly exciton-
coupled pure H-aggregate, the 0-0 transition is dipole forbidden and higher 
transitions are only allowed by coupling to vibrations of the appropriate symmetry. 
In real cases with weak coupling or rotational offset and disorder between 
chromophores, the 0-0 transition has a reduced intensity, as we observe here.109 
More extensive changes are seen for 3 in acetonitrile, where the broad spectrum 
lacking vibronic features is reminiscent of spectra found for ordered liquid 
crystalline phases of PDI derivatives that exhibit strong coupling between π-orbitals 
that become delocalized.152–156 This indicates that the solution of 3 in acetonitrile 
induces a spectroscopically distinct aggregation mode, for which the term “π-
aggregate” is used to refer to electronic interactions that manifest differently from 
the vibronically structured H-aggregate mode described above. In spite of solubility 
limiting spectroscopic investigations to micromolar concentrations that are too 
dilute for NMR spectroscopy, the peptide-PDI solutions display UV-vis spectra 
with rich and quantifiable behavioral detail. 
   
Figure 3.8   Data fitting to determine spectral contributions: (a) Representative 
spectra (normalized by peak area) of monomers, H-aggregates, and π-aggregates 
obtained from 3 in DMSO, water, and acetonitrile, respectively. (b) Absorption 
spectrum of 6 in 2,4,6-trimethylpyridine fit to a sum of the three spectral 
components (labeled as ‘calculated curve’). The evaluated individual spectral 
contributors (as determined by Equation 3.1) are overlaid for comparison. All 
solutions 3 μM. (Figure adapted from Eakins et al.88 with permission from ACS.) 
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Most absorption spectra appeared to reflect a combination of the three spectral 
components, as shown in the representative plot in Figure 3.8b (and other spectral 
data in the supporting information, Appendix D), prompting an approach to fit 
each spectrum to a sum of the three basis spectra. 
 
For the fitting procedure, all absorption spectra were first baseline corrected to 
remove effects attributed to scattering from aggregated particles, then normalized 
by their integrated area (on an energy scale). Each absorption spectrum, C(λ), was 
fit as a linear combination of three representative spectra corresponding to 
monomer (M(λ)), H-aggregate (H(λ)) and π-aggregates (A(λ)) as given by Equation 
3.1. Fits were accomplished by varying their respective coefficients x, y, and z, 
along with parameters m, h, and a, which compensated for any solvent-dependent 
spectral shifts. The residual sum of squares was minimized subject to the 
constraints that all coefficients have positive values and sum to one and spectral 
shifts for each component could not exceed 15 nm.  
 
 C(λ) = x[M(λ − m)] + y[H(λ − h)] + z[A(λ − a)]        (3.1) 
 
This simple model was found to fit the experimental spectra very well and gave a 
means to quantify the underlying aggregate components under different conditions 
and thereby develop meaningful structural and thermodynamic correlations. While 
many spectra were dominated by one or two components, others were only well fit 
with contributions of all three, as the example in Figure 3.8b shows. Earlier 
attempts at spectral data-fitting involving a simple subtraction of a scaled multiple 
of the monomer spectrum were unsuccessful. The rationale to the earlier approach 
was that if all monomers contributions were subtracted, all remaining contributions 
would be those of any aggregated species present. Using this approach and 
minimizing the residual sum of squares for the second derivative (as a measure of 
spectral trace smoothness) was found to produce unrealistic calculated aggregate 
spectral profiles which incorrectly evaluated effects from H-aggregate species and 
overstated monomer species contributions. This prompted the three-component 
spectral fitting described by Equation 3.1. 
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3.2.5 Thermodynamic Properties of PDIs in Aqueous Solution 
The effect of temperature was investigated in order to extract thermodynamic 
parameters associated with aggregation. In all cases, the fraction of monomeric 
species was found to increase with increasing temperature, as expected. For 
example, Figure 3.9a shows a room-temperature H-aggregate spectrum for an 
aqueous solution of PDI 3 that gradually becomes monomeric with increasing 
temperature as aggregates are broken up, at least in the spectroscopic sense of short-
range coupling. Clear isosbestic points were observed, suggesting that the transition 
is well described by these two species, as confirmed by the data fit in Figure 3.9b. 
 
Figure 3.9    (a) Temperature-dependent absorption spectra of an aqueous solution 
of 3. (b) Spectral fitting confirming dominance of monomer and H-aggregate 
contributions, and yielding (c) a calculated spectral-fit series, which was fit in (d) to 
Equation 3.2 (inset) to obtain ΔH and Tm. All solutions 6 μM. (Figure adapted from 
Eakins et al.88 with permission from ACS.) 
Spectral data fitting done as shown in Figure 3.9b at each selected temperature 
produced a calculated spectral series (Figure 3.9c) which closely matched the 
measured experimental series (Figure 3.9a). The temperature-dependent conversion 
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of H-aggregates to monomers was plotted in Figure 3.9d, and was also confirmed 
to be reversible upon cooling (Figure 3.10), justifying the thermodynamic approach. 
This reversibility is also important from the perspective of the self-assembly process, 
since different processes (for the same molecular units) have been shown to 
sometimes produce different self-assembly outcomes.151 In this context, is it 
important to underscore that, while a pH-triggered process was used to prompt the 
initial self-assembly of the nanofibers and a different heat-cycle process was used to 
disrupt (and reform) the nanofibers during the temperature-dependent analysis, 
both the pH-triggered and the heat-cycle processes arrived at the same self-assembly 
outcome (as verified by the spectral the profiles observed). 
 
Figure 3.10 Representative spectral data fitting for a solution of PDI 3 during 
heating and cooling, demonstrating thermodynamic reversibility with temperature. 
(a) Spectra collected during solution heating. (b) Spectra collected during solution 
cooling. (c) Spectral data fit at a selected temperature during solution heating and 
(d) during solution cooling. All solutions 7 μM. (Figure adapted from Eakins et al.88 
with permission from ACS.) 
As summarized in Table 3.1, thermodynamic parameters were then evaluated using 
Equations 3.2-3.4, which are derived from the isodesmic model of aggregation that 
considers the addition of monomers to an aggregate to be described by a single 
binding constant, regardless of the aggregate size.157,158 The temperature-dependent 
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data (e.g., Figure 3.9d) were fit to Equation 3.2, where αT is the measured total 
aggregated fraction, and the fitting parameters, ΔH and Tm are, respectively, the 
molar enthalpy of aggregation and the aggregate melting temperature (where αT = 
0.5).158 Using the aggregate fraction values at 298 K, Equation 3.3 afforded values 
for Ke (aggregation equilibrium constant) and DPN (average number of monomers 
in an aggregate stack),158 permitting the evaluation of the free energy (ΔG) and 
entropy (ΔS) of aggregation from temperature dependent data. 
 
         (3.2) 
  
         (3.3) 
 
It must be noted here that DPN measures the size of spectroscopic aggregates, 
which does not give an accurate measure of the much larger physical aggregates 
imaged in Figures 3.5-3.7 owing to the short range of optical coupling. Values of Ke 
and ΔG for nonaqueous PDI solutions at 298 K were determined using Equation 
3.4,157 where c1 is the molar concentration of monomer species present and cT is the 
molar concentration of the total number of molecules in the solution.  
 
     Ke = c1
−1
 − (c1cT)
−0.5
           (3.4) 
 
 
Within the thermodynamic data evaluated from the aqueous temperature-
dependent measurements summarized in Table 3.1, emerging trends can be seen. 
The ΔH and ΔS data give valuable insight into the influences that cause the 
emergence of the observed values of Ke and ΔG. Although many compounds had 
similar aggregation constants, ΔH and ΔS were found to be much more sensitive to 
structural changes including hydrophobicity, steric demand, charge, chiral centers, 
and the addition of an imide hexyl chain. In the next section, each of these effects is 
evaluated in order of their observed importance on the overall aggregation constant. 
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Table 3.1. Aggregation Constants and Thermodynamic Parameters of Peptide-
PDIs in Water  
cpd 
peptide 
(kJ mol
−1
)
 a
 
Ke 
b
 
(M
−1
) 
ΔG 
b
 
(kJ mol
−1
) 
ΔH 
(kJ mol
−1
) 
ΔS 
(J mol
−1
K
−1
) 
Tm
 c
 
(K) 
DPN
 d
 αH
 b,e
 αT
 b,f
 
           1 2.9 ± 0.63 4.6 ×10
6
 −38.0 −53.8 −52.9  385.6 5.7 0.76 1.00 
2 1.9 ± 0.54 1.8 × 10
6
 −35.7 −44.8 −30.5  373.4 3.9 0.78 1.00 
3 1.5 ± 0.63 7.6 × 10
5
 −33.6 −34.7 −3.8  357.4 2.6 0.88 0.89 
4 1.5 ± 0.63 2.0 × 10
6
 −35.9 −29.8 20.5  357.3 2.3 0.11 0.80 
5 1.5 ± 0.54 6.1 × 10
5
 −33.0 −32.3 2.4  354.6 2.4 0.86 0.86 
6 −0.14 ± 0.63 1.5 × 10
5
 −29.6 −14.6 50.3  305.1 1.5 0.10 0.87 
7 −0.34 ± 0.63 1.5 × 10
5
 −29.6 −12.8 56.3  312.9 1.5 0.50 0.59 
8 −0.34 ± 0.63 3.6 × 10
5
 −31.7 −16.4 51.4  375.2 1.9 0.25 0.71 
1H 2.9 ± 0.63 1.5 × 10
6
 −35.3 −34.3 3.2 1055 3.7 0.49 0.93 
2H 1.9 ± 0.54 9.6 × 10
6
 −39.9 −55.1 −51.0  447.0 9.5 0.00 0.99 
3H 1.5 ± 0.63 5.7 × 10
6
 −38.6 −43.3 −15.7  484.0 6.6 0.00 0.98 
4H 1.5 ± 0.63 3.1 × 10
6
 −37.1 −44.2 −23.9  407.8 5.0 0.20 0.97 
5H 1.5 ± 0.54 2.1 × 10
6
 −36.1 −34.4 5.6  756.1 4.6 0.49 0.95 
a 
Peptide substituent hydrophobicity calculated by summing and averaging the contribution of 
each residue according to the whole-residue octanol-interface scale reported by White and 
Wimley.
21
 More negative values indicate greater hydrophobicity. 
b
 Evaluated at 298 K. 
c
 Aggregate melting temperature defined where the aggregated fraction αT = 0.50. 
d
 Average stack length, representing the average number of monomers in an aggregate stack. 
e
 H is the fraction of H-aggregates. 
f 
 T is the total fraction of aggregates (H-aggregates and -aggregates). 
3.2.5.1 Effects from Peptide Hydrophobicity 
The peptide hydrophobicity may be tuned either by changing the number of 
ionizable amino acid residues or by employing amino acid residues with more 
hydrophobic side-chains (e.g., phenylalanine in 6 and leucine in 7). Both 
approaches carry other consequences, since ionizable amino acid residues bring 
electrostatic interactions and large hydrophobic residues are expected to induce 
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steric effects. Nevertheless, the effect of overall hydrophobicity can be established 
by observing whether thermodynamic parameters correlate with values obtained by 
applying an empirical hydrophobicity scale to the peptides considered in this study. 
The hydrophobicity values given in Table 3.1 were assessed using published values 
of the contribution of each amino acid that were derived from whole-residue 
hydrophobicity measurements at water interfaces.21 It is worth noting that these 
values from empirical measurements of amino acids do not quantify the dominant 
hydrophobic contributions of the perylene core or the hexyl chains (in the case of 
1H-5H). These measurements therefore underestimate the overall effect of 
hydrophobicity, but nevertheless allow a comparison of the relative effect that the 
peptide hydrophobicity has on tuning the assembly of compounds containing the 
same hydrophobic core. Comparing dipeptide PDIs 1-7 (excluding diastereomers 4 
and 8, which will be discussed later), increased peptide hydrophobicity (reflected by 
more negative values) is correlated with lower aggregation constants. Figure 3.11a 
shows how each of the thermodynamic parameters vary with hydrophobicity, with 
strong correlations observed across a wide range of binding energies. Since the 
hydrophobicity scale neglects effects like specific sequences, and electrostatic 
repulsion, the observed correlation suggests that crude hydrophobicity is of primary 
importance. 
 
   
Figure 3.11   Thermodynamic parameters of (a) dipeptide-PDIs and (b) hexyl-PDIs 
plotted against hydrophobicity (as ranked by the peptide residue average on the 
octanol-interface scale). (Figure adapted from ref. 88 with permission from ACS.) 
Figure 3.11a also shows that the variation in Gibbs free energy is underpinned by 
much more pronounced, but opposing changes in binding enthalpy and entropy. 
95 
 
The observation that aggregation is strongly entropically favored for hydrophobic 
peptides is in line with expectations. Aggregation allows hydrophobic residues to be 
buried away from the water interface to reduce the effect of the entropically 
disfavored ordered hydration shell. This trend is most clearly seen in PDIs 1, 3, 6, 
and 7, where the hydrophobicity in the central region progressively increases via 
replacing glycine with alanine, phenylalanine, and leucine, respectively. The 
variation in aggregation entropy across this series exceeds the difference between 2 
and 3, where the central alanine region is retained and lower hydrophobicity in 3 
results from the removal of two glutamic acid residues. 
 
The effects on binding enthalpy are more difficult to explain through 
hydrophobicity alone. Instead, the apparent trend that aggregation becomes more 
enthalpically disfavored for more hydrophobic peptides may reflect the greater 
steric demand of the more hydrophobic peptides (e.g., containing phenylalanine 
and leucine sequences). Large residues can interfere with hydrogen bonding 
between neighboring peptide backbones, and even disrupt π-stacking interactions 
between the nearby PDI units. Indeed, we find a steric effect on the spectroscopic 
nature of aggregation (H- vs. π-aggregate), as we discuss later. 
 
There was no discernible effect of hydrophobicity when comparing hexyl PDIs 1H-
5H in Figure 3.11b. The relative importance of hydrophobicity significantly 
diminished compared with the dipeptide series since the peptide accounts for a 
smaller fraction of the hexyl PDI molecules. 
3.2.5.2 Effects from an Imide Hexyl Chain 
Replacing one peptide substituent in dipeptide-PDIs 1-5 with a hexyl chain in order 
to produce hexyl-PDIs 1H-5H gave five PDI pairs to contrast. As illustrated in 
Figure 3.12a, with the exception of 1/1H, the five PDI pairs show that the 
replacement of a peptide substituent with a hexyl chain resulted in a more favorable 
Gibbs free energy of aggregation. This is largely driven by more attractive 
aggregation enthalpies for hexyl derivatives (Figure 3.12b), while no clear trend 
emerged in the widely varying entropic component (Figure 3.12c). 
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Figure 3.12 Thermodynamic comparisons of dipeptide and hexyl-peptide PDI 
pairs showing the effect of an imide hexyl substituent on; (a) ΔG; (b) ΔH; (c) –TΔS. 
(Figure adapted from Eakins et al.88 with permission from ACS.) 
More favorable enthalpies for the hexyl derivatives are likely the result of 
diminished charge repulsion, which will be specifically discussed later, and in spite 
of replacing hydrogen bonding peptides with hexyl chains that have a weaker van 
der Waals interaction. The strong amphiphilicity of the hexyl PDIs also suggests 
that ordered supramolecular assemblies such as cylindrical, rod-like fibers are likely 
to form, where the entropic penalty of ordering must be balanced against the 
entropic penalty associated with solvating hydrophobic chains. The entropic 
contributions specific to aggregate structures may account for the sequence-
dependent aggregation entropies observed. 
3.2.5.3 Effects from Ionizable Amino Acids Residues 
As previously illustrated in Scheme 3.1, the terminal charged and central uncharged 
peptide regions were subject to variation. The length of the charged region could be 
adjusted to impact solubility and to tune sensitivity to solvent composition (salts, 
pH, etc.). When comparing PDI 2 with 3 or PDI 2H with 3H, it was found that 
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increasing from one to three glutamic acid residues on each peptide leads to weaker 
aggregate binding. Delineating the enthalpic and entropic contributions, an 
increased number of charged residues was found to lead to significantly decreased 
enthalpic attraction, presumably due to the electrostatic repulsion associated with 
aggregating a more highly charged peptide. The enthalpic effects overwhelm more 
favorable binding entropy for peptides with more charged groups, where the 
binding entropy may be associated with changes to the hydration shell around the 
charged glutamate groups. The overall observation that decreasing the charge 
density favors aggregation parallels previous work where aggregation in highly 
charged peptides could be triggered by adding salts to screen charge repulsion.79 
 
The removal of three glycine residues from 1 to produce 5 decreased the length of 
peptide-peptide interface while retaining the same terminal glutamic acid region. 
This change resulted in weaker binding for 5, driven largely by a substantially 
decreased enthalpic attraction compared with 1. The diminished enthalpic 
contribution to binding is likely the result of removing the attractive glycine 
interface, which accommodates strong hydrogen bonding along the peptide 
backbone.20 Additionally, the glutamic acid region in 5 is positioned closer to the 
perylene core than in 1, where its increased steric demand and electrostatic 
repulsion could more effectively inhibit aggregation. 
3.2.5.4 Effects from Peptide Stereocenters 
Given that attractive peptide-peptide interactions are found to influence peptide-
PDI self-assembly, the effect of inverting stereocenters was interrogated in order to 
probe the extent of specific structural effects that go beyond hydrophobicity, size, 
and charge, none of which are affected by stereocenter inversion. PDIs 3/4, 7/8, 
and 3H/4H served as three diastereomeric PDI pairs with identical structures 
except in the stereochemistry of the three central amino acids. The diastereomeric 
pairs are not enantiomers (in which case thermodynamic parameters would not be 
affected), because the stereochemistry of the glutamic acid region (L-) remained 
constant. Comparison of these pairs in Table 3.1 shows that the thermodynamic 
parameters were significantly affected by stereocenter inversion, particularly in 3 vs. 
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4, however no universal trend was observed across all three pairs. Particularly 
noteworthy was the stereocenter influence on H-aggregate expression. Evaluating 
the H-aggregate fraction, H, as a percentage of T at room temperature (Table 3.1), 
diastereomeric pairs 3 vs. 4 contrasted, with 99% and 14% H-aggregates, 
respectively. The contrast was also evident for diastereomeric pairs 7 (85% H-
aggregates) vs. 8 (35% H-aggregates), which featured more sterically demanding 
leucine residues in the central region. While π-aggregates require direct overlap of 
π-orbitals, H-aggregates arise from dipolar coupling between chromophores that do 
not need to be electronically coupled. In line with this consideration, it was found 
that some degree of enforced orientation between PDI units impacts H-aggregation. 
Thus, molecular packing considerations were seen to play a dominant role in 
determining the type of aggregation, although the effect of a given stereocenter 
inversion cannot yet be predicted. Measurements in this study did not show that the 
percentage of H-aggregates correlated well with the other structural parameters 
interrogated in this study (vida supra), with solvent polarity (vida infra), or with the 
thermodynamic parameters of binding. 
3.2.5.5 Comparative Summary of Structural Effects 
 
Figure 3.13   A ranking (from greatest to least) of the impact of structural 
influences affecting the PDI thermodynamic parameters. (a) The bars indicate the 
magnitude of the range between the lowest value and the highest value observed for 
each parameter in the relevant PDIs, as well as (b) the standard deviation as a more 
collective measure of variation. Structural influences of higher impact produced 
greater variation in the parameters. (Adapted from ref. 88 with permission of ACS.) 
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Among the structural variations examined, hydrophobicity and the inclusion of an 
imide hexyl substituent produced the greatest changes in the thermodynamic 
properties. Comparatively smaller influences were seen from changing stereocenter 
chirality, varying the number of ionizable amino acid residues or the length of the 
central peptide sequence. This relative importance of the effects examined through 
comparison of thermodynamic binding parameters for various sets of compounds is 
summarized in Figure 3.13. 
3.2.6 PDI Binding in Nonaqueous Solutions 
The strong inherent amphiphilicity of the peptide-PDI molecules was expected to 
produce pronounced sensitivity to the solvent environment, which may be 
exploited to manipulate self-assembly. Spectroscopic data fitting as previously 
described was applied to probe aggregation at room temperature in selected organic 
solvents chosen to provide a range of solvent characteristics. Given that solvent-
solute interactions influence both solubility and chemical equilibria, Figure 3.14 
compares the aggregated fraction compounds 3 and 6 in solution versus empirical 
solvation parameters for a range of solvents (using the ET
N solvatochromic scale159), 
which permits indirect inference into aspects such as solvent polarity and hydrogen 
bonding interactions.159,160 
 
Figure 3.14   Selected plots of the aggregated fraction of (a) 3 and (b) 6 in various 
solvents across a wide range of solvent character (as described by the ET
N 
solvatochromic scale), showing the emergence of two solvent groups. All solutions 
3 μM. (Figure adapted from Eakins et al.88 with permission from ACS.) 
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Two separate solvent groups clearly emerge, as indicated by the circled regions in 
Figure 3.14. The first solvent group (solid red oval) covered a very wide range 
across the ET
N scale but maintained a consistently high aggregated fraction. 
Moreover, DMSO and acetonitrile had  similar  solvation  parameters,  but  DMSO 
 
 
Figure 3.15 Results of spectral data fitting for PDIs in various solvents showing 
changing species composition and aggregate binding. Compounds are listed in 
order of increasing hydrophobicity; solvents are listed in order of increasing polarity. 
(Figure shown from Eakins et al.88 with permission from ACS.) 
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produced a monomeric solution, while acetonitrile produced a highly aggregated 
solution. The second solvent group (dashed red oval), on the other hand, is 
characterized by widely varying aggregate fractions for solvents with similar 
solvation parameters. The emergence of these two solvent groups shows that the 
solvation parameter ET
N does not determine aggregation, and that other solvent 
characteristics must be considered. In particular, solvents capable of π-stacking gave 
noticeably lower aggregate fractions since such solvents can interact favorably with 
the PDI core. For example, a solution in benzonitrile gave much more monomeric 
character than did a solution in acetonitrile (Figure 3.14b). Other solvent structural 
features may provide an additional influence. Pyridine and benzonitrile, for 
example, are both capable of π-stacking to solvate the PDI core, but the more basic 
pyridine can interact with the acidic glutamic acid residues and produced a greater 
proportion of monomers in solution than benzonitrile. Similarly, the ability of 
DMSO to solvate the peptide-PDIs may reflect its Lewis base properties. A 
summary of calculated aggregate species fractions of PDIs 1-8 and 1H-5H in 
selected organic solvents is given in Figure 3.15. 
3.3 Conclusions 
A series of peptide-functionalized PDI molecules were synthesized which were 
designed to establish design rules for peptide-driven aggregation through 
incremental variations in peptide hydrophobicity, length, charge density, as well as 
stereocenter inversion and amphiphilic substitution. Having observed the formation 
of nanostructures in solution, a spectroscopic investigation of the thermodynamics 
and nature of aggregation for the series of peptides was implemented. It was found 
that non-specific effects like peptide hydrophobicity and nonsymmetrical 
substitution with a hexyl chain had the greatest impact on binding thermodynamics. 
However, more specific variations like diastereomeric substitution were also shown 
to have a significant impact, particular on the dominance of H- versus π-aggregates, 
highlighting how peptide packing modulates coupling between PDI units. Solvent 
dependent spectroscopy also highlighted the range of peptide- and PDI-based 
interactions responsible for aggregation in these materials. 
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Chapter 4 
Chiral Effects in Peptide-
Substituted Perylene Imide 
Nanofibers 
4.1 Introduction 
Molecules capable of supramolecular self-assembly into nanofibers often possess an 
amphiphilic structure, enabling strong solvophobic/solvophilic associations in 
solution which drive self-assembly. Accordingly, many moieties capable of non-
covalent interactions such as hydrogen-bonding or π-stacking have been utilized to 
form nanofibers, including amino acid  or amide groups,161–163 sugar units,164–166 
gluconamides,167,168 urea functionalities,169,170 and aromatic systems.171–173 Often 
these appended moieties also contain chiral centers that can exert significant 
influence on the nature and stability of the assembled supramolecular 
architectures.174 Such influences are strongly exemplified in gelators, the gels of 
which are comprised of large numbers of fibers, and therefore, highly sensitive to 
the molecular packing and thermodynamic constraints imposed on fiber growth by 
stereogenic centres.174 For example, in one reported case of a monosaccharide with 
five stereocenters, out of the eleven possible stereoisomer configurations, only five 
were found to be good gelators.164,165 Diastereomers, therefore, may behave very 
differently toward self-assembly and yield differing morphologies, as demonstrated 
by n-alkyl aldonamide-derived lipids, which haves been shown to form helical 
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ribbons, rolled-up sheets, or multiple helices, depending upon the particular 
diastereomeric configuration.167,175 
 
Even for self-assembling systems involving π-stacking of achiral chromophores, 
chiral substituents may impart a chiral bias (such as a twist or an orientation offset) 
to nanofiber architectures. Many examples of this have been reported including 
twisted ribbons made from stacked cholesteryl saccharidic porphyrins,171 a hydrogel 
made from a peptide-substituted naphthalene diimide,15 and a twisted tape was 
made of stacked oligoalanine-polyisobutylene-substituted quarterthiophene units.80  
 
This imparted chiral twist motif noted in the preceding examples is also commonly 
observed in self-assembling perylene imide systems with chiral imide substituents. 
Examples of this include: helical strands of a non-symmetric perylene diimide (PDI) 
with a phenyl-linked chiral monosaccharide moiety,176 helical assembly in a 
symmetric PDI employing the chiral disaccharide D-lactose linked to the imide by a 
two-carbon chain,50 and enantiomeric helices resulting from enantiomeric amino 
acid linkers acting as tethers to Newkome-type dendrimers (repetitively branched, 
tree-like molecules with a 1-to-3 carbon-branching pattern and carboxyl or ester 
terminal groups).122 For these perylene imide examples, the linkers adjoining to the 
perylene core, as well as the extended moieties are all different, but all have one or 
more chiral centers influencing the π-stacking of the perylene core. 
 
Perylene imide compounds with multiple chiral centers present added complexity. 
Such is the case for perylene imides with peptide substituents of 4-7 amino acids in 
length which have been reported to form fibers that possess a helical chirality.80,88 In 
these systems, up to seven chiral centers are in place at increasing distances from 
the perylene core. While chiral centers have been shown to induce a helical 
arrangement on the fibers formed in these systems,80,88 the position-specific effects 
of multiple stereogenic systems on chiral and structural changes have not been 
investigated. In this chapter, the effects of specific chiral variations are resolved 
within a series of peptide-functionalized perylene imide molecules that assemble 
into nanofibers. The impact of peptide stereogenic positions, stereochemical 
configurations, amino acid steric demand, and amphiphilic substitution along with 
perylene core modification is examined. 
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4.2 Results and Discussion 
To investigate the influence of peptide chiral centers on the self-assembly of N-
peptide-substituted perylene imides, a series of compounds was synthesized to 
provide key chiral and structural differences, as shown in Scheme 4.1.  
 
 
perylene diimide (PDI) N-hexyl perylene diimide (hexyl-PDI)
perylene imide bis(n-butyl) ester (PIBE)
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R2N
O
O
R1 N
O
O
N
O
O
R3
N
O
O
R4
O
O
O
O
1   R1 = R2 = -Gly-(Gly)3-(Glu)3
3
3E
3M
4
6
7
8 Q3
   R1 = R2 = -Gly-(Ala)3-(Glu)3
   R1 = R2 = -Gly-(D-Ala)3-(D-Glu)3
     R1 = -Gly-(L-Ala)3-(L-Glu)3
     R2 = -Gly-(D-Ala)3-(D-Glu)3
   R1 = R2 = -Gly-(D-Ala)3-(Glu)3
   R1 = R2 = -Gly-(Phe)3-(Glu)3
   R1 = R2 = -Gly-(Leu)3-(Glu)3
   R1 = R2 = -Gly-(D-Leu)3-(Glu)3
3H
3HE
   R3 = -Gly-(Ala)3-(Glu)3
   R3 = -Gly-(D-Ala)3-(D-Glu)3
4H   R3 = -Gly-(D-Ala)3-(Glu)3
   R4 = -Gly-(Ala)3-(Glu)3
 
 
Scheme 4.1 Summary of the N-peptide-substituted perylene imides examined for 
chiral effects, arranged by structural similarity, and an illustration of the self-
assembly strategy employed for these compounds. (Scheme adapted from Eakins et 
al.177 with permission from Taylor and Francis.) 
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The compounds in Scheme 4.1 provided enantiomer and diastereomer pairs to be 
examined in parallel with other structural variables such as peptide side-chain steric 
demand (1, 3, 6, 7), replacement of a peptide substituent with an alkyl chain (3/3H, 
4/4H), and modification of the perylene core (Q3). In conjunction with these 
comparisons, differentiating enantiomer pairs 3/3E and 3H/3HE along with 
diastereomer pairs 3/4 and 7/8 enabled the assessment of the impact of chiral 
center proximity to the perylene core when contrasted with 1 and 3M, which served 
as control compounds. 
 
The peptide substituents were designed to incorporate three regions: an achiral 
glycine linking unit, a central region of three residues to serve as the peptide 
structural variable, and a terminal region of three ionizable glutamic acid units to 
assist solubility and pH-triggered aggregation. The self-assembly strategy depicted 
in Scheme 4.1 capitalized on the innate β-sheet-forming tendency of the peptide 
moieties in concert with the strong π-stacking behavior intrinsic to perylene imides. 
Interactions in this manner thus generated self-assembly principally in one 
dimension, leading to the formation of chiral nanofibers as has been previously 
demonstrated for these compounds.88 This study examined influences related to the 
chiral architecture of these fibers. 
4.2.1 Solution Preparation and Self-Assembly Process 
Solutions for the CD spectroscopy analyses were prepared using the same methods 
and self-assembly processes as those described in Chapter 3 for the UV-vis analyses. 
Briefly, 40 μL aliquots of aqueous stock solutions of the peptide-PDI materials 
(prepared from 1.3-1.8 mg of each compound dissolved into 1 mL of a 
pyridine/water mixture) were diluted into 5 mL of the dilution solvents of interest, 
thus producing 6 μM solutions with residual base for analysis. Solutions for the CD 
spectroscopy in this chapter were prepared exactly as those presented in Chapter 3 
in order to examine chiral aspects under the same conditions as those under which 
the thermodynamic aspects were explored.   
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4.2.2 CD Spectroscopy Methodology 
CD spectra were collected in the visible range of the spectrum from 350-700 nm. 
Although it was desirable to also record the UV region of the CD spectra, which 
could allow identification of any secondary structures formed by the peptides14 (as 
noted in Chapter 2) and provide insight about their self-assembly behavior within 
any peptide-PDI architectures formed, strong light absorption from the residual 
pyridine present in the solutions prevented inspection of the UV range. The visible 
region of the CD spectrum, however, was of primary interest since chirally ordered 
architectures built from the self-assembly of the achiral chromophore cores of the 
peptide-PDIs would manifest distinctively within the visible region of the spectrum. 
Accordingly, the results discussed in this chapter focus on the visible range of the 
CD spectra collected. 
 
During the collection of the CD spectra, the photomultiplier tube detector voltage, 
which is sometimes called the dynode voltage or the high tension (HT) voltage, 
provides a useful instrumental detector response indicator which should be 
monitored during data collection. Appropriate HT voltage ranges during spectral 
acquisition ensures a suitable signal-to-noise ratio and detector response is 
maintained for good data quality. The HT data are further useful to assess spectral 
profiles for potential artifacts. HT data may also be used to assess the extent of 
scattering produced by aggregates in solution, which manifests in the HT data as a 
sloping baseline.  In general, the HT voltage should be maintained below 600 V for 
the data to be valid; however, the signal-to-noise ratio declines significantly above 
500 V and may produce noisy spectra which must be evaluated cautiously.14  
 
For all CD spectra presented in this chapter (and elsewhere), HT voltages were 
maintained below 600 V with most spectra exhibiting HT profiles near or below 
500 V. Some extent of baseline noise was observed but was not sufficient to 
disqualify the spectral data. Also, some moderate sloping of the HT data baseline 
(indicative of scattering) was observed at longer wavelengths for some spectra, but 
the impact of the scattering was determined not to compromise the spectral data 
acquired. Due to the detected scattering, however, the evaluation of apparent fine 
spectral features at the longer wavelengths must be made very cautiously.  
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4.2.3 Chiral Templation 
The formation of chiral chromophore architectures was indicated by circular 
dichroism (CD) spectroscopy in the visible region of the absorption spectrum, 
where only the perylene chromophore contributes. The chiral environment of the 
perylene was found to depend upon the proximity of the peptide chiral centers to 
the perylene core. As shown in Figure 4.1a, compound 1 was CD silent, 
independent of solvent. Although the glutamic acid residues of perylene diimide 
(PDI) 1 have chiral centers, these residues are distal to the perylene core. The 
proximal positions occupied by the glycine residues conversely lack chiral centers. 
These results indicate that effective templation of a chiral arrangement on the 
perylene chromophore requires closer proximity of the chiral centers.  
 
 
Figure 4.1 CD and UV-vis spectra for the control compounds: (a) CD spectra of 
compounds 1 and 3M in three solvents; (b,c) UV-vis spectra of compounds 1 and 
3M (respectively) showing spectral profiles indicative of solvent-dependent changes 
in the modes aggregation adopted by the compounds. (Figure adapted from Eakins 
et al.177 with permission from Taylor and Francis.) 
The presence of proximal chiral centers alone, however, is not sufficient to induce 
an extended chiral architecture with a dominant handedness during self-assembly, 
(a) 
(b) 
(c) 
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as demonstrated by PDI 3M in Figure 4.1. Although 3M has chiral centers close to 
the perylene core, 3M is a meso-compound, an achiral compound containing chiral 
centers but having an internal mirror plane. As a result, since 3M lacks an overall 
chirality, the chirally opposed proximal peptide stereocenters appear to engender a 
mixed templation of left- and right-handed chiral orientations to segments of the π-
stacking perylene chromophores within the self-assembled fibers. Consequently, no 
dominant, extended chiral orientation is expressed throughout the fibers to a 
sufficient extent to produce a strong, well-defined, dominant  CD spectral profile as 
expressed by the weak, but  non-zero CD response of 3M in Figure 4.1a. 
 
In spite of the lack of a strong CD response by PDIs 1 and 3M, the UV-vis spectra 
of the compounds (Figure 4.1b,c) gave clear indications of solvent-dependent 
aggregate assembly behavior.79,88 In DMSO, the spectral profiles exhibited a well-
defined, three-peak vibronic progression indicative of well-solvated, isolated 
(monomeric) PDI units with electronic transitions coupled to the primary 
vibrational mode (C=C stretch). In water, however, the spectral profiles indicated 
an H-aggregated system, having a diminished 0-0 vibronic transition.109 More 
dramatic changes were seen for solutions in acetonitrile, in which the spectral 
profiles of the compounds exhibited a broad, band-like shape similar to spectra 
reported for ordered liquid crystalline phases of PDI derivatives,152–156 suggesting a 
high degree of aggregated π-stacking behavior (termed π-aggregate here in 
distinction to H-aggregates). Thus, while PDIs 1 and 3M illustrated solvent 
responsive self-assembly, the architectures formed were found to be achiral or to 
lack an extended, dominant orientation. 
4.2.4 Chiral Self-Assembly Behavior 
In distinction to the cases of PDIs 1 and 3M, for PDIs 3, 3E, and 4 which possess 
peptide chiral centers positioned proximal to the perylene core, an extended, 
dominant chiral sense was found to be imparted onto the self-assembling perylene 
units resulting in a bisignate couplet (Cotton Effect) in the CD spectra (Figure 
4.2a,c) indicative of exciton-coupled chromophores in a helical arrangement.120,121 
The positive sign of the couplet for PDI 3 (for which the couplet lobes switch from 
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negative Δε to positive Δε with increasing wavelength) indicates a right-handed, P-
helix, wherein the helix twists clockwise around the helical axis viewed with the 
direction of helical propagation.119 For 3E (the enantiomer of 3) in which all 
stereocenters are inverted relative to 3, a mirror image CD spectrum was produced, 
corresponding to the opposite case with a negative sign of the CD couplet and a 
left-handed, counter-clockwise M-helix. Interestingly, when comparing 
diastereomers 3/4, a similar spectral scenario (Figure 4.2c) was seen to that of the 
enantiomers 3/3E (Figure 4.2a).  
 
 
 
Figure 4.2 CD and UV-vis spectra of enantiomers 3/3E and diastereomers 3/4: 
(a) CD spectra of enantiomers 3/3E showing the impartation of a chiral sense on 
the perylene core by the proximal amino acid residues; (b) UV-vis spectra of  3 (3E) 
showing spectral profiles indicative of solvent-dependent changes in the modes 
aggregation; (c) CD spectra of diastereomers 3/4 indicating a chiral chromophore 
assembly and displaying pseudo-enantiomeric behavior; (d) UV-vis spectra of 4 
showing a similar solvent-dependent aggregation response to that of PDIs 3/3E. 
(Figure adapted from Eakins et al.177 with permission from Taylor and Francis.) 
Since the chiral templation originates from the amino acid residues proximal to the 
perylene core, the selective inversion of the stereocenters in just the alanine residues 
(a) 
(b) 
(c) 
(d) 
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allows PDI 4 to influence the chirality of the supramolecular self-assembly much 
the same as does 3E. PDI 4, therefore, acts as a pseudo-enantiomer to PDI 3. 
For PDIs 3, 3E, and 4, the UV-vis spectra (Figure 4.2b,d) were mutually similar 
consistent with the solvent-dependent changes to the mode of aggregation 
previously described; however, for 3, 3E, and 4, the placement of proximal chiral 
centers translated into chiral architectures associated with the aggregate behavior. 
With the chiral architectures formed, a solvent-dependent response was also seen in 
the CD spectra. Slight differences were seen in the CD spectral profiles between the 
aqueous and acetonitrile solutions (Figure 4.2a,c) consistent with the different 
solvent-dependent modes of aggregation indicated by UV-vis spectroscopy. 
Solutions in DMSO were seen to express a weak, but non-zero CD response near 
the baseline, suggesting the absence of a PDI assembly comprised of a majority 
population of PDI units with a dominant, extended chiral order. This result was 
consistent with a solution having a majority population of well-solvated, 
monomeric (unassembled) PDI units as indicated by the spectral signature observed 
in the UV-vis spectra of the DMSO solutions. 
4.2.4.1 Effect of Side-Chain Changes 
Modification of the central structural region of the peptides to incorporate amino 
acid residues with side-chains of higher steric demand (PDIs 7, 8, and 6) yielded 
compounds with similar spectral behavior to that observed for PDIs 3/3E and 4, as 
illustrated in Figure 4.3. The increase in side-chain size, therefore, was not found to 
prevent the impartation of chirality onto the aggregate assembly. Side-chain steric 
demand was observed, however, to impact the absolute intensity of Δε. In a 
sequential progression from PDI 3 to 7 to 6, the absolute intensity of Δε was seen to 
decrease with increasing steric demand. An explanation of this trend can be 
inferred from a simplified model of two identical, parallel, perpendicularly-
separated, and exciton-coupled chromophores, for which the derived relationship 
describing Δε is expressed by Equation 4.1, where μa and μb are the electronic 
transition dipoles of the two chromophores, Rab is their center-to-center transition, θ 
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is the angle between the transition dipoles, and λ is the associated wavelength of the 
transition.119 
 
    Δε ≈ ±(π/4λ)μaμbRab
−2 sin(2θ)   (4.1) 
 
 
Figure 4.3 CD and UV-vis spectra of diastereomers 7/8 and PDI 6: (a) CD 
spectra of diastereomers 7/8 indicating chiral perylene self-assembly and displaying 
pseudo-enantiomeric behavior; (b) UV-vis spectra of diastereomers 7/8 showing 
mutually similar spectral profiles indicative of solvent-dependent changes in the 
modes aggregation; (c) CD spectra of PDI 6 indicating a weak chiral chromophore 
assembly with a solvent-dependent response; (d) UV-vis spectra of 6 showing 
solvent-dependent aggregation response. (Figure adapted from Eakins et al.177 with 
permission from Taylor and Francis.) 
In the simplified model, the intensity of Δε is inversely proportional to the square of 
the separation distance between the chromophores. As a result, the trend of 
decreasing Δε (from 15 to 8 to 4 M−1cm−1) in the progression from PDI 3 to 7 to 6, 
respectively, indicates that the increasing steric demand of the amino acid side-
chains in the progression imposed a larger separation distance and/or a larger 
torsional angle between the dipoles of the PDI units in the chiral assemblies, thus 
diminishing the exciton coupling and intensity of the Cotton Effect across the series. 
(a) 
(b) 
(c) 
(d) 
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Another notable and distinct aspect seen in the CD spectra of Figure 4.3 is the 
emergence of a broad peak or band-like feature centered near 580 nm. While the 
peaks near 425 and 475 nm which comprise the Cotton Effect (centered near 450 
nm) are due to the in-phase and out-of-phase dipolar interactions associated with 
exciton coupling,112,178 the additional, lower energy feature centered near 580 nm 
appears to emerge from other interactions associated with the longer-wavelength 
edge of the band-like π-aggregate profiles seen in the UV-vis absorption spectra. 
Although a scattering artifact cannot be completely ruled out with regard to these 
features, since the HT data do show some scattering in this range, the size and 
shape of these features may suggest something real. It is proposed here that this CD 
feature centered near 580 nm is the result of an interchain excimer within highly 
ordered, π-stacked species. Delocalization within the π-stacked perylene aggregates 
would prompt such a feature to occur at lower energy (longer wavelengths) within 
the spectra. The sign of Δε for the feature would arise from the coincident 
interaction of the precise helical form of the perylene aggregate and the specific 
helicity of the circularly polarized light absorbed. As illustrated in Figure 4.4, both 
left-handed circularly polarized light (EL) and an M-helix made of perylene 
chromophores have dipoles which rotate counter-clockwise around the helical axis 
when moving along the direction of propagation. Similarly, right-handed circularly 
polarized light (ER) and a P-helix have a clockwise configuration along the 
direction of propagation. Absorption of EL by an M-helix would, therefore, induce 
a favorable, coincident interaction not present between EL and a P-helix. (A similar 
case would exist between ER and a P-helix versus an M-helix.) An excimer 
transition dipole which is delocalized along the length of a helix through the same 
π-stacked, chiral environment would experience the same helical interactions with 
the circularly polarized light. Therefore, the sign of Δε for the low energy lobe of a 
Cotton Effect associated with a given perylene helix configuration should be the 
same expressed by the interchain excimer. 
 
By way of example, in Figure 4.3a, PDI 8 shows a negative Cotton Effect (Δε of the 
exciton couplet lobes switches from positive to negative with increasing 
wavelength), indicating that the perylene chromophores are arranged in a left-
handed M-helix with a counter-clockwise rotation (Figure 4.4). Since the lower 
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energy lobe of the Cotton Effect of PDI 8 (near 530 nm) has a negative Δε, a 
negative Δε should also be expected for the interchain excimer (but at a longer 
wavelength). This is indeed seen in the spectra near 580 nm. In fact, for all cases in 
the CD spectra of Figures 4.2 and 4.3, the sign of Δε for the low energy lobe of the 
Cotton Effect is matched at longer wavelengths by the expressed excimeric feature. 
Overall across the CD spectra, with an increasing central amino acid side-chain 
length, a decreasing exciton coupling was seen along with a greater propensity 
toward the expression of this excimeric coupling. 
 
 
Figure 4.4 Illustrations of M and P perylene imide helices compared to the 
helical configurations of left and right circularly polarized light. Clockwise and 
counter-clockwise conventions around the helical axes are specified moving along 
the direction of helix propagation. (Figure shown from Eakins et al.177 with 
permission from Taylor and Francis.) 
4.2.4.2 Effect of a Hexyl Chain Replacement 
An additional structural variation investigated in this study was that of replacing 
one of the imide peptide substituents with an alkyl hexyl chain to generate a 
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strongly amphiphilic, unsymmetrical structure for self-assembly. Although 
enantiomers 3H and 3HE were synthesized along with the corresponding 
diastereomer 4H, these compounds produced a weak CD response near the 
baseline, as shown by the diastereomer pair plots in Figure 4.5. This minimal, but 
non-zero CD response indicated the absence of a singular, dominant, extended 
chiral architecture, suggesting the highly amphiphilic nature of these structures is 
less conducive to extended chiral self-assembly.  
 
 
Figure 4.5 CD and UV-vis spectra of unsymmetrical, highly amphiphilic 
diastereomers 3H/4H: (a) CD spectra showing a weak, non-zero response; (b) UV-
vis spectra of diastereomers 3H/4H showing mutually similar spectral profiles 
indicative of solvent-dependent changes in the modes aggregation. (Figure adapted 
from Eakins et al.177 with permission from Taylor and Francis.) 
4.2.4.3 Effect of a Modified Perylene Core 
One final structural variation investigated in this study was that of modifying the 
perylene core itself to yield perylene imide bis(n-butyl)ester (PIBE) Q3. Although 
this core structure is typically just an intermediate used in the synthesis of 
unsymmetrical perylene imide derivatives such as 3H, 3HE, 3M, or 4H (as it was in 
this study), investigation of Q3 yielded, interesting results. As shown in Figure 4.6a, 
a strong solvent-dependent CD response with clear Cotton Effects was observed. 
While the DMSO solution of Q3 was CD silent, indicating a well-solvated, 
monomeric solution, solutions in both water and acetonitrile expressed strong signs 
of exciton coupling and chiral self-assembly. The CD spectrum for the acetonitrile 
(a) (b) 
116 
 
solution also expressed an apparent dual peak, which may represent the overlap of 
the positive lobe of the Cotton Effect with an interchain excimer feature or an 
axially chiral arrangement. Unlike the other compounds in this study, PIBE Q3 
displayed an inversion of the CD couplet when changing from an acetonitrile 
solution to an aqueous solution. These distinctly different CD features along with 
the Cotton Effect inversion suggest that the PIBE core is more configurationally 
responsive to a changing solvent environment than are the PDI compounds, in 
spite of minimal differences between the aggregate UV-vis spectral profiles for 
acetonitrile and water shown in Figure 4.6b. In addition to these spectral 
characteristics, however, PIBE Q3 was also found by atomic force microscopy 
(AFM) to form very diffusive networks of long fibers as seen in Figure 4.6c. These 
results suggest that the PIBE structures more generally are worthy of consideration 
for further study in self-assembly applications as alternative perylene moieties 
having greater solubility and solvent responsiveness. 
 
 
 
Figure 4.6 CD and UV-vis spectra of perylene imide bisester Q3: (a) CD spectra 
of PIBE Q3 indicating solvent-responsive, chiral self-assembly behavior; (b) UV-vis 
spectra of PIBE Q3 showing solvent-dependent changes in the modes aggregation; 
(c) AFM image of nanofibers formed by the self-assembly of PIBE Q3 (scale bar = 
1 μm). (Figure adapted from ref. 177 with permission from Taylor and Francis.) 
(a) 
(b) 
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4.3 Conclusions 
A series of chiral peptide-functionalized perylene imide molecules were designed 
and synthesized to examine the effect of peptide chirality on the self-assembly of 
nanofibers. An investigation was undertaken to evaluate peptide stereogenic 
positions, stereochemical configurations, and amphiphilic substitution along with 
perylene core modification as structural features impacting chiral influence. It was 
found that stereocenters in peptide residue positions proximal to the perylene core 
(1-5 units) were effective to impart helical chirality to the perylene core, while 
stereocenters in more distal residue positions were not seen to exert a chiral 
influence. Accordingly, it was observed that diastereomers involving an inverted 
stereocenter configuration within the proximal residues manifested 
spectroscopically as pseudo-enantiomers. The use of amino acids with increased 
side-chain steric demand in the proximal positions exhibited similar chiral behavior, 
but the increased steric demand was seen to diminish the intensity of the observed 
bisignate Cotton Effects likely due to an increased monomer separation distance or 
a larger torsional angle (or both) within the assembled aggregates. Amphiphilic 
substitution of a peptide with an alkyl chain was seen to disrupt self-assembly (as 
evidenced by the absence of Cotton Effects) possibly due to the formation of axial 
or micelle-like assemblies. On the other hand, an amphiphilic structure achieved 
through the modification of the perylene imide core to incorporate a bisester moiety 
was seen to achieve strongly exciton-coupled, solvent-responsive self-assembly into 
long, chiral nanofilaments observed by AFM, advancing such bisester moieties as 
good candidates for future self-assembly studies. Among the compounds studied, 
band-like features seen at longer wavelengths in the CD spectra were found to 
correlate with the helical configuration of the self-assembled fiber, and are proposed 
as interchain excimers delocalized through the helical stack which interact with 
circularly polarized light to produce a dichroism with a sign matching that 
produced by the configuration of the helical fiber. These structural and 
spectroscopic observations highlight the importance of stereogenic positions and 
the nature of the amphiphilic structural design within self-assembling peptide-
substituted perylene imides. 
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Chapter 5 
Functional Organic 
Semiconductors Assembled via 
Natural Aggregating Peptides 
5.1 Introduction 
The emergence of complex molecular assemblies in natural biological systems 
highlights the potential of using proteins and peptides to rationally encode the 
assembly of functional synthetic structures in water.179–181 For example, while the 
peroxiredoxin (Prx) family of proteins principally exist as obligate homodimers that 
further self-assemble into toroidal oligomers,182 some Prx proteins can be induced to 
form other supramolecular assemblies183 such as toroidal stacks,184,185 tubes,182,186 
clusters,187 and cages.188 Identifying the native binding interfaces opens the 
possibility of exploiting them as building blocks in hybrid materials. Such materials 
may then be used in devices with entirely different functionalities from their parent 
proteins. Here, we advance this idea by augmenting organic semiconductor 
materials with peptides identified from Prx proteins to create organic 
semiconductor assemblies and transistor devices. 
 
Central to the Prx architectures is the antiparallel β-continuous interface that 
enables the non-covalent dimerization of two protein units via the same β-strand of 
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each. Isolation of the β-strand peptides (typically a 7-8 amino acid sequence) out of 
such interfaces from a variety of protein types has been shown to yield sequences 
which show liquid crystallinity and which intrinsically self-assemble into nano-
architectures while also retaining some properties of their parent protein 
interfaces.18 Thus, peptides collected from these types of naturally optimized 
protein interfaces129,131 are excellent candidates as tectons for synthetic self-
assembly.18 
 
While natural peptide interfaces have yet to be exploited in electronic devices, a 
number of related studies using natural materials highlight the potential of this 
approach to create new properties and applications.189 For example, peptides,190 
natural proteins,191 and DNA-based biopolymers derived from meat processing 
waste192 have been used as insulating gate dielectric layers in field-effect transistors. 
Peptides, proteins, and DNA have also been explored as the active layer 
components of transistor devices;193–196 however, this approach is hindered by the 
wide bandgap and low conductivity of the naturally available electroactive units. 
Coupling peptides to synthetic organic semiconductors offers a more promising 
avenue to exploit peptide assembly in the conductive components of electronic 
devices.15,70,74 Non-natural peptides have been used to control the assembly of 
synthetic molecular semiconductors22,27,79,88 and have been shown to enhance 
change mobilities in organic photovoltaic and field-effect transistor devices.197 
 
Herein, is presented a new family of bioelectronic materials featuring the 
semiconducting molecule perylene diimide coupled to derivatives of the natural 
self-assembling peptide identified in the bovine Prx3 protein. The β-continuous 
interface is retained in the hybrid material upon triggered aggregation of nanofibers. 
The electronic coupling between neighboring perylene diimides is profoundly 
affected by the peptide tecton, as revealed by optical spectroscopy. These new 
properties are exploited through fabricating a water-processed bioorganic field-
effect transistor (biOFET) based on a native β-interface. 
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5.2 Results and Discussion 
5.2.1 Material Design 
Scheme 5.1a illustrates the natural self-assembly of the Prx3 protein via a β-
continuous interface with the IKHLSVN sequence. Before attempting to synthesize 
this sequence and couple it to perylene diimides (Scheme 1b), the synthetic route 
must be carefully considered. Standard solid-phase peptide synthesis (SPPS) 
protocols is used to access the 7-mer peptide88,198 and after cleaving from the resin, 
the peptide amine groups are condensed with perylene anhydride precursors in 
molten imidazole.86,88 Accordingly, the native IKHLSVN sequence presented the 
possibility of amine condensation reactions at both the peptide amino terminus as 
well as on the lysine side-chain.  
 
 
Scheme 5.1 (a) Protein homo-oligomer (pdb crystal structure for peroxiredoxin 
III (Prx3) homo-dodecamer (1ZYE) with enlarged view into the homodimer 
IKHLSVN peptide interface (interface contacts shown in red, as determined by 
PISA software). (b) Incorporation of the modified IKHLSVN interface peptide into 
a perylene diimide, yielding organic semiconductor nanofiber self-assembly from 
perylene core π-stacking directed by interface peptide β-sheet formation. (Scheme 
adapted from Eakins et al.199 with permission from Wiley-VCH.) 
While perylene imides formed exclusively with the lysine side-chain were initially 
synthesized as test compounds 12 and 12H, coupling through the peptide amine 
(a) (b) 
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terminus was of primary interest since it would not disrupt the β-interface. This 
issue was addressed via two alternate strategies. The lysine residue of the original 
IKHLSVN sequence could either be protected until after forming the imide, or it 
could be replaced with arginine to permit the terminal coupling mode depicted in 
Scheme 1b (i.e., IRHLSVN). 
 
Based on residue substitution matrices, which assess the probability of a given 
amino acid substitution in natural systems,200,201 arginine was expected to be a 
favorable natural mutation and synthetically advantageous. While acting as a 
favorable natural replacement preserving the charged character of the lysine 
position in the peptide sequence, arginine also afforded the advantage of being inert 
toward the amine condensation reaction. 
 
The primary aggregating IRHLSVN sequence was further augmented at either end 
with groups to control its hybridization with perylene and to manipulate the hybrid 
material, as shown in Scheme 5.2a. The opposite end to where the perylene imide 
core is to be coupled featured three glutamic acid residues. These ionizable residues 
assisted with solubility of the final peptide-perylene imide product and also 
provided a means to invoke pH-triggered self-assembly in the compounds.22,23,79,88,97 
At the other end, a two-carbon linking unit with a reactive amino moiety was 
added to provide a low steric demand spacer unit between the perylene core and the 
central binding region of the peptide. 
 
Using this three-region strategy, two versions of the peptide moiety were 
synthesized in order to permit two modes of attachment to the perylene imide core 
and investigate how the peptide assembly influenced the electronic properties of the 
core. In the “forward-attached” case, the peptide was attached via the amino 
terminus using a glycine linker such that peptide backbone extends away from the 
core with an N to C orientation. In the “reverse-attached” case, the peptide was 
attached via the carboxyl terminus using an ethylamino linker, allowing reversal of 
the peptide backbone orientation to C to N extending away from the core. This did 
not simply represent the reversal of residue sequence order relative to the core 
(which would conserve the N to C peptide backbone orientation relative to the 
perylene imide core); rather, as shown Scheme 5.2, this design produced compound 
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pairs in which the same central binding sequence is attached in each compound 
within the pair by opposite ends of its backbone with the -Glu-Glu-Glu region 
always positioned distal to the perylene imide core.  
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Scheme 5.2 Structures of the compounds investigated in this study, employing 
adaptations of the Prx3 homo-dodecamer protein interface peptide: (a) Dipeptide-
PDIs 13, 14, and (b) Peptide-PIBEs 15, 16. (Scheme adapted from Eakins et al.199 
with permission from Wiley-VCH.) 
Additionally, for the forward- and reverse-attached peptide modes, two different 
perylene imide core variations were examined for self-assembly using the adapted 
(a) 
(b) 
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Prx3 interface. Compounds 13 and 14 represented a complementary pair of 
symmetrically disubstituted perylene diimides (PDIs), while compounds 15 and 16 
provided an analogous pair of perylene imide bisesters (PIBEs) each substituted 
with a single peptide substituent.  
5.2.2 Solution Preparation and Self-Assembly Process 
Solutions of compounds used for spectroscopy were prepared using the same 
methods and self-assembly processes as those described in Chapters 3-4 by diluting 
small aliquots of compound stock solutions into water or DMSO. The solvent used 
for the stock solutions, however, was changed to accommodate the needs of the 
analyses undertaken. Stock solutions to be used for UV-vis spectroscopy were 
prepared in TFA (for the PDIs) and HFIP (for the more acid-labile PIBEs), yielding 
aqueous solutions with residual acid upon dilution. Stock solutions to be used for 
CD spectroscopy in the visible range were prepared in 2% aqueous pyridine, while 
stock solutions to be used for CD spectroscopy in the UV range were prepared in 
0.01 M NaOH (to avoid UV interference from pyridine) and then promptly 
analyzed (to prevent potential degradation from prolonged exposure to NaOH).   
5.2.3 CD Spectroscopy Methodology 
CD spectra were collected in both the UV and the visible ranges of the spectrum to 
assess compound self-assembly. Here it is noted that the CD spectra in Chapters 3-4 
did not examine the UV region of the CD spectrum due to the strong interference 
from the residual pyridine present in the desired solutions for those studies. Here, 
however, the UV region of the spectrum is examined to address important 
considerations about the peptide substituent behavior during chromophore self-
assembly. Solution analysis in the UV was enabled through careful preparation of 
stock solutions of the compounds in dilute NaOH as outlined in Section 5.2.2. 
 
For all CD spectra presented in this chapter, HT voltages were maintained below 
600 V with most spectra exhibiting HT profiles below 500 V. Sloping of the HT 
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data baseline (indicative of scattering) was moderately observed at longer 
wavelengths (in the visible spectra) and at the shorter wavelengths (in the UV 
spectra), but the impact of the scattering was determined not to compromise the 
spectral data acquired. 
5.2.4 Aggregation in Peptide-Perylene Imide Conjugates 
Since the peptide sequences to be coupled with perylene imides were adaptations of 
the original Prx3 peptide, synthetic peptides lacking the perylene imide were first 
compared with the original peptide. Several complementary experiments confirmed 
that the adapted peptides retained the strong β-sheet forming behavior of the 
original sequence after the modifications. Spectral features indicative of β-sheets are 
characterized in the UV range of CD spectra via a spectral profile with a positive 
band maximum near 190-200 nm followed by a single, often broad, and trailing 
negative band with a minimum near 215-220 nm.115 Consistent with this profile, 
Figure 5.1a shows that each of the peptide mutants retains the same CD spectral 
shape that characterizes β-sheets (Figure 5.1b) in the native sequence. The 
formation of β-sheets was further verified via a thioflavin-T fluorescence assay of 
the peptide mutations (Figure 5.1c). When this fluorophore binds to β-sheets, its 
excitation and emission maxima shift from 385 and 445 nm to 450 and 485 nm, 
enabling simple quantification of the extent of β-sheet assembly,202,203 which is what 
was observed when thioflavin-T was blended with the native and mutant peptide 
sequences investigated here. Affirmation was further seen in a turbidity assay of the 
same samples (Figure 5.1d). These observations were found to be in agreement 
with analysis of the amide I band of the IR spectra98–101 for the targeted 
GIRHLSVNEEE and Ac-EEEIRHLSVN-ethylamine sequences (Appendix C, 
Figures C.26, C.27), which displayed a band near 1630 cm−1 indicative of β-sheet 
structures. The β-sheet interactions expressed by the native peptide variants, were 
ultimately found to produce ordered peptide nanostructures as observed via 
transmission electron microscopy (Figure 5.1e-h). The results in Figure 5.1 
confirmed that each of our modifications to the native sequence were innocent with 
respect to self-assembly; the lysine residue can be replaced with arginine, short 
linking units can be added, likewise for solubilizing glutamic acid residues. 
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Figure 5.1 (a) CD spectra of the native peptides for five relevant sequence 
variations (aqueous buffer solution, 0.1 mg/mL peptide concentration). (b) 
Illustration of an anti-parallel β-sheet structure. (c) Results of a thioflavin-T assay of 
the native peptides (24 hour duration, at three peptide concentrations). (d) Results 
of a turbidity assay of the same solutions measured in the ThT assay. Selected TEM 
images of the self-assembled native peptide nanofibers are shown for: (e) Ac-
IKHLSVN-NH2, (f) GIRHLSVN, (g) Ac-EEEIRHLSVN-ethyl-NH2, and (h) 
GIRHLSVNEEE (all scale bars = 200 nm). Peptide sequence Ac-IRHLSVN did 
not form large-scale nanofibers under the range of conditions tested. (Figure 
adapted from Eakins et al.199 with permission from Wiley-VCH.) 
The CD signature of peptide β-sheet formation was also retained in the peptide-
perylene imide conjugates. Seen in Figure 5.2, PDIs 12, 12H, 13, 14 and PIBEs 15, 
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16 all displayed CD spectral profiles in the UV range consistent with that of β-sheet 
secondary structures. These spectra importantly show that the peptide substituents 
themselves are actively involved in the self-assembly of secondary structures for the 
overall peptide-perylene imide conjugates and are not just unnecessarily complex 
substituents exerting simple steric effects on the perylene core. 
 
Figure 5.2 CD spectra along the 180-260 nm ultraviolet range, showing peptide 
substituent β-sheet formation in 0.01 mg/mL aqueous solutions of: (a) self-
assembled test compounds 12, 12H and (b) self-assembled PDIs 13, 14 and PIBEs 
15, 16. (Figure adapted from Eakins et al.199 with permission from Wiley-VCH.) 
Overlapping absorption and fluorescence from the perylene chromophore meant 
that the thioflavin-T assay could not be applied to these hybrid materials; however, 
the amide I bands of the IR spectra98–101 for the PDIs and PIBEs (Appendix C, 
Figures C.28-C.31), also exhibited a band near 1630 cm
−1 consistent with β-sheet 
structure formation. 
5.2.5 Optical Spectroscopy of the Aggregates 
Assembly of perylene moieties results in significant changes to visible optical 
absorption spectra. Since imide substituents do not directly affect the frontier 
molecular orbitals responsible for the visible electronic transition,39 spectral changes 
can be used to understand how the substituents affect the relative orientations and 
(a) (b) 
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electronic coupling between neighboring perylene monomers.126,204 The UV-visible 
absorption spectra shown in Figure 5.3 show that solutions of each of the peptide-
substituted perylene imides exhibited clear signatures of aggregation and reveal 
important distinctions between each. 
 
Solutions of PDIs 13, 14 in DMSO (Figure 5.3a) both displayed a monomeric 
spectral profile with minimal differences between each other. Their monomeric 
nature was indicated by a band with a distinctive three-peak vibronic progression 
with ~1400 cm−1 splitting (indicative of vibrational coupling to the C=C stretching 
mode) and diminishing intensity for higher energy transitions. However, in 
aqueous solution, spectra of compounds 13 and 14 were dramatically different, 
indicating very different modes of monomer self-assembly. In water, PDI 13 
displayed a very broad spectral profile, echoing traits of spectra reported for ordered 
liquid crystalline phases of PDI derivatives.152–156 The suppression of vibronic 
structure, along with the enhanced low energy absorption beyond 600 nm, suggest 
strong coupling between delocalized π-orbitals, which is a highly desirable property 
for electronic devices. Moreover, a Cotton effect observed in the visible region of 
the CD spectrum (inset, Figure 5.3a) indicated that the peptide directs assembly of 
the perylene monomers into ordered, chiral aggregates.80,119 
 
 
Figure 5.3 UV-vis spectra in DMSO and water with visible CD spectra of 6 μM 
aqueous solutions (insets) for (a) PDIs 13, 14 and (b) PIBEs 15, 16. (Figure adapted 
from Eakins et al.199 with permission from Wiley-VCH.) 
(a) (b) 
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PDI 14 – in which the peptide backbone orientation is reversed – gave a very 
different spectral profile than PDI 13 in water, in spite of their similar composition. 
The absorption spectrum of PDI 14 does not show the broadening to low energy 
found for PDI 13, yet it still differs considerably from the monomer spectrum. In 
PDI 14, the intensity of the 0-0 vibronic transition near 540 nm is diminished 
relative to the 0-1 transition near 500 nm. This intensity pattern is a signature of an 
H-aggregated system in which co-facially stacked perylene units are rotational 
displaced with minimal lateral displacement.55 For strongly exciton-coupled H-
aggregates, the 0-0 transition is dipole forbidden, while higher vibronic transitions 
gain intensity via symmetry breaking vibrational modes. Observing a weaker 0-0 
transition relative to the 0-1 transition, as in this case, is expected in a weaker 
coupling regime and when there is a rotational offset between chromophores.109 
The aggregates formed by PDI 14, however, did not show a Cotton effect in the 
visible region of the CD spectrum (inset, Figure 5.3a), indicating that the assembly 
of the perylene units did not produce a chirally ordered arrangement. The 
contrasting absorption spectra of PDIs 13 and 14 for the aqueous solutions show 
that coupling between neighboring electronic units can be impacted by the 
backbone orientation of the naturally derived β-sheet forming peptide. 
 
In contrast to PDIs 13 and 14, the spectral profiles of PIBEs 15 and 16 (Figure 5.3b) 
were mutually very similar. In DMSO, PIBEs 15, 16 both exhibited vibronically 
structured spectral profiles consistent with predominantly monomeric species; 
however, the vibronic peak ratio and the presence of a feature near 580 nm 
suggested some extent of aggregation. Regardless, a distinctive transition to a more 
highly aggregated state was evident in the aqueous solutions of PIBEs 15, 16. 
Similar to PDI 14 (above), the spectra of PIBEs 15 and 16 in water both displayed 
traits consistent with H-aggregate formation, and Cotton effects were absent in the 
visible CD spectra (inset, Figure 5.3b). The band observed for PIBE 15, however, 
expressed a shoulder feature between 580-660 nm, suggesting additional 
contributions from some other aggregate species with a band-like character similar 
to that seen for PDI 13. The absorption spectrum of PIBE 16 was slightly red-
shifted compared to PIBE 15, and with a slightly different vibronic ratio; however, 
these differences were minimal relative to the comparison of PDIs 13 and 14. Since 
the same peptides are compared in both pairs of hybrids, the spectral similarity of 
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PIBEs 15 and 16 may be explained by greater orientational freedom of the perylene 
moieties with aggregating peptides on only one side. Conversely, the peptide β-
sheets in the symmetrical structures of PDIs 13 and 14 appear to constrain the 
perylene moiety in a specific configuration, which is strongly π-stacked in the case 
of PDI 13. 
 
The reversed peptide backbones of PDIs 13 versus 14 suggested the possibility of 
blending the two materials to assemble them via anti-parallel β-sheets that more 
closely mimic the natural protein system. Such an arrangement could be supported 
in alternating stacks of PDIs 13 and 14, and may result in modified electronic 
properties for the central PDI core. However, equimolar binary mixtures of PDIs 
13 and 14 were not found to produce any synergistic spectroscopic effects, rather 
the spectra could be explained by a statistical mixture of 13 and 14 (Figure 5.4).  
 
 
Figure 5.4 Spectroscopic evaluation of 5 μM aqueous solutions of PDIs 13 and 
14 made by injecting small volumes of monomeric TFA stock solutions into water 
to induce aggregation.  (a) UV-vis spectral profiles for solutions of PDIs 13 and 14 
alone as well as a 1:1 molar mixture of 13+14 (mixed concentrated equimolar stock 
volumes in TFA prior to injection into water). The spectral profile of the mixture 
matches that of a calculated linear combination of 13 and 14, showing no 
synergistic self-assembly in the mixture. (b) CD spectral profiles for 5 μM solutions 
of PDIs 13 and 14 alone as well as a 1:1 molar mixture 13+14 (mixed concentrated 
equimolar stock volumes in TFA prior to injection into water). (Figure adapted 
from Eakins et al.199 with permission from Wiley-VCH.) 
(a) (b) 
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These results do not exclude the possibility of realizing an anti-parallel self-
assembly motif, but they suggest that the assembly conditions may need to be 
optimized and the linker groups refined (length, conformational flexibility, etc.) in 
order to achieve the desired registry between neighboring molecules. 
5.2.6 Nanostructure Formation 
The aggregate species spectroscopically characterized in solution were confirmed, 
in most cases, to result from ordered nanofiber assemblies that were visualized by 
atomic force microscopy (AFM) and transmission electron microscopy (TEM). As 
shown in Figure 5.5a-c, PDIs 13, 14, and PIBE 15 assembled into diffusive 
interlaced networks of narrow fibers. The notable exception was compound PIBE 
16 (Figure 5.5d), which appeared to form only amorphous, plate-like accretions 
under the conditions tested. 
 
Figure 5.5 AFM images of dry nanofibers deposited on mica of (a) PDI 13 (scale 
bar = 500 nm), (b) PDI 14 (scale bar = 500 nm), (c) PIBE 15 (scale bar = 25 nm), 
and (d) PIBE 16  (scale bar = 500 nm). (Figure adapted from Eakins et al.199 with 
permission from Wiley-VCH.) 
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Extensive fibrillar formation was also seen for PDIs 13, 14 via TEM, as shown in 
Figure 5.6. Out of the fiber-forming compounds, PDI 13 appeared to have a slight 
morphological distinction, presenting clusters of fiber networks with greater fiber 
density, length, and width. By AFM, the fiber segments formed by PDI 14 and 
PIBE 15 appeared to be roughly 100-200 nm in length; whereas the fibers formed 
by PDI 13 were longer, being roughly 200-300 nm long within the fiber clusters and 
exceeding a micron for isolated strands visible between the clusters. By both TEM 
and AFM, PDI 13 was clearly seen to form fibers of greater size than PDI 14, with 
PDI 13 forming more ribbon-like structures in comparison to the thread-like 
assemblies of PDI 14 (Figure 5.6). 
 
Figure 5.6 TEM images of self-assembled nanofibers of (a) PDI 13 (scale bar = 
200 nm) and (b) PDI 14 (scale bar = 100 nm). (Figure adapted from Eakins et al.199 
with permission from Wiley-VCH.) 
The morphological differences between compound pairs 13, 14 and 15, 16 (along 
with the spectroscopic distinctions noted previously) highlight the relevance of the 
mode of peptide sequence attachment toward self-assembly outcomes. Comparison 
of the morphologies observed via microscopy informed by the spectroscopic 
indications from solution suggested that PDI 13 provided larger, longer range 
nanostructures which were the most promising for field-effect device applications 
out of the four compounds studied. 
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5.2.7 OFET Fabrication and Performance 
After examining the peptide-driven aggregation of each compound, bio-organic 
field-effect transistor (biOFET) devices were fabricated using them as the active 
semiconductor layer. As shown in Figure 5.7a,b the devices were fabricated on 
highly doped silicon substrates (serving as the back gate) using a bottom-contact 
gold electrode channel configuration, with a spin coated layer of 
polydimethylsiloxane PDMS acting as dielectric layer. Flakes of the perylene imide 
active material were grown via slow solvent evaporation in small vials (from a 1:4 
pyridine/water solution heated overnight to 75-80 °C) and transferred to span 
across an electrode channel on substrates with pre-patterned electrodes applied onto 
a PDMS dielectric layer.   
 
 
Figure 5.7 Device performance measurements of an organic field-effect 
transistor fabricated utilizing PDI 13 across a 40 μm channel: (a) Protein to device 
development pathway; (b) Device fabrication schematic; (c) Output characteristics; 
(d) Transfer characteristics with threshold voltage evaluation (inset). (Figure 
adapted from Eakins et al.199 with permission from Wiley-VCH.) 
(a) (b) 
(c) (d) 
134 
 
Contact between the flakes and the gold electrodes were enhanced by the 
conductive silver paste. This approach was taken because the films were too brittle 
to survive mechanical contact with the shadow mask required for thermal 
evaporation of contacts. The PDMS layer also acted as an adhesive for the flakes 
on the device substrate.  The brittle nature of the active material samples also made 
it very easy to break the devices by mechanical actions post deposition onto the 
PDMS films. 
 
Of the materials examined in this study, only PDI 1 yielded functioning devices, 
giving output and transfer characteristics as shown in Figure 5.7b,c. Although n-
type semiconducting behavior was anticipated as being most probable for PDI 1 
because of the high electron affinity of the perylene core and numerous examples of 
n-type behavior reported for perylene imide materials in literature,205 the output 
characteristics of PDI 13 (Figure 5.7c) are consistent with weak p-type behavior, 
yielding a decreasing current with increasing positive gate bias. Ongoing 
investigations of this unexpected behavior may reveal the role of the peptide and 
associated ions in modulating charge injection and transport in this material. Using 
these output curves to extract the ratio between the magnitude of the drain current 
(IDS) at the highest and lowest gate voltage (IDS taken at VDS = 45 when VG = ±50, 
the on/off ratio (Ion/Ioff) for the device was evaluated to be 1.7. From the transfer 
plot in Figure 5.7c, the threshold voltage for the device was evaluated to occur near 
−55 V. The poorly defined channel dimensions in this contact configuration 
prevented deeper analysis of the device response. It should also be noted that the 
PDMS layer is on the order of 10 µm thick and therefore the field dependent nature 
of the PDI 13 may be more apparent if a thinner dielectric or a material with a 
higher dielectric constant is used.  The field dependency was observed on several 
samples and the example shown in Figure 5.7c,d is representative of the behavior 
and was observed, irrespective of the doping polarity of underlying Si back gate. 
 
The p-type (hole-conducting) behavior observed for the device performance in 
Figure 5.7 is notably rare for devices made from perylene diimide materials. PDI 
materials almost invariably exhibit n-type (electron-conducting) properties in 
reported OFETs, as exemplified by a recent review of such PDI devices.205 
Nevertheless, a few p-type examples of PDI OFETs have been reported by Pron 
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and coworkers.206 Due to its rarity, therefore, the p-type PDI biOFET behavior 
observed here merits further discussion. 
 
Theoretically, all organic semiconductors should be capable of conveying either 
electron vacancies (holes) or electrons as charge carriers (depending upon which is 
most efficiently relayed through the material); however, material factors usually 
preferentially select one or the other.207 Such factors include the internal molecular 
reorganization energy of the organic compound and the work function of the device 
electrode relative to the HOMO and LUMO of the organic semiconductor.207–210 
Despite the theoretical possibilities, in practice, the intrinsic instability of most 
organic anions in air and water145,211 and complications from oxygen-trapping 
within the organic materials212,213 cause p-type behavior to be most common in 
organic semiconductors, generally.214 On these points, PDIs are distinctive, having 
high electron affinity and good n-type characteristics, arising (in part) from the 
ability to form highly stable radical anion, dianion, and oxidized species215–217 as 
well as from the ability to associate in closely packed π-planes which may inhibit 
the ingress of oxygen and promote greater n-type OFET stability in air.205,218 
Exceptions to n-type behavior by PDI materials in OFETs are accordingly rare. 
Instances of p-type PDI OFET behavior, therefore, are worth some consideration. 
 
Pron and coworkers have reported both a N,N'-bis(triphenylamino)naphthalene 
diimide and a N,N'-bis(triphenylamino)perylene diimide OFET each exhibiting 
unexpected p-type characteristics.206 The p-type behavior in these cases was 
proposed to have resulted from the amorphous nature of the thin diimide 
semiconducting layers applied, such that the amorphous film distribution not 
significantly perturb the transport pathways of holes via triphenylamine segments 
but strongly impeded the transport of electrons through diimide core segments.206 A 
similar explanation seems less certain for the biOFET reported here in Figure 5.7. 
In the OFETs reported by Pron et al., the triphenylamino N-substituent used is also 
a known p-type organic semiconductor, and morphologically influenced charge 
carrier pathways to p-type outcomes are plausible. Yet for the biOFET in Figure 
5.7, the peptide substituent seems unlikely to function as a p-type semiconductor. 
Although cyclic peptides have been utilized to modulate charge transfer between 
appended chromophores219 and self-assembled cyclic peptide nanotubes alone have 
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been shown to be minimally conductive (with current only in the nanoamp 
range),194 in OFETs, peptides normally behave as insulating dielectric materials.190 
Even a highly ordered peptide β-sheet domain within the peptide-PDI material of 
the biOFET in Figure 5.7 seems unlikely to serve as a p-type semiconductor 
suitable to convey current in the microamp range observed. Nevertheless, the non-
redox protein apoferritin has been successfully utilized as the semiconducting active 
layer in a reported biOFET with operating output in the microamp range.193  
 
Another aspect to consider is that of charge injection into the peptide-PDI 
semiconductor active layer. In an OFET device, charge is usually injected into the 
organic semiconductor via metal electrodes (as is the case with the biOFET 
reported here). At this interface, an important property is the work function of the 
metal (defined as the energy needed to move an electron to the vacuum level209). 
For charge carriers (electron or holes) to be efficiently injected into the organic 
semiconductor from the metal electrode, a metal should be chosen with a work 
function that matches either the HOMO or the LUMO of the organic 
semiconductor within a few tenths of an electron volt.208,220 Although larger 
differences may be operable, significant energetic misalignment will increase in the 
contact resistance of the device.209 Selecting an appropriate metal for the electrode 
contact depends upon the energy levels of the organic semiconductor to be used as 
well as the nature of the device to be fabricated. For p-type OFETs, the metal used 
for the electrodes should have a work function near that of the organic 
semiconductor HOMO energy level; conversely, for n-type OFETs, the electrode 
metal work function should be near that of the LUMO energy level.209 As shown in 
Figure 5.7b and Figure 5.8a, the biOFET reported in this chapter employs a dual 
metallic contact; the first is the primary gold electrode fabricated with the silicon 
device substrate, whereas the other is an amorphous silver contact (from the silver 
paste used to affix the organic semiconductor flake on top of the gold electrodes). 
Using the electrochemically determined reduction and oxidation potentials versus 
the ferrocene/ferrocenium redox couple (−1.0 V and 1.1 V, respectively) reported 
for a typical PDI with an unsubstituted rylene core,221 HOMO and LUMO levels 
were calculated according to previously reported methods222 and compared to the 
values of the gold and silver metal work functions (Φ)210 as illustrated in Figure 5.8b. 
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Figure 5.8 Evaluation of a device with a dual metallic electrode contact: (a) 
Device fabrication schematic; (b) A comparison of the HOMO and LUMO energy 
levels for a typical PDI with an unsubstituted rylene core with to work functions of 
gold and silver. Energy values are reported with respect to vacuum level (0.0 eV). 
Although many metals have a lower work function than gold and should, in 
principle, work better for n-type device electrodes due to better energy level 
alignment with typical organic semiconductor LUMOs, in practice these metals 
often degrade or form oxides which make them unsuitable. The stability and lack of 
reactivity by gold, therefore, make it desirable, and it has been shown to make 
excellent contacts for n-type materials in spite of the added contact resistance.214,223 
In fact, the vast majority of reported PDI OFETs use gold for the device contact 
electrodes. In light of this background, the biOFET presented in this chapter would 
still be expected to exhibit n-type performance despite its work function being closer 
to the HOMO level. Moreover, the proximity of the silver work function to the 
LUMO (see Figure 5.8b) might be expected to enhance such an outcome. The 
observed p-type behavior, therefore suggest that a combination of morphological 
factors (such as those proposed by Pron et al.206) and the proximity of the gold work 
function to the HOMO level (Figure 5.8b) together promoted the atypical injection 
of holes as charge carriers through the PDI material. 
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5.3 Conclusion 
We have created a new class of hybrid materials featuring organic semiconductors 
augmented with aggregating β-sheet peptide interfaces derived from natural 
peroxiredoxin proteins. We confirmed that the peptides retain their β-sheet forming 
propensity when additional amino acids and linker units were added to manipulate 
their solubility and coupling with perylene imides. A series of perylene imides 
substituted with the same core peptide sequence (IRHLSVN) were synthesized to 
compare the effect of the number of peptide substituents and the directionality of 
their connectivity. Optical absorption and circular dichroism spectroscopy revealed 
distinct differences in the electronic coupling between neighboring perylene units 
imparted by the peptides, which was also manifest in different fiber morphologies. 
The bis-substituted material where the peptides were oriented in the N-to-C 
direction (away from the perylene diimide) resulted in strong π-stacking and long-
range order. These properties were exploited in the realization of a biOFET device 
with unexpected p-type behavior. The approach outlined highlights the opportunity 
to create hybrid functional materials with new properties by repurposing natural 
peptide sequences to encode their self-assembly. 
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Chapter 6 
Conclusions 
Throughout the course of this study, the self-assembly and photophysical properties 
of several perylene imides have been explored to better understand the behavior 
and application of these materials. These endeavors had been roughly followed 
three avenues of inquiry: (1) The evaluation of structure-property relationships from 
a thermodynamic perspective, (2) The examination of peptide chiral effects upon 
properties and self-assembly, and (3) An application of the understanding gained 
from the rationally designed systems to effectively utilize naturally optimized 
peptides in bio-organic electronics. The major conclusions and outcomes from 
these lines of inquiry are summarized here followed by a wider view forward. 
To investigate structure-property relationships from a thermodynamic perspective, 
a series of peptide-functionalized PDI molecules were synthesized which were 
designed to establish design rules for peptide-driven aggregation through 
incremental variations in peptide hydrophobicity, length, charge density, as well as 
stereocenter inversion and amphiphilic substitution. Having observed the formation 
of nanostructures in solution, a spectroscopic investigation of the thermodynamics 
and nature of aggregation for the series of peptides was implemented. It was found 
that non-specific effects like peptide hydrophobicity and nonsymmetrical 
substitution with a hexyl chain had the greatest impact on binding thermodynamics. 
However, more specific variations like diastereomeric substitution were also shown 
to have a significant impact, particularly on the dominance of H- versus π-
aggregates, highlighting how peptide packing modulates coupling between PDI 
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units. Solvent dependent spectroscopy also highlighted the range of peptide- and 
PDI-based interactions responsible for aggregation in these materials. 
To examine the effect of peptide chirality on the self-assembly of the perylene imide 
core into nanofibers, a series of chiral peptide-functionalized perylene imide 
molecules was synthesized. CD spectroscopy of the series evaluated peptide 
stereogenic positions, stereochemical configurations, and amphiphilic substitution 
along with perylene core modification as structural features impacting chiral 
influence, and the results revealed that stereocenters in peptide residue positions 
proximal to the perylene core (1-5 units) were principally responsible  for imparting 
helical chirality to the perylene core, while stereocenters in more distal residue 
positions were not seen to exert a chiral influence. Accordingly, diastereomers 
involving an inverted stereocenter configuration within the proximal residues were 
found to behave spectroscopically as pseudo-enantiomers. The use of amino acids 
with increased side-chain steric demand in the proximal positions exhibited similar 
chiral behavior, but the increased steric demand was seen to diminish the intensity 
of the observed bisignate Cotton Effects, which was likely due to increased 
monomer separation distance or a larger torsional angle (or both) between the 
assembled aggregate monomers. Amphiphilic substitution of a peptide with an 
alkyl chain was seen to disrupt self-assembly (as evidenced by the absence of 
Cotton Effects) possibly due to the formation of axial or micelle-like assemblies; 
however, amphiphilic structures achieved through the modification of the perylene 
imide core to incorporate a bisester moiety were seen to achieve strongly exciton-
coupled, chiral, solvent-responsive self-assembly into long nanofilaments (as 
observed by AFM). Among the compounds studied, band-like features seen at 
longer wavelengths in the CD spectra were found to correlate with the helical 
configuration of the self-assembled fiber, and are proposed as interchain excimers 
delocalized through the helical stack which interact with circularly polarized light 
to produce a dichroism with a sign matching that produced by the configuration of 
the helical fiber. These structural and spectroscopic observations highlight the 
importance of stereogenic positions and the nature of the amphiphilic structural 
design within self-assembling peptide-substituted perylene imides. 
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To apply the understanding gained in this study, a new class of hybrid materials 
featuring organic semiconductors augmented with aggregating β-sheet peptide 
interfaces derived from natural peroxiredoxin proteins was produced to 
demonstrate an important proof-of-concept. The results reported confirmed that the 
peptides utilized retained their β-sheet forming propensity when additional amino 
acids and linker units were added to manipulate their solubility and coupling with 
perylene imides. The synthesized series of perylene imides substituted with the 
same core peptide sequence (IRHLSVN) gave valuable insight for the effect of the 
number of peptide substituents and the directionality of their connectivity, which 
has not been as widely explored in the literature. Optical absorption and circular 
dichroism spectroscopy revealed distinct differences in the electronic coupling 
between neighboring perylene units imparted by the peptides, which was also 
manifest in different fiber morphologies. The bis-substituted material where the 
peptides were oriented in the N-to-C direction (away from the perylene diimide) 
resulted in strong π-stacking and long-range order. These properties were exploited 
in the realization of a biOFET device with unexpected p-type behavior. This 
protein-to-device approach outlined highlights the opportunity to create hybrid 
functional materials with new properties by repurposing natural peptide sequences 
to encode their self-assembly. 
Across these investigations, the results from the bisester compounds suggest that 
bisester moieties may be good candidates for future self-assembly studies as a 
perylene derivative with similar photophysical properties to PDIs, but greater 
solubility and solvent-responsiveness. The bisesters also highlight a very important 
point, which is that all of the insights gained in this study regarding the use of 
peptides as an agent of self-assembly may be more widely applied with other 
molecular systems. While perylene compounds have been the emphasis of this 
study, other intriguing molecules for self-assembly and bio-organic electronics 
abound. One such example will be discussed in the next section which looks ahead 
to propose future work with peptide-substituted, self-assembling systems.   
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Chapter 7 
Future Work 
7.1 Introduction 
Designing systems which invoke and control the self-assembly of perylene imide 
chromophores is an important step toward utilizing these materials in beneficial 
applications such as electronic devices and sensors. While numerous, previously 
unknown aspects of the self-assembly and function of peptide-perylene imide 
systems have been revealed during this study, these discoveries yet highlight many 
additional questions and intriguing possibilities. These opportunities broadly reside 
in three categories: (1) new structural designs, (2) new applications, and (3) new 
materials for peptide-guided self-assembly. 
 
First, with regard to new structural designs, the most obvious next step would be 
the further exploration of new peptide sequences. Through both rational design and 
the utilization of the multitude of promising peptides found in nature, a vast range 
of sequences are possible. Sequence change alone, however, may be insufficient to 
invoke dramatically new or advantageous modes of self-assembly. While 
measurable, sequence-dependent aggregate tuning was observed and quantified 
during this study (Chapter 3), the differences seen were small. Invoking changes of 
greater distinction and magnitude during tuning may require the alteration of the 
self-assembly design in order to capitalize on additional aspects afforded by peptide 
structures. To this end, residue-specific traits may be useful. For example, residues 
such as histidine and lysine which are capable of forming metal complexes could be 
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strategically used within the peptide as units to aid, alter, or tune self-assembly 
through the addition of metal ions. Similarly, the redox sensitivity of cysteine 
towards the formation of disulfide links could be employed to achieve or switch 
modes of self-assembly. Beyond sequence changes or residue-specific influences, 
the design of the underlying peptide-chromophore unit being self-assembled could 
also be altered. Employing two or more chromophores linked by a single peptide 
scaffold would bring enforced intramolecular chromophore associations in addition 
to intermolecular self-assembly interactions between the peptide-chromophore 
dimer (or oligomer) units. The imposed constraints within the unit structure would 
translate into further constraints for the overall mode of self-assembly of the units. 
 
Second, with regard to applications for peptide-perylene imide compounds, 
applying these materials in electronic devices remains highly desirable. However, 
achieving suitable conductive thin film morphologies for devices during this study 
was unsuccessful, and the devices fabricated involved semi-crystalline flakes 
(Chapter 5). Developing processing methods to remedy this limitation remains an 
area needing further research. Structural modifications to enhance solubility may be 
further helpful in this effort. 
 
Although this study focused primarily on the application of self-assembled perylene 
imides as semiconductors for electronic devices (Chapter 5), sensors could also be 
possible perylene imide applications. For example, structures involving amino acid 
residues capable of metal complex formation might be applied as colorimetric or 
fluorometric metal ion sensors provided that compounds could be designed to self-
assemble in ways which exhibit discriminating photophysical responses upon 
complexation with different metal ions. Alternatively, the presently untapped 
ability of peptides to impart a chiral sense on the supramolecular chromophore 
architectures formed (Chapter 4) could potentially be a feature applied in chiro-
optical sensors for the detection biomolecules with particular chiral configurations 
provided that suitable, selective target interactions could be encoded into the self-
assembly design. Beyond this, a more radical sensing design might be applied using 
aspects of aptasensing, wherein an aptamer (perhaps a shorter aptamer) with a 
selective affinity to a desired target molecule could be conjugated to a peptide-
perylene imide moiety. If conformational changes by the aptamer (upon target 
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acquisition) could be harnessed to induce spectroscopically detectible changes in 
the perylene imide electronic environment, sensing might be accomplished using 
the structural composite. 
 
Finally, the principles described in this study for the use of peptides to aid in the 
self-assembly of perylene imides may more broadly be applied to other molecules of 
interest. Since many other moieties in addition to perylene imides also possess 
desirable properties for organic electronics or for sensing, applying peptides for self-
assembly with these systems would continue as a wide area open for investigation. 
      
With the preceding discussion in mind, the remaining sections of this chapter 
present two specific avenues for future exploration directly inspired and informed 
by this study.  
7.2 New Structural Designs Using Lysine 
The use of lysine residues in peptide sequences would offer unique structural 
possibilities due to the presence of its side-chain amino group. If suitable protecting 
group strategies were applied to guard against unwanted side-reactions during 
synthetic steps, the side-chain amino group could be employed as a useful peptide 
scaffold component enabling new structural opportunities. The side-chain amino 
group could be used to bond to new chromophore moieties, or it could be left 
available in the final synthetic product produced to act as a moiety to apply in pH 
triggered self-assembly, to assist in solubility of the final product, or to be available 
to form metal complexes. For purposes of bonding the peptide to a chromophore as 
was done in this study, lysine could, thus, act as a branching moiety for the 
attachment of more than one chromophore onto a peptide scaffold. The structural 
differences this could provide in a molecular unit designed for self-assembly 
strategies could be important. 
 
As a demonstration and a proof of concept for future work, this section briefly 
describes some comparisons of some synthesized test structures involving lysine. 
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Highlighted in this section are some key differences achieved with the test 
structures in comparison to the compounds analyzed in this study. 
 
In comparison to PDI 3, which is disubstituted with peptide -Gly-(Ala)3-(Glu)3, 
replacement of the glutamic acid residues with lysine to form test compound PDI 9 
generated a differing aggregate spectral profile and an inverse pH behavior to that 
seen for PDI 3 (Figure 7.1b).    
  
 
Figure 7.1   Spectroscopic comparisons of PDIs 3 and 9 in various solvents: (a) 
Spectra of each compound alone and a 1:1 molar mixture of each in DMSO; (b) pH 
response of  each compound in aqueous solution; (c,d) Spectra of PDI 3 in selected 
solvents; (e,f) Spectra of PDI 9 in selected solvents. 
Consistent with the compounds from this study, both PDI 3 and 9 exhibited 
monomeric behavior in DMSO, but the complimentary acid-base natures of the 
two compounds nevertheless induced some extent of aggregation — even in DMSO 
(a) (b) 
(c) (e) 
(d) (f) 
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— upon mixing the two compounds in a 1:1 molar ratio (Figure 7.1a). 
Comparatively, PDI 3 exhibited greater responsiveness to a change in solvent 
environment than did PDI 9 (Figure 7.1c,d vs. Figure 7.1e,f) which may be due to 
greater hydrogen-bonding behavior in PDI 9. From this result, the use of lysine as a 
peptide scaffold branch appears to hold greater promise in achieving new self-
assembly architectures. 
 
As a modification of the glycine linker used in this study, lysine could instead be 
applied as a bifurcated linker. Using this approach permitted the successful 
synthesis of test PDIs 10 and 11. These perylene imide “dimers” linked by the same 
peptide displayed spectral profiles different to similar non-bifurcated structural 
designs, as seen in Figures 7.2 and 7.3. The associated structural constraints arising 
from the peptide linkage configuration enforced a particular geometric 
configuration between the chromophores which would not otherwise be obtained. 
In the case of PDI 10, this produced an intense H-aggregated response, not seen in 
PDI 3H.  
 
 
Figure 7.2    Spectral comparisons of (a) PDI 3H with (b) PDI 10 in various 
solvents, giving spectral profiles for 3H (c,d) contrasted with the profiles of 10 (e,f).  
(a) (b) 
(c) (e) 
(d) (f) 
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Figure 7.3    Spectral comparisons of (a) PIBE Q3 with (b) PIBE 11 in various 
solvents, giving spectral profiles for Q3 (c,d) contrasted with the profiles of 11 (e,f). 
While a less pronounced spectral difference was seen between an analogous test 
compound bisester dimer (11) and the structurally related compound Q3, the 
important development was that of again achieving a spectral difference from the 
bifurcated design. Based on these results, the strategy could be further developed by 
examining tuning from differently sized side-chain lengths (via synthetic amino 
acid analogs of lysine). Additionally, lysine (or similar linkers) could be applied to 
position chromophores along the length of a peptide at specific residue positions. 
 
Beyond simply facilitating changes in the number or position of chromophores 
along a peptide scaffold, lysine may allow the construction of responsive dimer 
assemblies which close more tightly upon hydrogen-bonding or metal cation 
addition. While test compounds 10 and 11 incorporate simple alkyl imide 
substituents in the unsymmetrical structures, other moieties with strong hydrogen-
bonding affinity or those with a strong ability to form metal complexes could 
instead be incorporated into the structures in place of the simple alkyl groups. 
Invoking hydrogen-bonding or complex-formation would engage an added self-
(a) (b) 
(c) (e) 
(d) (f) 
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assembly dimension in the fundamental units undergoing π-stacking and would 
prompt an altered photophysical response as the chromophores mutually reorient 
configurationally. A generalized schematic of this strategy is depicted in Figure 7.4. 
A multitude of other similar strategies using modified designs (even cyclic motifs) 
would doubtlessly be possible. 
 
 
Figure 7.4    A general schematic showing the self-assembly of a peptide linked 
chromophore dimer enhanced by hydrogen-bonding or metal complex forming 
substituents (R groups). Action by the R-group moieties drives a responsive 
reorientation of the perylene units.    
7.3 New Molecules to Assemble 
Informed by the work with peptide-substituted perylene imides from this study, 
natural and rationally-designed peptides may be advantageously applied for the 
self-assembly of other organic semiconductors of interest. While numerous 
molecular candidates could be considered, this section will examine possible future 
work with indigo and the related compound Tyrian purple, which both have 
distinctive appeal. A synthetic union of these natural indigoids with natural 
peptides found in protein interfaces would generate a “natural” ensemble for self-
assembly and form a structural partnership of natural components which could be 
(a) 
(b) 
(c) 
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applied within organic electronics. As will be discussed, these indigoid compounds 
also possess structures which could lend well to synthetic methods employing 
peptides.  
 
Although indigo and Tyrian purple are natural dyes which have been known for 
more than 4000 years, the semiconducting properties of these compounds was only 
discovered in recent years.224–226 From an electronic perspective, these indigoids 
have many desirable properties. These compounds are noted to have good 
resistance toward degradation by heat or chemical redox processes, and the 
structures also show a strong tendency toward long range order via their strong, 
intrinsic, extensive, intermolecular (and intramolecular) hydrogen-bonding 
behavior.189 Along with the low bandgaps of indigo (1.7 eV) and Tyrian purple (1.8 
eV), both compounds possess a reversible two-electron reduction and oxidation and 
give high, almost perfectly balanced electron and hole charge transport in OFET 
devices.189 Due to these factors, these indigoids have been shown to perform very 
well among small molecule semiconductors, with the reported field effect mobility 
of Tyrian purple falling within one order of magnitude of the highest reported value 
from molecules in its class.189,227 The high device performance of these indigoids in 
spite of their Spartan intramolecular conjugation appears to be due to highly 
ordered self-assembly driven by hydrogen-bonding. Given the importance of 
hydrogen-bonding for the performance and behavior of these compounds, the 
primary question if applying peptides for self-assembly of these indigoids is whether 
or not the introduction of the peptide moiety into the indigoid structures will 
enhance self-assembly or disrupt it. 
 
An initial investigation of these compounds could begin with the commercially 
available, lower cost indigo. An immediate avenue for investigation would be a 
possible synthetic route for peptide attachment. Since the structure of indigo 
contains two secondary, heterocyclic amines, and since peptide chemistry makes 
extensive use of amines, these moieties would be of initial interest. As shown in 
Scheme 7.1, one immediately essential reaction to explore would be to see if an 
amide link could be formed between the cyclic amines and a low steric demand 
amino acid (such as glycine). Due to the inherent steric hindrance present in the 
indigo structure, and the strong intermolecular hydrogen-bonding between the 
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cyclic amines and the neighboring carbonyl, a successful amide linkage here would 
not be guaranteed. Even if requiring extended reaction times or strong conditions, if 
the amide linkage could be achieved, a significant synthetic avenue would thus be 
open for peptide inclusion. In such a case, indigoid precursors could be formed as 
outlined in Scheme 7.1, using either an excess of Fmoc-protected amino acid to 
achieve an indigoid with two amino acid linkers, or using an excess of indigoid to 
achieve a product having a single linker. The excess reagent would drive the amide 
formation equilibrium toward completion, and the chosen reagent of excess would 
select the product obtained. Purification could likely be performed using extraction 
(with water) followed by column chromatography.  
 
N
N
O
H
H
O
R1
R1
indigo:             R
1
 = H
Tyrian purple:  R
1
 = Br
+
OH
O
R2
N
Fmoc
H
R
2
 = amino acid
side-chain
N
N
O
H
O
R1
R1
O
R2N
Fmoc
H
N
N
O
O
R1
R1
O
R2
N
Fmoc
H
O
R2N
Fmoc
H
N
N
O
H
H
O
R1
R1
+
OH
O
R2
N
FmocH
+
1:1 DMF/CH
2
Cl
2
HBTU or other activator
excess amino acidexcess indigoid
separation via column chromatography
 
Scheme 7.1   A proposed reaction for the formation of amino acid indigoid 
conjugates to be used as precursors in peptide-indigoid synthesis. 
If the reaction in Scheme 7.1 were successful, the chosen linker applied could also 
play a role in tuning the indigoid bandgap. Strong intramolecular hydrogen 
bonding between the heterocyclic N-H and the neighboring carbonyl have been 
shown to influence the indigoid bandgap by influencing conjugation and molecular 
alignment,189 and structural changes which add a linker at this N-H position may be 
accordingly relevant. If the reaction in Scheme 7.1 were found to be unworkable, 
alternative functional group strategies could be considered such as a metal-
152 
 
catalyzed coupling through the bromine functionality of Tyrian purple, or the 
synthesis of functionalized indigoids via substituted precursors (analogous to 
Scheme 7.2).228  
 
 
 
Scheme 7.2   Synthetic pathway for the synthesis of Tyrian purple. (Scheme 
adapted for review from Wolk and Frimer228 with permission from MDPI.) 
While the commercially available indigo would be attractive for synthesis on larger 
scales, synthetic pathways such as that outlined in Scheme 7.2 could provide access 
to other derivatives. In fact, if suitable naphthalene building blocks could be 
obtained, such precursors might be similarly applied to produce indigoids with 
additional fused rings and extended conjugation. Once the appropriate indigoids 
were obtained or synthesized, if the solubility of the compounds was compatible 
with the conditions of solid-phase peptide synthesis (SPPS), a potentially facile, 
solid-phase route to produce peptide-substituted indigoids could be envisioned. 
 
Following from these ideas discussed in this section, a proposed solid-phase 
reaction protocol is presented here in Scheme 7.3. While the peptide sequence 
presented in Scheme 7.3 is that of an oligo-alanine (for illustrative simplicity), it 
could be easily replaced by a natural peptide sequence of interest. For this protocol, 
a solvent combination such as a 1:1 mixture of DMF and dichloromethane would 
(glycine) 
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be anticipated to satisfy the solubility demands of both the SPPS reagents as well as 
the indigoids. SPPS would initially proceed as usual to produce the first oligo-
alanine strand. Following this, the first of two aspartic acid linkers with an allyl 
ester would be appended. This represents a key feature of this protocol. The 
aspartic acid provides two carboxylic acid moieties for synthesis (through the 
terminus and side-chain), and the allyl ester strategy would make them selectively 
available without disrupting the Fmoc group or other protecting groups used in the 
synthesis. The allyl ester (OAll) could be removed when needed via the use of 
Pd(PPh3)4. During amino acid coupling reactions, these aspartic acid linkers would 
also allow a selective “switch” that could change the on-chain receptive site of the 
peptide from an amino group to a carboxyl group (or vice versa). 
 
The use of the Fmoc-protected aspartic acid linking units with the allyl esters would 
effectively give a means to “reverse” the direction of the oligo-amide backbone of 
the peptide attached to the indigoid by linking through the aspartic acid side-chain. 
Two versions of the aspartic acid would be applied; one would have the allyl ester 
on the side-chain carboxyl group, while the other would have a carboxyl terminus 
allyl ester. These would be applied on the opposite sides of the indigoid moiety 
during synthesis. While the synthesis of a unsymmetrical product is shown in 
Scheme 7.3 (with the peptides each attached by a different end), a symmetrical 
product could be obtained by altering the aspartic acid switching decisions and 
coupling the resin-bound chain with an Fmoc-protected oligoalanine peptide. 
Alternatively, additional nonsymmetrical products with a single appended peptide 
strand could be obtained by stopping the reaction after the coupling of the indigoid. 
 
The reactions with the indigoid shown in Scheme 7.3 assume sufficient reactivity of 
the cyclic indigoid amines to permit the reaction to occur. Even though two amino 
groups are free on the indigoid, protecting groups should be unnecessary for 
preventing crosslinking between resin-bound peptide strands by the indigoid — 
provided that a high excess of the indigoid is used during the coupling reaction. 
Otherwise, an unsymmetrical derivative like that shown in Scheme 7.1 might be 
necessary. If steric constraints were to forbid the coupling reaction from occurring 
as shown in Scheme 7.3, and if indigoid precursors with linkers already attached 
were necessary, Scheme 7.3 could still be applied with slight modifications. 
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Scheme 7.3   A proposed SPPS protocol to produce a peptide-substituted indigoid.  
7.4 Summary 
Informed by the work with peptide-substituted perylene imides from this study, 
residue-specific traits for lysine and other amino acids remain rich areas for the 
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exploration of self-assembly. A multitude of peptide sequences (from both natural 
protein interfaces and rational design) hold further opportunities for guiding self-
assembly. Applying this potential of peptides to enhance self-assembly may be 
advantageous in a variety of semiconductor moieties aside from perylene imides. 
Among those worth consideration are natural dyes such as indigo and Tyrian 
purple, which could form the basis for self-assembling natural moiety ensembles.        
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Chapter 8 
Experimental 
8.1 Materials 
The termini end-capped (acetylated and amidated) Ac-IKHLSVN-NH2 peptide was 
purchased from Mimotopes (R.P. 617113, Melbourne, Australia) with a purity >95% 
(as an acetate salt). All other peptides were synthesized via standard Fmoc solid-
phase peptide synthesis (SPPS) protocols as outlined in Chapter 2. 
 
Non-symmetric perylene precursors Q1, Q2, Q3, and Q4 were received from the 
lab of Dr. Pall Thordarson (University of New South Wales, Sydney, Australia) 
and were synthesized according to previously published methods as indicated in 
Section 8.15. Synthesis of all peptide-perylene imide conjugates was accomplished 
via condensation of the terminal peptide amines (or amine linkers) with the desired 
perylene anhydride moiety as discussed generally in Chapter 2. 
 
For the syntheses described, all amino acid derivatives, synthetic resins, chemical 
reagents, and solvents were purchased in high purity from various commercial 
suppliers and used as received. Specific synthetic and characterization details are 
discussed in this chapter along with a presentation of compound characterization 
data. NMR spectra, MALDI mass spectra, and IR spectra for all compounds are 
shown as supporting information in the appendices.  
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8.2 NMR Spectroscopy 
NMR data were collected on a Varian Unity Inova operating at 500 MHz (1H) or 
125 MHz (13C), or on a Varian Direct-Drive spectrometer equipped with a HCN 
cold probe operating at 600 MHz (1H) or 150 MHz (13C). All NMR spectra were 
referenced internally to residual solvent peaks.229 PDI compound spectra were 
collected from solutions with concentrations matching the solubility limit of each 
compound. 1H NMR peak assignments were based on two-dimensional nuclear 
magnetic resonance (2D NMR) correlation spectroscopy (COSY) assessments 
evaluated from the free peptide solutions in DMSO-d6. Residue assignment labels 
are numbered sequentially along the N- to C-terminal directionality. 
8.3 High Resolution (ESI) Mass Spectrometry 
High resolution mass spectrometry analyses for the synthesized peptides were 
performed on an Agilent 6530 Q-TOF system equipped with an electrospray ion 
(ESI) source operated in positive ion mode. All mass spectra were obtained using a 
system mixture of water:acetonitrile (5:95) with 5 mM ammonium formate added.  
8.4 Matrix-Assisted Laser Desorption Ionization 
 (MALDI-TOF) Mass Spectrometry 
Spectra were collected on an AB Sciex TOF/TOF 5800 mass spectrometer. 
Samples were analyzed in a matrix consisting of 2,5-dihydroxybenzoic acid (10 
mg/mL) dissolved in an aqueous solution of 50% acetonitrile and 0.1% (v/v) 
trifluoroacetic acid. Small portions (1 μL) of dilute (10-4 to 10-6 M) solutions of each 
compound in 0.2% (v/v) pyridine/water were added with 20-40 μL of the matrix. 
One microliter volumes of the PDI/matrix mixtures were deposited on a sample 
plate and air-dried prior to analysis. 
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8.5 Fourier Transform Infrared Spectroscopy 
Conversion of the anhydride functional group to the imide structure was verified 
using Fourier-transform infrared (FT-IR) spectroscopy. The FT-IR spectra were 
collected on a Perkin Elmer Spectrum One spectrometer using freshly prepared 
potassium bromide pellets and recorded in the range of 4000-450 cm−1 and averaged 
over 16 scans. FT-IR analysis of the amide I and II peptide bands was 
accomplished based on methods reported in literature.98–101 Briefly, spectra were 
collected in solid-state (KBr) and averaged over 50 scans. The spectra were then 
baseline-corrected and smoothed using the Savitzky-Golay method with a 
polynomial order of 3 (via Matlab software) prior to numerically evaluating the 
second derivative of each spectrum. Using the minima of the second derivative to 
determine the number and positions of the Gaussian peaks to be applied, the 
measured IR spectra were then computationally fit as a sum of Gaussian peaks. 
The peak parameters were computationally, iteratively adjusted to minimize the fit 
residual. For the fitting process, peak positions were constrained to ±5 cm−1 from 
the initial values set on the basis of the second derivative minima. 
8.6 UV-vis Spectroscopy 
UV-vis absorption spectra were collected on an Agilent 8463 UV-vis spectrometer 
using a 1.0 cm quartz cell. All spectra were baseline corrected to remove effects 
attributed to scattering from aggregated particles. General solution preparation: 
Concentrated stock solutions were prepared in either an aqueous base or in an 
organic acid by dissolving 1.3-1.8 mg samples of the perylene imide compounds 
into 1 mL of the chosen stock solvent, thus producing 800 μM perylene imide stock 
solutions. Aqueous bases used as stock solvents were aqueous pyridine (200 μL 
pyridine in 10 mL of water) or 0.01 M NaOH. Organic acids used as stock solvents 
were TFA or HFIP. (Stock solvents were selected according to the compound 
characteristics and the demands of the analysis to be performed.) Subsequently, 
solutions for spectroscopic analyses were prepared by diluting (injecting) small 
volumes (20-40 μL) of the previously prepared perylene imide stock solutions into 5 
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mL of the solvents of interest, thus triggering self-assembly and producing 3-6 μM 
solutions for spectroscopic analysis. Specific solution preparations for a given study 
are given in their respective chapters.    
8.7 Circular Dichroism Spectroscopy 
Circular dichroism (CD) spectra were recorded at room temperature using a 1.0 cm 
quartz cell. Far UV circular dichroism (CD) spectra were collected with a Jasco J-
815 spectrometer, and visible CD spectra were recorded on an Applied 
Photophysics Chirascan CD spectrometer. Solutions for analysis were prepared 
using the methods outlined for UV-vis spectroscopy (Section 8.6). (CD spectra in 
the far UV were collected by collaborators at Canterbury University – Christchurch, 
New Zealand.) 
8.8 Thioflavin-T Fluorescence Binding Assays 
Peptide samples were dissolved in an aqueous solution of Thioflavin-T (ThT), such 
that the final concentrations in each sample were 25 μM ThT and 1-10 mg/mL of 
peptide. The peptide solutions analyzed were prepared by diluting from aqueous 
stock solutions with concentrations of 20-30 mg/mL. Upon dilution, the resulting 
solutions to be analyzed were left to equilibrate at 4°C for 24 h before recording 
fluorescence intensity. Fluorescence intensity was measured from 100 μL aliquots 
placed into sample well plates using a Molecular Devices SpectraMax M5 
fluorimeter equipped with a plate reader. Samples were excited at 440 nm, and 
fluorescence intensity was recorded at 482 nm, using a 25 μM ThT solution in 
water as a blank. The fluorescence intensity values reported resulted from the 
average of 3 recordings for each sample. For the samples analyzed, an additional 
turbidity assay was also performed as supporting evidence for the aggregation of the 
peptide sequences, showing the absorbance of the peptide solutions recorded at 600 
nm. (ThT assays were performed by collaborators at Canterbury University – 
Christchurch, New Zealand.) 
161 
 
8.9 Transmission Electron Microscopy (TEM) 
TEM imaging for Chapter 3 was performed using a Tecnai T12 transmission 
electron microscope operated at 120 kV. Sample Preparation: 8 µL of each sample 
was applied to 300-mesh copper grid coated with carbon (on nitrocellulose support) 
and was left to air dry for 10 minutes; the remaining solvent was blotted from the 
back side of the grid. (TEM imaging was performed by collaborators at the 
Weizmann Institute of Science – Rehovot, Israel.) 
 
TEM imaging for Chapter 5 was performed using a FEI Morgagni 268D 
transmission electron microscope operating at 80 kV, with magnifications up to 
180k. Micrographs were captured using a SIS/Olympus Megapixel III digital 
camera mounted above the phosphor screen. Sample Preparation: The peptide 
samples were pelleted by centrifuging at 10k rpm for 10 minutes. The pellet was 
then re-suspended in 2.5% gluteraldehyde solution and stored overnight at 4 ˚C. 
Following overnight incubation, the peptide sample was re-pelleted and further 
suspended in water prior to grid preparation. (Note: The volume of water added 
was the same as that of the decanted supernatant to maintain the concentration.) 
Carbon-coated Formvar 200-mesh copper grids (ProSciTech, Australia) were 
deposited successively for one minute each onto 15 μL drops of (i) aqueous peptide 
solutions, (ii) water (3 times) and (iii) a 2% w/w uranyl acetate solution in water (as 
a negative stain). Filter paper was used to remove the excess liquid from the grids, 
which were then left to dry for a few hours before electron microscopy observations. 
(TEM imaging was performed by collaborators at Canterbury University – 
Christchurch, New Zealand.) 
 
Cryogenic TEM (cryo-TEM) imaging was performed using a Tecnai F20 
transmission electron microscope operating at 200 kV, using a Gatan 626 cooling 
holder, and a transfer station with a Gatan US4000 CCD digital camera, or a 
Tecnai T12 transmission electron microscope operating at 120 kV, using a Gatan 
626 cooling holder and transfer station, with a TVIPS F244HD CCD digital camera. 
Sample Preparation: 8 μL of each sample was applied to a 300-mesh copper grid 
coated with holey carbon (Pacific Grid-Tech supplies). The samples were blotted at 
25 °C and 95% relative humidity, and plunged into liquid ethane using a Leica EM-
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GP Automatic Grid Plunger. Specimens were equilibrated at −178 °C in the 
microscope prior to the imaging process. (TEM imaging was performed by 
collaborators at the Weizmann Institute of Science – Rehovot, Israel.) 
8.10 Atomic Force Microscopy (AFM) 
AFM images were acquired using a Bruker MultiMode® 8 with Nanoscope J 
controller. Samples were scanned in ScanAsyst mode using a ScanAsyst-Air tip 
(Silicon Nitride, 2-12 nm tip radius, k = 0.4 N/m). The sample environment was a 
Bruker stainless steel cantilever holder (MFMA), and all samples were imaged in 
air. Images were processed using Gwyddion 2.28 software. 
Sample Preparation (Chapter 3): PDI samples were sonicated into an aqueous sodium 
hydroxide (0.01 M) yielding a red solution (0.5 mM). An aliquot (2 μL) of this 
solution was dropped into aqueous hydrochloric acid (0.1 M, 20 μL) or into water, 
yielding a cloudy dark red solution (0.05 mM). This solution was left for 72 hours 
to allow fiber formation, and was then pipetted onto a freshly cleaved muscovite 
mica surface, and incubated in the dark until dried (≈ 1 h). Solution concentrations 
and solution aging times were adjusted where required to investigate concentration 
and kinetic effects. 
Sample Preparation (Chapter 4): Samples were prepared at a concentration of 4 
mg/mL in DMSO and a drop of this solution (≈ 50 μL) added to 500 μL of water. 
A drop of this mixture was then spin coated onto a freshly cleaved mica substrate 
for three minutes at 3000 rpm. After spin coating, these samples were left to dry in 
air overnight.  
Sample Preparation (Chapter 5): In a typical experiment, 1 mg of sample was briefly 
sonicated and gently heated into a pyridine/water mixture (9:1) yielding a red 
solution. An equimolar equivalent of glacial acetic was then added to neutralize the 
residual pyridine in solution. An aliquot (50 μL) of this solution was then spread 
onto a freshly cleaved mica substrate and left to dry for 24 hours before imaging. 
(AFM imaging was performed by collaborators at the University of New South 
Wales – Sydney, Australia.) 
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8.11 OFET Device Fabrication 
Bioorganic field-effect transistor (biOFET) devices were fabricated by integrating 
flakes of the hybrid peptide material as the active channel in a bottom contact, back 
gate device structure. Initially the device substrates were prepared by taking highly 
doped n-type silicon substrates (Silicon Quest International) and depositing a gold 
electrode onto the silicon to act as the back gate. P-type silicon substrates were also 
tested for a comparison. The top surfaces were then spin-coated with 
polydimethylsiloxane (PDMS) (sylgard 184) at 6000 rpm for 60 s on highly doped 
(0.01-0.02 ·cm) n-type silicon substrates to provide the dual purpose of a gate 
dielectric, as well as being a soft and adhesive site for the peptide flakes. Gold 
electrodes (70 nm) with channel widths of 40 μm channel spacing were deposited 
via a precision Osilla OFET shadow mask using the Angstrom Engineering 
Nexdep evaporator. Flakes of the active materials grown in vials via slow solvent 
evaporation from a 1:4 pyridine/water solution (heated to 75-80 °C) were then 
mounted across the gold electrode channels using conductive silver paste (ethyl 
acetate paste solvent). All device measurements were conducted in air at room 
temperature. (The biOFET devices were fabricated jointly by the author and the 
Plank Research Group – Victoria University of Wellington.) 
8.12 General Solid-Phase Peptide Synthesis (SPPS) 
Synthesis employed standard Fmoc-based solid-phase peptide synthesis (SPPS) 
protocols,198  which are discussed in detail Chapter 2. Following below is a brief 
detailed summary of the general SPPS protocols used as the basis for the synthesis 
of the peptides presented in this work. 
 
A sample of Fmoc-Glu(OtBu)-Wang resin (0.50 g, loading 0.33-0.56 mmol/g) was 
prepared by swelling the resin in dichloromethane (DCM) (7 mL) for 30 minutes 
and then washing the resin with dimethylformamide (DMF) (7 mL). Sequentially 
alternating Fmoc-deprotection and amino acid coupling reactions with the desired 
Fmoc-protected amino acids afford the desired peptide sequence. Fmoc-
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deprotection reactions were performed using 30% (v/v) piperidine/DMF (7 mL) 
with gentle shaking for 30 minutes followed by thorough washes of the resin with 
DMF. Amino acid coupling reactions were performed using a mixture of the 
desired amino acid (4 molar equivalents), O-benzotriazole-N,N,N',N'-
tetramethyluronium hexafluorophosphate (HBTU) (3.95 molar equivalents), and 
N,N-diisopropylethylamine (DIPEA) (6 molar equivalents) in molar excess relative 
to the loading of the Wang resin. The coupling reaction mixtures were gently 
shaken for 30 minutes followed by a thorough wash of the resin. A Kaiser test was 
conducted after each coupling reaction to confirm completion. Upon removal of 
the terminal Fmoc protecting group from the completed peptide sequence, the resin 
was washed thoroughly with DMF followed by several washes with DCM. 
Cleavage of the completed peptide sequence from the Wang resin was achieved by 
gently shaking the resin for 3 hours in a mixture of trifluoroacetic acid (TFA) and 
DCM (7 mL, 3:4 TFA/DCM) or an alternative TFA cleavage mixture with added 
scavenger compounds (such as triisopropylsilane and phenol). The cleavage 
solution was collected, the resin was washed with DCM (5 mL), and the wash was 
added with the collected cleavage solution. Cold diethyl ether (40 mL, 0-5 °C) was 
added to the cleavage solution and chilled for 30 minutes to precipitate the peptide 
product. The precipitate was collected by filtration, washed with cold diethyl ether, 
and dried under vacuum to yield the peptide product. Residual traces of scavengers 
or other compounds detected in the peptide product were removed via additional 
washes with acetonitrile or ethyl acetate. 
  
Where applicable, modifications to the resin used, to the cleavage solution applied 
(including the use of scavengers), or to the washing steps performed during specific 
syntheses are noted within the details for the relevant compound within the 
compound-specific information listed in section 8.15.  
8.13 General Perylene Imide Synthesis Procedures 
Synthesis of the peptide-substituted perylene imides was based on amine 
condensation with an anhydride moiety following methods for the synthesis of 
perylene imide derivatives as reported in literature.86  
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For the N,N'-dipeptide perylene diimides, a mixture of the desired peptide and 
perylene 3,4,9,10-tetracarboxylic acid dianhydride (PTCDA) were combined in a 
2:1 molar ratio (with a slight peptide excess) in imidazole (0.80-1.0 g) and stirred at 
124-135 °C for 12-24 hours under nitrogen. 
 
Synthesis of N-hexyl-N'-peptide perylene diimides was performed by analogous 
procedures used for the dipeptide diimides using a mixture of the desired peptide 
and perylene-3,4-anhydride-9,10-hexylimide in a 1:1 molar ratio with a slight 
peptide excess. 
 
Synthesis of N-peptide perylene imide bis(n-butyl)esters (peptide-PIBEs) was 
performed by condensation reaction of the desired peptide with a perylene-3,4-
monoanhydride-9,10-bis(n-butyl)ester87 precursor by heated stirring in DMF or by 
stirring in imidazole in a 1:1 molar ratio with a slight peptide excess. 
 
Following the condensation reaction, the mixture was allowed to cool to room 
temperature with continued stirring followed by the addition of 3 mL of water to 
the mixture upon reaching 90 °C. Upon cooling, the solution was loaded onto an 
HP20ss column with the addition of small amounts of water. Once fully loaded 
onto the resin, the mixture was eluted and cyclically loaded through the column 
using dilute aqueous acetic acid with an increasing acid gradient until all dark 
red/purple components were retained within the resin and the eluted solvent 
became yellow to colorless. The dark solids retained in the resin were then 
thoroughly washed with 5-7% (v/v) acetic acid (700-1200 mL) until the eluted wash 
changed from yellow to nearly colorless. A subsequent wash with acetone (150-300 
mL) was made to remove traces of any reddish impurity. Removal of the desired 
product from the resin following the washes was accomplished using 20-50% (v/v) 
pyridine in water. Removal of the solvent under reduced pressure afforded the dark 
colored peptide-substituted perylene imides. 
 
Where applicable, modifications to these protocols are noted within the specified 
details for the relevant compound within the compound-specific information listed 
in section 8.15. 
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8.14 Purification of the Compounds 
The purification protocol reported here capitalized on the low solubility and pH-
triggered aggregation of the desired final products to accomplish separation. The 
reverse-phase HP20ss resin allowed charged species to pass through the column 
while retaining uncharged species. The use of the acetic acid washes easily 
protonated species such as the imidazole and free peptide, rendering them as 
charged ionic components not retained by the resin, while simultaneously triggering 
the aggregation and retention of the desired perylene imide product within the resin. 
Removal of the remaining imidazole and other impurities was accomplished via the 
use of polar acetone washes. The product was then easily removed by flushing with 
basic washes to ionize the glutamic acid units.  
  
During the synthesis of dipeptide-perylene diimides, the formation of monopeptide-
perylene species was expected to be minimal since the reactions were conducted 
with a slight excess of the peptides; however, any monopeptide-perylene imide 
species formed would have greater solubility than the desired products. As such, 
these monopeptide species would release from the HP20ss resin more readily than 
the desired dipeptide products during the successive acetic acid/acetone flushes 
during the purification protocol. 
 
While the strongly aggregating products obtained in this study were not amenable 
to quantification by HPLC, on the basis of cross-checking the combined 
characterization data collected, the compound purity was estimated to be >95% 
(exclusive of residual solvents). Persistent residual solvents (from synthetic or 
washing steps) were not rigorously removed since the free peptides primarily served 
as synthetic intermediates for the formation of the peptide-perylene imide 
conjugates (which were subsequently purified by reverse-phase chromatography) A 
summary of residual solvent impurities detected in some NMR spectra of the 
compounds are given in Table 8.1. 
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Table 8.1. NMR Chemical Shifts of Residual Solvent Impurities  
NMR 
Solvent 
Impurity a 1H Resonances (ppm) 13C Resonances (ppm) 
      
DMSO-d6 DMSO residual
 b 2.50 s 39.52 hept. 
 water b 3.33 br. s —  
 diethyl ether c 3.38 t 15.12  
  1.09 q 62.05  
 TFA c 11.5 br. s 158.68 q g 
    117.02  q g,h 
 acetone d 2.09 s 206.31  
 acetonitrile d 2.07 s 117.91  
 ethyl acetate d 1.99 s 20.68  
  4.03 q 59.74  
  1.17 t 14.40  
  — - 170.31  
      
CDCl3  CHCl3 residual
 b 7.27 s 77.16 t 
 TFA b 11.5 br. s 162.77 q g 
  6.60 3 (s) f 114.66  q g,i 
 acetic acid e 2.10 s 20.81  
  — - 175.99  
 dichloromethane b 5.30 s 53.52  
a 
Persistent solvent residuals present with the peptide samples  
b
 Traces present in the NMR solvent used 
c
 Persistent traces introduced during peptide synthesis 
d
 Introduced from peptide washing, filtration, and drying steps 
e
 Present along with partially fluorine-substituted acetic acid variants within the TFA used 
f
 TFA/CDCl3 interaction  gives a weak, triplet-like formation  (peaks at 6.69, 6.60, 6.50)  
g
 Mutual splitting between 
13
C and 
19
F, produces two quartet-type formations 
h
 Large coupling constant. Resembles four well-separated peaks: 120.5, 118.1, 115.8, 113.4 
i
 Large coupling constant. Resembles four well-separated peaks: 117.5, 115.6, 113.7, 111.8 
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The most commonly observed solvent impurities in the peptide 1H NMR spectra 
were diethyl ether and TFA, since the final synthetic step for peptide collection 
involved a mixture of these solvents. Diethyl ether was seen to be remarkably 
persistent despite lengthy drying under vacuum, and TFA residuals were expected 
since the peptide initially precipitates as a trifluoroacetate salt upon addition of 
diethyl ether into the TFA cleavage mixture. It should be noted here that the 
presence of TFA in the samples exhibits distinctive resonance groups within the 13C 
NMR spectra due to mutual splitting by the 13C and 19F nuclei. This produces two 
quartet-like signals centered at 158.7 and 117.0 ppm (in DMSO-d6). A large 
coupling constant is observed for the signal at lower chemical shift, making the 
formation appear somewhat like four distinct, well-separated peaks in the aromatic 
region of the spectrum. These TFA resonances are seen to occur with aromatic 
compound resonances such as those from phenylalanine or histidine, but the TFA 
signal can be distinguished by identifying the regularly-spaced splitting intervals. 
 
In cases where persistent scavengers (introduced from the peptide cleavage solution) 
were present, the peptide solids were washed in solvents such as acetonitrile and 
ethyl acetate to draw out adsorbed scavenger materials. Traces of these solvents 
were sometimes observed in the NMR spectrum; however, these solvents (and the 
others previously noted) were inert to subsequent reactions using the peptides and 
were not rigorously removed from the samples.  
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8.15 Compound Synthesis and Characterization 
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Figure 8.1    Chemical structure of peptide P1 
Synthesis was performed according to the general SPPS procedure with a sample of 
Fmoc-Glu(OtBu)-Wang resin (0.50 g, loading 0.52 mmol/g, 0.26 mmol) affording 
title compound P1 as a pale, off-white solid (0.15 g, 88%). 1H NMR (500 MHz, 
DMSO-d6): δ = 8.62 (1H, t, J = 5.5 Hz, NH Gly #2), 8.30 (1H, t, J = 5.7 Hz, NH 
Gly #3), 8.17 (1H, d, J = 7.6 Hz, NH Glu #3), 8.13 (1H, t, J = 5.6 Hz, NH Gly #4), 
8.02 (4H, m, NH2 Gly #1, NH Glu #1-2), 4.29 (1H, m, αCH Glu #1), 4.24 (1H, m, 
αCH Glu #2), 4.17 (1H, m, αCH Glu #3), 3.85 (2H, d, J = 5.4 Hz, CH2 Gly #2), 
3.75 (4H, d, J = 5.9 Hz, CH2 Gly #3-4), 3.61 (2H, br s, CH2 Gly #1), 2.26 (6H, m, 
γCH2 Glu #1-3), 1.92 (3H, m, βCH2 Glu #3, βCHb Glu #2), 1.75 (3H, m, βCHa 
Glu #2, βCH2 Glu #1); 
13C NMR (125 MHz, DMSO-d6): δ = 174.1, 174.0, 173.8, 
173.1, 171.2, 171.0, 169.1, 168.8, 168.7, 166.3, 51.8, 51.5, 51.3, 45.3, 42.0, 41.9, 
40.2, 30.7, 30.1, 30.0, 27.5, 27.3, 26.2; HRMS (ESI+) m/z: Calculated for 
C23H36N7O14 [M+H]
+ 634.2315, found 634.2297; Calculated for C23H35N7NaO14 
[M+Na]+ 656.2129, found 656.2115.  
 
N,N′-di[ – Gly – (Gly)3 – (Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (1). Condensation of PTCDA (0.052 g, 0.13 mmol) and peptide P1 (0.15 g, 
0.23 mmol) performed according to the general perylene imide synthesis procedures 
afforded title compound 1 as dark purple solid (0.15 g, 70%). 1H NMR (600 MHz, 
CDCl3/CF3COOH, 2:1): δ = 8.84 (m, Ar-H), 8.15-7.38 (NH proton exchange 
traces), 5.22 (m, CH2 Gly #1), 4.47-4.12 (m, αCH Gly #2-4, αCH Glu #1-3), 2.85-
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2.11 (m, γCH2 Glu #1-3), 1.77-1.23 (m, βCH2 Glu #1-3); MS (MALDI) m/z: 
Calculated for C70H74N14NaO32 [M+Na]
+ 1645.45, found 1645.42; IR (KBr): ν = 
3436, 2926, 2855, 1692, 1659, 1594, 1439, 1401, 1366, 1341, 1277, 1249, 1175, 
1125, 1033, 1010, 862, 810, 755, 698, 656 cm−1. 
 
Perylene-3,4-anhydride-9,10-hexylimide (Q1). Synthesis and purification were 
accomplished as previously reported.88 Characterization data matched that reported 
in the literature. 
 
N-hexyl-N′-[ – Gly – (Gly)3 – (Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (1H). Condensation of perylene-3,4-anhydride-9,10-hexylimide Q1 (0.015 
g, 0.032 mmol) and peptide P1 (0.023 g, 0.036 mmol) performed according to the 
general perylene imide synthesis procedures afforded title compound 1H as dark 
purple solid (0.021 g, 61%). 1H NMR (600 MHz, CDCl3/CF3COOH, 2:1): δ = 8.83 
(m, Ar-H), 8.73-7.41 (NH proton exchange traces), 5.23 (s, CH2 Gly #1), 5.20 (s, 
CH2 Gly #2), 4.47 (m, αCH Glu #1-3), 4.33 (s, CH2 Gly #3), 4.32 (s, CH2 Gly #4), 
4.28 (t, J = 6.5 Hz, hexyl NCH2), 2.46 (m, γCH2 Glu #1-3), 2.23 (m, βCH2 Glu #1-
3), 1.80 (quin. J = 6.5 Hz, hexyl βCH2), 1.71-1.24 (m, hexyl CH2), 0.92 (t, J = 6.0 
Hz, hexyl CH3); MS (MALDI) m/z: Calculated for C53H54N8NaO18 [M+Na]
+ 
1113.34, found 1113.38; IR (KBr): ν = 3413, 3150, 3070, 2925, 2853, 1696, 1656, 
1593, 1438, 1403, 1374, 1343, 1248, 1174, 1087, 1022, 997, 855, 809, 794, 749, 628 
cm−1. 
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Figure 8.2    Chemical structure of peptide P2 
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Synthesis was performed according to the general SPPS procedure with a sample of 
Fmoc-Glu(OtBu)-Wang resin (0.50 g, loading 0.56 mmol/g, 0.28 mmol) affording 
title compound P2 as a pale, off-white solid (0.10 g, 89%). 1H NMR (500 MHz, 
DMSO-d6): δ = 8.55 (1H, d,  J= 7.3 Hz, NH Ala #1), 8.23 (1H, d, J = 7.6 Hz, NH 
Ala #2), 8.10 (1H, d, J = 7.8 Hz, NH Glu), 7.99 (2H, br s, NH2 Gly), 7.90 (1H, d, J 
= 7.3 Hz, NH Ala #3), 4.39 (1H, quin, J = 7.0 Hz, αCH Ala #1), 4.27 (2H, quin, J 
= 6.7 Hz, αCH Ala #2-3), 4.19 (1H, td, J = 8.4 Hz, J = 5.2 Hz, αCH Glu), 3.56 (2H, 
br s, CH2 Gly), 2.27 (2H, t, J = 7.9 Hz, γCH2 Glu), 1.96 (1H, td, J = 13.4 Hz, J = 
7.6 Hz, βCHb Glu), 1.76 (1H, m, βCHa Glu), 1.21 (9H, m, CH3 Ala #1-3); 
13C 
NMR (125 MHz, DMSO-d6): δ = 173.8, 173.1, 172.2, 171.6, 171.5, 165.5, 51.1, 
48.2, 48.0, 47.9, 30.7, 30.0, 26.4, 18.5, 18.2, 18.1; HRMS (ESI+) m/z: Calculated 
for C16H27N5NaO8 [M+Na]
+ 440.1752, found 440.1736, Calculated for C16H28N5O8 
[M+H]+ 418.1932, found 418.1917. 
 
N,N′-di[ – Gly – (Ala)3 – Glu – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (2). Condensation of PTCDA (0.047 g, 0.12 mmol) and peptide P2 (0.10 g, 
0.24 mmol) performed according to the general perylene imide synthesis procedures 
afforded title compound 2 as a dark purple solid (0.11 g, 74%). 1H NMR (600 MHz, 
CDCl3/CF3COOH, 2:1): δ = 8.84 (m, Ar-H), 8.15-7.32 (NH proton exchange 
traces), 5.22 (m, CHa Gly), 5.12 (m, CHb Gly), 4.90-4.51 (m, αCH Ala #1-3, αCH 
Glu), 2.63 (m, γCH2 Glu), 2.43 (m, βCHa Glu), 2.13 (m, βCHb Glu), 1.70-1.38 (m, 
CH3 Ala #1-3); MS (MALDI) m/z: Calculated for C56H58N10NaO20 [M+Na]
+ 
1213.37, found 1213.64, Calculated for C56H58N10Na2O20 [M+2Na]
+ 1236.36, found 
1235.93; IR (KBr): ν = 3425, 3283, 3060, 3025, 2922, 2850, 1773, 1693, 1661, 1630, 
1595, 1542, 1492, 1452, 1401, 1364, 1301, 1275, 1235, 1174, 1122, 1025, 860, 810, 
757, 696, 624 cm−1. 
 
N-hexyl-N′-[ – Gly – (Ala)3 – Glu – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (2H). Condensation of perylene-3,4-anhydride-9,10-hexylimide Q1 (0.0200 
g, 0.042 mmol) and peptide P2 (0.0198 g, 0.047 mmol) performed according to the 
general perylene imide synthesis procedures afforded title compound 2H as dark 
purple solid (0.023 g, 63%). 1H NMR (600 MHz, CDCl3/CF3COOH, 2:1): δ = 8.83 
(m, Ar-H), 8.15-7.32 (NH proton exchange traces), 5.23 (m, CHa Gly), 5.07 (m, 
CHb Gly), 4.88-4.50 (m, αCH Ala #1-3, αCH Glu #1-3), 4.28 (t, J = 6.5 Hz, hexyl 
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NCH2), 2.62 (m, γCH2 Glu), 2.42 (m, βCHa Glu), 2.14 (m, βCHb Glu), 1.80 (quin. J 
= 6.5 Hz, hexyl βCH2), 1.65-1.23 (m, CH3 Ala #1-3, hexyl CH2), 0.90 (t, J = 6.0 Hz, 
hexyl CH3); MS (MALDI) m/z: Calculated for C46H46N6NaO12 [M+Na]
+ 897.31, 
found 897.72; IR (KBr): ν = 3396, 3302, 3080, 2929, 2856, 1697, 1657, 1594, 1541, 
1439, 1403, 1343, 1279, 1248, 1174, 1128, 1089, 1029, 997, 853, 810, 742, 625 cm−1. 
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Figure 8.3    Chemical structure of peptide P3 
Synthesis was performed according to the general SPPS procedure with a sample of 
Fmoc-Glu(OtBu)-Wang resin (0.50 g, loading 0.52 mmol/g, 0.26 mmol) affording 
title compound P3 as a pale, off-white solid (0.16 g, 91%). 1H NMR (500 MHz, 
DMSO-d6): δ = 8.55 (1H, d,  J= 7.3 Hz, NH Ala #1), 8.22 (1H, d, J = 7.3 Hz, NH 
Ala #2), 8.19 (1H, d, J = 7.6 Hz, NH Glu #3), 7.97 (4H, m, NH Ala #3, NH Glu 
#2, NH2 Gly), 7.91 (1H, d, J = 7.8 Hz, NH Glu #1), 4.39 (1H, quin, J = 7.1 Hz, 
αCH Ala #1), 4.25 (4H, m, αCH Ala #2-3, αCH Glu #1-2), 4.17 (1H, m, αCH Glu 
#3), 3.56 (2H, br s, CH2 Gly), 2.29 (6H, m, γCH2 Glu #1-3), 1.93 (3H, m, βCH2 
Glu #3, βCHa Glu #2), 1.75 (3H, m, βCH2 Glu #1, βCHb Glu #2), 1.20 (9H, m, 
CH3 Ala #1-3); 
13C NMR (125 MHz, DMSO-d6): δ = 174.0, 173.8, 173.1, 172.4, 
172.1, 171.8, 171.5, 171.1, 170.8, 165.5, 51.7, 51.6, 51.3, 48.21, 48.16, 48.1, 40.2, 
30.7, 30.1, 29.9, 27.5, 27.4, 26.2, 18.5, 18.1, 18.0; HRMS (ESI+) m/z: Calculated 
for C26H42N7O14 [M+H]
+ 676.2784, found 676.2764. 
 
N,N′-di[ – Gly – (Ala)3 – (Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (3). Condensation of PTCDA (0.060 g, 0.15 mmol) and peptide P3 (0.19 g, 
0.28 mmol) performed according to the general perylene imide synthesis procedures 
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afforded title compound 3 as a dark purple solid (0.20 g, 84%). 1H NMR (600 MHz, 
CDCl3/CF3COOH, 2:1): δ = 8.84 (m, Ar-H), 5.20 (m, CHa Gly), 5.08 (m, CHb Gly), 
4.88-4.45 (m, αCH Ala #1-3, αCH Glu #1-3), 2.63 (m, γCH2 Glu #1-3), 2.50-1.98 
(m, βCH2 Glu #1-3), 1.67-1.19 (m, CH3 Ala #1-3); MS (MALDI) m/z: Calculated 
for C76H86N14NaO32 [M+Na]
+ 1729.54, found 1729.56, Calculated for 
C76H86N14Na2O32 [M+2Na]
+ 1752.53, found 1752.55; IR (KBr): ν = 3416, 3283, 
3061, 2979, 2929, 2855, 1696, 1662, 1594, 1546, 1438, 1401, 1364, 1339, 1277, 
1245, 1174, 1038, 1003, 861, 810, 737, 699, 660, 626 cm−1. 
 
N-hexyl-N′-[ – Gly – (Ala)3 – (Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (3H). Condensation of perylene-3,4-anhydride-9,10-hexylimide Q1 (0.020 
g, 0.042 mmol) and peptide P3 (0.029 g, 0.044 mmol) performed according to the 
general perylene imide synthesis procedures afforded title compound 3H as a dark 
purple solid (0.038 g, 79%). 1H NMR (600 MHz, CDCl3/CF3COOH, 2:1): δ = 8.82 
(m, Ar-H), 8.13-7.29 (NH proton exchange traces), 5.22 (m, CHa Gly), 5.04 (m, 
CHb Gly), 4.83-4.49 (m, αCH Ala #1-3, αCH Glu #1-3), 4.27 (t, J = 7.7 Hz, hexyl 
NCH2), 2.60 (m, γCH2 Glu #1-3), 2.43 (m, βCH2 Glu #3), 2.29-2.00 (m, βCH2 Glu 
#1-2), 1.79 (quin. J = 7.6 Hz, hexyl βCH2), 1.66-1.19 (m, CH3 Ala #1-3, hexyl CH2), 
0.90 (t, J = 6.8 Hz, hexyl CH3); MS (MALDI) m/z: Calculated for C56H60N8NaO18 
[M+Na]+ 1155.39, found 1155.36; IR (KBr): ν = 3385, 3304, 3150, 2952, 2927, 
2855, 1693, 1656, 1594, 1439, 1402, 1342, 1279, 1248, 1173, 1088, 1033, 997, 843, 
810, 794, 742, 655, 625 cm−1. 
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Figure 8.4     Chemical structure of peptide P3E 
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Synthesis was performed according to the general SPPS procedure with a sample of 
Fmoc-D-Glu(OtBu)-Wang resin (0.50 g, loading 0.52 mmol/g, 0.27 mmol) 
affording title compound P3E as a pale, off-white solid (0.11 g, 60%). 1H NMR (500 
MHz, DMSO-d6): δ = 8.54 (1H, d,  J= 7.3 Hz, NH D-Ala #1), 8.23 (1H, d, J = 7.5 
Hz, NH D-Ala #2), 8.20 (1H, d, J = 7.5 Hz, NH D-Glu #3), 7.97 (4H, m, NH D-
Ala #3, NH D-Glu #2, NH2 Gly), 7.91 (1H, d, J = 7.8 Hz, NH D-Glu #1), 4.40 
(1H, quin, J = 7.1 Hz, αCH D-Ala #1), 4.26 (4H, m, αCH D-Ala #2, αCH D-Ala 
#3, αCH Glu #1, αCH D-Glu #2), 4.17 (1H, m, αCH D-Glu #3), 3.57 (2H, dd, J = 
4.4 Hz, J = 2.0 Hz, CH2 Gly), 2.26 (6H, m, γCH2 D-Glu #2, γCH2 D-Glu #3, γCH2 
D-Glu #1), 1.95 (3H, m, βCH2 D-Glu #3, βCHa D-Glu #2), 1.75 (3H, m, βCH2 D-
Glu #1, βCHb D-Glu #2), 1.21 (9H, m, CH3 D-Ala #1-3); 
13C NMR (125 MHz, 
DMSO-d6): δ = 174.1, 173.9, 173.2, 172.3, 172.0, 171.9, 171.7, 171.2, 170.9, 165.6, 
51.9, 51.7, 51.4, 48.30, 48.27, 48.2, 40.2, 30.2, 30.1, 30.0, 27.6, 27.4, 26.3, 18.5, 
18.2, 18.0; HRMS (ESI+) m/z: Calculated for C26H42N7O14 [M+H]
+ 676.2784, found 
676.2808. 
 
N,N′-di[ – Gly – (D-Ala)3 – (D-Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (3E). Condensation of PTCDA (0.014 g, 0.036 mmol) and peptide P3E 
(0.050 g, 0.074 mmol) performed according to the general perylene imide synthesis 
procedures afforded title compound 3E as a dark purple solid (0.040 g, 66%). 1H 
NMR (500 MHz, CDCl3/CF3COOH, 2:1): δ = 8.84 (m, Ar-H), 8.13-7.30 (NH 
proton exchange traces), 5.24 (m, CHa Gly), 5.06 (m, CHb Gly), 4.88-4.45 (m, αCH 
Ala #1-3, αCH Glu #1-3), 2.63 (m, γCH2 Glu #1-3), 2.50-1.98 (m, βCH2 Glu #1-3), 
1.70-1.26 (m, CH3 Ala #1-3); MS (MALDI) m/z: Calculated for C76H86N14NaO32 
[M+Na]+ 1729.54, found 1729.67; IR (KBr): ν = 3281, 3069, 2982, 1703, 1652, 
1594, 1542, 1439, 1402, 1366, 1338, 1310, 1246, 1174, 1039, 1002, 963, 853, 811, 
794, 743, 627 cm−1. 
 
N-hexyl-N'-[ – Gly – (D-Ala)3 – (D-Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic 
acid diimide (3HE). Condensation of perylene-3,4-anhydride-9,10-hexylimide Q1 
(0.020 g, 0.042 mmol) and peptide P3E (0.030 g, 0.044 mmol) performed according 
to the general perylene imide synthesis procedures afforded title compound 3HE as 
dark purple solid (0.040 g, 77%).1H NMR (500 MHz, CDCl3/CF3COOH, 2:1): δ = 
8.86 (m, Ar-H), 8.16-7.30 (NH proton exchange traces), 5.27 (m, CHa Gly), 5.12 (m, 
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CHb Gly), 4.91-4.56 (m, αCH Ala #1-3, αCH Glu #1-3), 4.32 (t, J = 7.7 Hz, hexyl 
NCH2), 2.67 (m, γCH2 Glu #1-3), 2.47 (m, βCH2 Glu #3), 2.35-2.00 (m, βCH2 Glu 
#1-2), 1.83 (quin. J = 7.5 Hz, hexyl βCH2), 1.54 (m, CH3 Ala #1-2, hexyl CH2CH2), 
1.40 (m, CH3 Ala #3, hexyl CH2), 0.93 (t, J = 6.8 Hz, hexyl CH3); MS (MALDI) 
m/z: Calculated for C56H60N8NaO18 [M+Na]
+ 1155.39, found 1155.54; IR (KBr): ν 
= 3289, 2953, 2930, 2855, 1695, 1654, 1594, 1577, 1541, 1440, 1403, 1374, 1343, 
1250, 1174, 1088, 1029, 997, 853, 810, 794, 748, 627 cm−1. 
 
Perylene-3,4-monoanhydride-9,10-bis(n-butyl) ester (Q2). Synthesis and 
purification were accomplished as previously described.87 Characterization matched 
that reported in the literature.  
 
N-[-Gly-(Ala)3-(Glu)3]perylene-3,4-imide-9,10-bis(n-butyl) ester (Q3). Peptide P3 
(0.060 g, 0.089 mmol) was combined with perylene-3,4-monoanhydride-9,10-bis(n-
butyl ester) Q2 (0.090 g, 0.17 mmol) in DMF (2.5 mL) and DMSO (2.5 mL) with 
diisopropylethylamine (0.10 mL) and stirred overnight at room temperature. The 
reaction was then precipitated with addition of hydrochloric acid solution (2 M, 0.5 
mL). The precipitate was collected via filtration and washed sequentially with 
hydrochloric acid (2 M, aq., 3 x 10 mL), methanol (3 x 10 mL), and 
dichloromethane (2 x 10 mL). Drying of the washed precipitate yielded peptide-
perylene bisester Q3 as a fuzzy red solid (0.069 g, 66%). 1H NMR (300 MHz, 
DMSO-d6): δ = 8.72 (4H, d, J = 8.4 Hz, Ar-H), 8.55 (1H, d, J = 6.9 Hz, NH Ala 
#1), 8.46 (2H, d, J = 7.8 Hz, NH Ala #2-3), 8.05 (4H, m, Ar-H), 7.90 (3H, m, NH 
Glu #1-3), 4.74 (2H, m, αCH2 Gly), 4.40-4.10 (10H, m, αCH Ala #1-3, αCH Glu 
#1-3, OCH2 esters), 2.24 (6H, m, γCH2 Glu #1-3), 1.91 (3H, m, βCH2 Glu #3, 
βCHa Glu #2), 1.73 (6H, m, βCHb Glu #2, βCH2 Glu #1, CH3 Ala #1), 1.44 (4H, 
hex, J = 7.5 Hz, βCH2 esters), 1.24 (6H, dd, J = 7.1 Hz, J = 1.5 Hz, CH3 Ala #2-3), 
1.14 (4H, d, J = 7.2 Hz, γCH2 esters), 0.95 (6H, t, J = 7.8 Hz, CH3 esters). 
 
N-[ – Gly – (D-Ala)3 – (D-Glu)3 – OH]-N′-[ – Gly – (L-Ala)3 – (L-Glu)3 – 
OH]perylene-3,4,9,10-tetracarboxylic acid diimide (3M). N-[-Gly-(Ala)3-
(Glu)3]perylene-3,4-imide-9,10-bis(n-butyl) ester Q3 (0.053 g, 0.045 mmol) and p-
toluenesulfonic acid (0.050 g) were suspended in toluene and heated to 90 °C for 6 
hours. The reaction mixture was then cooled to room temperature and the resulting 
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dark red solid collected via filtration. This dark red solid was washed with toluene 
(3 x 25 mL) and methanol (3 x 25 mL), collected and dried under high vacuum 
overnight. Condensation of a portion of the resulting dried peptide-substituted 
perylene imide anhydride (0.020 g, 0.019 mmol) with peptide P3E (0.020 g, 0.030 
mmol) performed according to the general perylene imide synthesis procedures 
afforded title compound 3M as a dark purple solid (0.026 g, 82%). 1H NMR (500 
MHz, CDCl3/CF3COOH, 2:1): δ = 8.88 (m, Ar-H), 8.05-7.29 (NH proton 
exchange traces), 5.24 (m, CHa Gly), 5.10 (m, CHb Gly), 4.88-4.51 (m, αCH Ala 
#1-3, αCH Glu #1-3), 2.64 (m, γCH2 Glu #1-3), 2.53-2.03 (m, βCH2 Glu #1-3), 
1.72-1.22 (m, CH3 Ala #1-3); MS (MALDI) m/z: Calculated for C76H86N14NaO32 
[M+Na]+ 1729.54, found 1729.26; IR (KBr): ν = 3297, 3060, 2965, 2928, 2855, 
1694, 1658, 1595, 1578, 1541, 1439, 1401, 1365, 1337, 1277, 1245, 1174, 1102, 
1002, 964, 852, 811, 794, 748, 698, 656, 627, 582 cm−1. 
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Figure 8.5    Chemical structure of peptide P4 
Synthesis was performed according to the general SPPS procedure with a sample of 
Fmoc-Glu(OtBu)-Wang resin (0.51 g, loading 0.52 mmol/g, 0.27 mmol) affording 
title compound P4 as a pale, off-white solid (0.16 g, 88%). 1H NMR (500 MHz, 
DMSO-d6): δ = 8.55 (1H, d,  J= 7.6 Hz, NH D-Ala #1), 8.22 (1H, d, J = 7.1 Hz, 
NH D-Ala #2), 8.17 (1H, d, J = 7.6 Hz, NH Glu #3), 8.02 (4H, m, NH D-Ala #3, 
NH Glu #2, NH2 Gly), 7.96 (1H, d, J = 6.8 Hz, NH Glu #1), 4.39 (1H, quin, J = 
7.0 Hz, αCH D-Ala #1), 4.25 (4H, m, αCH D-Ala #2, αCH D-Ala #3, αCH Glu #1, 
αCH Glu #2), 4.16 (1H, m, αCH Glu #3), 3.56 (2H, d, J = 5.1 Hz, CH2 Gly), 2.27 
(4H, q, J = 8.6 Hz, γCH2 Glu #2, γCH2 Glu #3), 2.20 (2H, t, J = 7.9 Hz, γCH2 Glu 
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#1), 1.94 (3H, m, βCH2 Glu #3, βCHa Glu #2), 1.74 (3H, m, βCH2 Glu #1, βCHb 
Glu #2), 1.21 (9H, m, CH3 D-Ala #1-3); 
13C NMR (125 MHz, DMSO-d6): δ = 
174.1, 174.0, 173.8, 173.2, 172.2, 171.8, 171.6, 171.2, 170.9, 165.6, 51.8, 51.6, 51.3, 
48.5, 48.2, 48.1, 40.2, 30.1, 30.07, 30.06, 27.5, 27.4, 26.2, 18.5, 18.4, 18.0; HRMS 
(ESI+) m/z: Calculated for C26H42N7O14 [M+H]
+ 676.2784, found 676.2796, 
Calculated for C26H41N7NaO14 [M+Na]
+ 698.2604, found 698.2598; HRMS (ESI−) 
m/z: Calculated for C26H40N7O14 [M−H]
− 674.2639, found 674.2647. 
 
N,N′-di[ – Gly – (D-Ala)3 – (Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (4). Condensation of PTCDA (0.022 g, 0.056 mmol) and peptide P4 (0.076 
g, 0.11 mmol) performed according to the general perylene imide synthesis 
procedures afforded title compound 4 as a dark purple solid (0.086 g, 90%). 1H NMR 
(600 MHz, CDCl3/CF3COOH, 2:1): δ = 8.83 (m, Ar-H), 8.15-6.90 (NH proton 
exchange traces), 5.19 (m, CHa Gly), 5.05 (m, CHb Gly), 4.85-4.41 (m, αCH D-Ala 
#1-3, αCH Glu #1-3), 2.61 (m, γCH2 Glu #1-3), 2.50-1.77 (m, βCH2 Glu #1-3), 
1.70-1.19 (m, CH3 D-Ala #1-3); MS (MALDI) m/z: Calculated for C76H86N14NaO32 
[M+Na]+ 1729.54, found 1729.58; IR (KBr): ν = 3435, 2971, 2929, 1697, 1664, 
1632, 1595, 1545, 1440, 1403, 1384, 1368, 1247, 1204, 1175, 1129, 1044, 810, 699, 
600 cm−1. 
 
N-hexyl-N′-[ – Gly – (D-Ala)3 – (Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic 
acid diimide (4H). Condensation of perylene-3,4-anhydride-9,10-hexylimide Q1 
(0.015 g, 0.032 mmol) and peptide P4 (0.028 g, 0.041 mmol) performed according 
to the general perylene imide synthesis procedures afforded title compound 4H as 
dark purple solid (0.025 g, 89%). 1H NMR (600 MHz, CDCl3/CF3COOH, 2:1): δ = 
8.83 (m, Ar-H), 8.15-7.33 (NH proton exchange traces), 5.24 (m, CHa Gly), 5.05 (m, 
CHb Gly), 4.85-4.46 (m, αCH Ala #1-3, αCH Glu #1-3), 4.29 (t, J = 6.5 Hz, hexyl 
NCH2), 2.63 (m, γCH2 Glu #1-3), 2.50-2.04 (m, βCH2 Glu #1-3), 1.80 (quin. J = 
7.7 Hz, hexyl βCH2), 1.66-1.24 (m, CH3 Ala #1-3, hexyl CH2), 0.92 (t, J = 6.0 Hz, 
hexyl CH3); MS (MALDI) m/z: Calculated for C56H60N8NaO18 [M+Na]
+ 1155.39, 
found 1155.09; IR (KBr): ν = 3430, 2929, 2857, 1697, 1655, 1594, 1540, 1440, 1403, 
1375, 1344, 1281, 1249, 1174, 1129, 1089, 1033, 997, 853, 810, 748, 628 cm−1. 
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Figure 8.6    Chemical structure of peptide P5 
Synthesis was performed according to the general SPPS procedure with a sample of 
Fmoc-Glu(OtBu)-Wang resin (0.50 g, loading 0.56 mmol/g, 0.28 mmol) affording 
title compound P5 as an hygroscopic, off-white solid (0.13 g, 98%). 1H NMR (500 
MHz, DMSO-d6): δ = 8.54 (1H, d, J = 7.8 Hz, NH Glu #1), 8.22 (2H, m, NH Glu 
#2-3), 8.01 (2H, br s, NH2 Gly), 4.40 (1H, m, αCH Glu #1), 4.25 (1H, m, αCH Glu 
#2), 4.18 (1H, m, αCH Glu #3), 3.59 (2H, d, J = 6.8 Hz, CH2 Gly), 2.28 (6H, m, 
γCH2 Glu #1-3), 1.92 (3H, m, βCH2 Glu#1, βCHa Glu#2), 1.75 (3H, m, βCHb 
Glu#3); 13C NMR (125 MHz, DMSO-d6): δ = 174.1, 174.0, 173.8, 173.1, 171.1, 
170.6, 165.8, 54.8, 51.8, 51.3, 40.2, 30.8, 30.09, 30.07, 27.9, 27.4, 26.2, 24.7; 
HRMS (ESI+) m/z: Calculated for C17H27N4O11 [M+H]
+ 463.1671, found 463.1666; 
Calculated for C17H26N4NaO11 [M+Na]
+ 485.1490, found 485.1481. 
 
N,N′-di[ – Gly – (Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic acid diimide (5). 
Condensation of PTCDA (0.021 g, 0.053 mmol) and peptide P5 (0.049 g, 0.11 
mmol) performed according to the general perylene imide synthesis procedures 
afforded title compound 5 as dark purple solid (0.038 g, 55%). 1H NMR (600 MHz, 
CDCl3/CF3COOH, 2:1): δ = 8.89 (m, Ar-H), 8.43-7.35 (NH proton exchange 
traces), 5.24 (m, CH2 Gly), 5.00-4.76 (m, αCH Glu #1-3), 2.72 (m, γCH2 Glu #1-3), 
2.58-2.13 (m, βCH2 Glu #1-3); MS (MALDI) m/z: Calculated for C58H56N8NaO26 
[M+Na]+ 1303.32, found 1303.16; IR (KBr): ν = 3428, 3060, 1692, 1658, 1593, 
1577, 1437, 1401, 1364, 1339, 1274, 1245, 1173, 1132, 1002, 862, 810, 794, 752, 
655, 625 cm
−1. 
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N-hexyl-N′-[ – Gly – (Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic acid diimide 
(5H). Condensation of perylene-3,4-anhydride-9,10-hexylimide Q1 (0.015 g, 0.032 
mmol) and peptide P5 (0.027 g, 0.058 mmol) performed according to the general 
perylene imide synthesis procedures afforded title compound 5H as dark purple solid 
(0.020 g, 67%). 1H NMR (600 MHz, CDCl3/CF3COOH, 2:1): δ = 8.84 (m, Ar-H), 
8.15-7.33 (NH proton exchange traces), 5.20 (m, CH2 Gly), 4.28 (t, J = 6.5 Hz, 
hexyl NCH2), 3.26 (q, J = 6.0, αCH Glu #1-3), 2.80-2.58 (m, γCH2 Glu #1-3), 2.51-
2.09 (m, βCH2 Glu #1-3), 1.79 (quin. J = 6.5 Hz, hexyl βCH2), 1.68-1.21 (m, hexyl 
CH2), 0.92 (t, J = 6.0 Hz, hexyl CH3); MS (MALDI) m/z: Calculated for 
C47H45N5NaO15 [M+Na]
+ 942.28, found 942.28; IR (KBr): ν = 3409, 2954, 2925, 
2854, 1696, 1658, 1593, 1507, 1438, 1403, 1372, 1343, 1248, 1174, 1087, 1032, 997, 
855, 809, 793, 748, 698, 628 cm−1.  
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Figure 8.7    Chemical structure of peptide P6 
Synthesis was performed according to the general SPPS procedure except that 
reaction times for the coupling reactions of the phenylalanine amino acids were 
increased to 4 hours. A sample of Fmoc-Glu(OtBu)-Wang resin (0.51 g, loading 
0.52 mmol/g, 0.27 mmol) was used for the reaction sequence. Precipitation, 
filtration, and drying of the product from the Wang resin cleavage solution afforded 
title compound P6 as a pale off-white solid (0.19 g, 80%). 1H NMR (500 MHz, 
DMSO-d6): δ = 8.50 (1H, d, J = 8.5 Hz, NH Phe #1), 8.34 (1H, d, J = 8.5 Hz, NH 
Phe #2), 8.23 (3H, d, J = 7.5 Hz, NH Phe #3, NH Glu #2, NH Glu #3), 8.04 (1H, 
d, J = 8.0 Hz, NH Glu #1), 7.93 (2H, br s, NH2), 7.12-7.31 (15H, m, Ph-H), 4.56 
(3H, m, αCH Phe #1, αCH Phe #2, αCH Phe #3), 4.31 (2H, m, αCH Glu #1, αCH 
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Glu #3), 4.18 (1H, m, αCH Glu #2), 3.47 (2H, d, J = 14.0 Hz, CH2 Gly), 3.02 (2H, 
td, J = 13.9 Hz, J = 3.9 Hz, βCHa Phe #2, βCHa Phe #3), 2.94 (1H, dd, J = 13.9 Hz, 
J = 3.4 Hz,  βCHa Phe #1), 2.84 (1H, dd, J = 13.9 Hz, J = 9.3 Hz,  βCHb Phe #3), 
2.76 (1H, dd, J = 13.9 Hz, J = 9.5 Hz,  βCHb Phe #2), 2.63 (1H, dd, J = 13.9 Hz, J 
= 9.8 Hz,  βCHb Phe #1), 2.27 (6H, m, γCH2 Glu #1, γCH2 Glu #2, γCH2 Glu #3), 
1.95 (3H, m, βCH2 Glu #3, βCHa Glu #2), 1.77 (3H, m, βCH2 Glu #1, βCHb Glu 
#2); 13C NMR (125 MHz, DMSO-d6): δ = 177.3, 174.2, 174.1, 173.8, 173.2, 171.2, 
171.0, 170.9, 170.5, 165.5, 137.8, 137.7, 137.5, 129.4, 129.3, 128.2, 128.1, 126.4, 
126.3, 56.4, 54.0, 53.9, 53.8, 51.9, 51.7, 51.4, 38.0, 37.6, 37.4, 30.3, 30.2, 30.1, 27.7, 
27.6, 26.3; HRMS (ESI+) m/z: Calculated for C44H54N7O14 [M+H]
+ 904.3723, found 
904.3703, Calculated for C44H53N7NaO14 [M+Na]
+ 926.3543, found 926.3547.  
 
N,N′-di[ – Gly – (Phe)3 – (Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (6). Synthesis was performed according to the general perylene imide 
synthesis procedures with the exception that the acetone wash was omitted since 6 
was found to elute from the HP20ss with acetone. Condensation of PTCDA (0.022 
g, 0.057 mmol) and peptide P6 (0.10 g, 0.11 mmol) afforded title compound 6 as dark 
purple solid (0.11 g, 90%). 1H NMR (600 MHz, CDCl3/CF3COOH, 2:1): δ = 8.83 
(m, Ar-H), 8.39-7.49 (NH proton exchange traces), 7.43-6.95 (m, Ph-H), 5.13 (m, 
CHa Gly), 5.03 (m, CHb Gly), 4.97-4.55 (m, αCH Phe #1-3, αCH Glu #1-3), 3.25-
2.70 (m, βCH2 Phe #1-3), 2.70-1.85 (m, γCH2 Glu #1-3), 1.78-1.16 (m, βCH2 Glu 
#1-3); MS (MALDI) m/z: Calculated for C112H110N14NaO32 [M+Na]
+ 2185.73, 
found 2185.76; IR (KBr): ν = 3430, 3276, 3061, 3025, 2921, 2852, 1701, 1667, 1638, 
1594, 1539, 1492, 1452, 1403, 1365, 1339, 1273, 1248, 1174, 1122, 1068, 1028, 
1013, 971, 942, 906, 810, 747, 698, 534 cm
−1. 
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Figure 8.8    Chemical structure of peptide P7 
Synthesis was performed according to the general SPPS procedure with a sample of 
Fmoc-Glu(OtBu)-Wang resin (0.50 g, loading 0.52 mmol/g, 0.26 mmol) affording 
title compound P7 as a pale, off-white solid (0.20 g, 95%). 1H NMR (600 MHz, 
DMSO-d6): δ = 8.47 (1H, d, J = 8.5 Hz, NH Leu #1), 8.24 (1H, d, J = 8.2 Hz, NH 
Leu #2), 8.22 (1H, d, J = 7.6 Hz, NH Glu #3), 7.95 (5H, m, NH2 Gly, NH Glu #1-
2, NH Leu #3), 4.44 (1H, m, 1H, αCH Leu #1), 4.28 (3H, m, αCH Leu #2-3, αCH 
Glu #2), 4.17 (2H, m, αCH Glu #1,3), 3.56 (2H, q, J = 5.6 Hz, CH2 Gly), 2.24 (6H, 
m, γCH2 Glu #1-3), 1.81 (6H, m, βCH2 Glu #1-3), 1.57 (3H, m, γCH Leu #1-3), 
1.42 (6H, m, βCH2 Leu #1-3), 0.85 (18H, m, CH3 Leu #1-3); 
13C NMR (150 MHz, 
DMSO-d6): δ = 174.5, 174.4, 174.1, 173.5, 172.0, 171.8, 171.5, 171.1, 170.9, 165.9, 
51.7, 51.2, 51.2, 41.9, 40.8, 40.5, 30.5, 30.4, 30.0, 28.0, 27.8, 26.6, 24.6, 24.5, 24.5, 
23.6, 23.4, 22.2, 22.1, 21.9, 21.7, 21.5; HRMS (ESI+) m/z: Calculated for 
C35H60N7O14 [M+H]
+ 802.4193, found 802.4177. 
 
N,N′-di[ – Gly – (Leu)3 – (Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (7). Condensation of PTCDA (0.035 g, 0.09 mmol) and peptide P7 (0.14 g, 
0.18 mmol) performed according to the general perylene imide synthesis procedures 
afforded title compound 7 as a dark purple solid (0.12 g, 71%). 1H NMR (500 MHz, 
DMSO-d6): δ = 8.85 (m, Ar-H), 8.20-7.30 (NH proton exchange traces), 5.22 (m, 
CHa Gly), 5.12 (m, CHb Gly), 4.87-4.48 (m, αCH Leu #1-3, αCH Glu #1-3), 2.64 
(m, γCH2 Glu #1-3), 2.52-2.03 (m, βCH2 Glu #1-3), 1.84-1.47 (m, βCH2 Leu #1-3), 
1.08-0.78 (m, γCH Leu #1-3, CH3 Leu #1-3); MS (MALDI) m/z: Calculated for 
C94H122N14NaO32 [M+Na]
+ 1981.82, found 1982.09; Calculated for 
C94H122N14Na2O32 [M+2Na]
+ 2004.81, found 2005.11; IR (KBr): ν = 3426, 3291, 
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3074, 2959, 2931, 2872, 1703, 1663, 1642, 1595, 1542, 1438, 1402, 1369, 1341, 
1248, 1174, 1130, 1038, 1002, 811 cm−1. 
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Figure 8.9    Chemical structure of peptide P8 
Synthesis was performed according to the general SPPS procedure with a sample of 
Fmoc-Glu(OtBu)-Wang resin (0.50 g, loading 0.52 mmol/g, 0.26 mmol) affording 
title compound P8 as a pale, off-white solid (0.19 g, 92%). 1H NMR (500 MHz, 
DMSO-d6): δ = 8.50 (1H, d,  J= 8.1 Hz, NH D-Leu #1), 8.28 (1H, d, J = 8.1 Hz, 
NH D-Leu #2), 8.19 (1H, d, J = 7.3 Hz, NH Glu #3), 8.02 (4H, m, NH D-Leu #3, 
NH Glu #2, NH2 Gly), 7.93 (1H, d, J = 8.1 Hz, NH Glu #1), 4.44 (1H, q, J = 7.6 
Hz, αCH D-Leu #1), 4.27 (4H, m, αCH D-Leu #2, αCH D-Leu #3, αCH Glu #1, 
αCH Glu #2), 4.18 (1H, q, J = 7.0 Hz, αCH Glu #3), 3.58 (2H, q, J = 5.4 Hz, CH2 
Gly), 2.28 (4H, m, γCH2 Glu #2, γCH2 Glu #3), 2.21 (2H, t, J = 8.0 Hz, γCH2 Glu 
#1), 1.94 (3H, m, βCH2 Glu #3, βCHa Glu #2), 1.76 (3H, m, βCH2 Glu #1, βCHb 
Glu #2), 1.57 (3H, m, γCH D-Leu #1, γCH D-Leu #2, γCH D-Leu #3), 1.44 (6H, 
m, βCH2 D-Leu #1, βCH2 D-Leu #2, βCH2 Glu #3), 0.85 (24H, m, CH3 D-Leu #1, 
CH3 D-Leu #2, CH3 D-Leu #3, γCH2 Glu #1, γCH2 Glu #2, γCH2 Glu #3); 
13C 
NMR (125 MHz, DMSO-d6): δ = 174.1, 174.0, 173.8, 173.1, 172.1, 171.6, 171.5, 
171.2, 170.9, 165.6, 51.6, 51.4, 50.9, 41.5, 41.0, 40.2, 30.8, 30.11, 30.0, 27.5, 27.4, 
26.3, 24.3, 24.14, 24.11, 23.2, 23.1, 22.9, 21.9, 21.7, 21.5; HRMS (ESI+) m/z: 
Calculated for C35H60N7O14 [M+H]
+ 802.4193, found 802.4204, Calculated for 
C35H59N7NaO14 [M+Na]
+ 824.4012, found 824.4009. 
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N,N′-di[ – Gly – (D-Leu)3 – (Glu)3 – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (8). Condensation of PTCDA (0.024 g, 0.061 mmol) and peptide P8 (0.097 
g, 0.12 mmol) performed according to the general perylene imide synthesis 
procedures afforded title compound 8 as dark purple solid (0.076 g, 64%). 1H NMR 
(500 MHz, DMSO-d6): δ = 8.88 (m, Ar-H), 8.15-7.36 (NH proton exchange traces), 
5.22 (m, CHa Gly), 5.14 (m, CHb Gly), 4.88-4.53 (m, αCH Leu #1-3, αCH Glu #1-
3), 2.67 (m, γCH2 Glu #1-3), 2.54-2.06 (m, βCH2 Glu #1-3), 1.90-1.52 (m, βCH2 
Leu #1-3), 1.12-0.80 (m, γCH Leu #1-3, CH3 Leu #1-3); MS (MALDI) m/z: 
Calculated for C94H122N14NaO32 [M+Na]
+ 1981.82, found 1981.88, Calculated for 
C94H122N14Na2O32 [M+2Na]
+ 2004.81, found 2005.90; IR (KBr): ν = 3430, 3284, 
3066, 2958, 2872, 1703, 1665, 1641, 1594, 1540, 1437, 1401, 1364, 1339, 1277, 
1245, 1172, 1123, 1032, 1012, 859, 810, 738, 659, 626 cm−1. 
NH2 – Gly – (Ala)3 – [Lys(Boc)]3 – OH     (P9) 
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Figure 8.10    Chemical structure of peptide P9 
Synthesis was performed according to the general SPPS procedure using a sample 
of H-Lys(Boc)-2-Cl-Trt resin (0.65 g, loading 0.33 mmol/g, 0.21 mmol). Resin 
cleavage was accomplished by shaking the resin in a 1:4 HFIP/CH2Cl2 solution
83 
with 5% (v/v) TIPS for a duration of 1 h, 15 min. Removal of the HFIP under 
reduced pressure afforded title compound P9 as a pale, off-white solid (0.13 g, 63%). 
1H NMR (500 MHz, DMSO-d6): δ = 8.41 (1H, m, NH Ala #1), 8.32 (1H, d, J = 7.3 
Hz, NH Ala #2), 8.00 (1H, d, J = 6.6 Hz, NH Lys #3), 7.93 (1H, d, J = 7.8 Hz, NH 
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Lys #2), 7.87 (1H, d, J = 6.8 Hz, NH Ala #3), 7.64 (1H, d, J = 5.9 Hz, NH Lys #1), 
6.75 (3H, m, NH-Boc Lys #1-3), 4.32 (1H, m, αCH Ala #1), 4.24 (1H, m, αCH Ala 
#2), 4.15 (2H, m, αCH Lys #2-3), 4.02 (1H, m, αCH Ala #3), 3.92 (1H, m, αCH 
Lys #1), 3.32 (2H, br s, CH2 Gly), 2.85 (6H, m, εCH2 Lys #1-3), 1.64 (3H, m, βCH2 
Lys #3, βCHa Lys #2), 1.49 (3H, m, βCHb Lys #2, βCH2 Lys #1), 1.35 (27H, m, 
CH3 Lys-Boc #1-3), 1.20 (9H, m, CH3 Ala #1-3), 0.97 (12H, m, γCH2 Lys #1-3, 
δCH2 Lys #1-3); HRMS (ESI
+) m/z: Calculated for C44H81N10O14 [M+H]
+ 973.5928, 
found 973.5947, Calculated for C44H80N10NaO14 [M+Na]
+ 995.5748, found 
995.5761; MS (MALDI) m/z: Calculated for C44H80N10NaO14 [M+Na]
+ 995.57, 
found 995.63, Calculated for C44H80N10KO14 [M+K]
+ 1011.55, found 1011.57. 
 
N,N′-di[ – Gly – (Ala)3 – (Lys)3 – OH]perylene-3,4,9,10-tetracarboxylic acid 
diimide (9). PTCDA (0.020 g, 0.050 mmol) and peptide P9 (0.10 g, 0.11 mmol) 
were stirred under N2 in imidazole (1.0 g) at 130-135 °C for 27 hours, producing a 
dark purple mixture. The mixture was then cooled to 95 °C and diluted with 3 mL 
of water to prevent solidification. After cooling to room temperature, the mixture 
was diluted with 40 mL of water and acidified by the dropwise addition of glacial 
acetic acid (1.2 mL). The resulting precipitate was collected via filtration and 
washed with water. The collected solid was added to a deprotection solution 
consisting of TFA (6 mL), CH2Cl2 (8 mL), water (1 mL), and TIPS (0.70 mL) and 
stirred vigorously for 3 hours under N2. Ice cold diethyl ether (40 mL) was then 
added to the solution to induce precipitation and the mixture was chilled (4 °C) and 
allowed to settle. Collection of the resulting precipitate via filtration followed by 
washes with cold diethyl ether (40 mL) and drying of the solids afforded the TFA 
salt of the title compound 9 as granular purple solid (0.11 g, 95%). 1H NMR (600 
MHz, CF3COOD): δ = 8.92 (8H, m, Ar-H), 5.38 (2H, m, CHa Gly), 5.25 (2H, m, 
CHb Gly), 4.75 (12H, m, αCH Ala #1-3, αCH Lys #1-3), 3.34 (12H, m, εCH2 Lys 
#1-3), 2.44 (6H, m, βCH2 Lys #3, βCHa Lys #2), 1.96 (24H, m, βCHb Lys #2, 
βCH2 Lys #1, CH3 Ala #1-3), 1.67 (24H, m, γCH2 Lys #1-3, δCH2 Lys #1-3); MS 
(MALDI) m/z: Calculated for C82H116N20NaO20 [M+Na]
+ 1723.86, found 1723.81; 
IR (KBr): ν = 3448, 3293, 3181, 3008, 1699, 1662, 1643, 1574, 1426, 1410, 1335, 
1249, 1172, 1019, 925, 877, 809, 748, 667, 643, 520 cm−1. 
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NH2 – Lys – (Ala)3 – (Glu)3 – OH     (P10) 
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Figure 8.11    Chemical structure of peptide P10 
Synthesis was performed according to the general SPPS procedure with a sample of 
Fmoc-Glu(OtBu)-Wang resin (0.50 g, loading 0.48 mmol/g, 0.24 mmol) affording 
title compound P10 as a pale, off-white solid (0.16 g, 91%). 1H NMR (500 MHz, 
DMSO-d6): δ = 8.61 (1H, d,  J = 7.1 Hz, NH Ala #1), 8.20 (1H, d, J = 7.3 Hz, NH 
Ala #2), 8.17 (1H, d, J = 7.3 Hz, NH Ala #3), 7.98 (2H, t, J = 6.8 Hz, NH Glu #3, 
NH Glu #2),  7.93 (1H, d, J = 7.6 Hz, NH Glu #1), 7.89 (4H, br. s, αNH2, εNH2, 
Lys), 4.36 (1H, quin, J = 7.1 Hz, αCH Ala #1), 4.25 (4H, m, αCH Ala #2, αCH 
Glu #1-3), 4.16 (1H, m, αCH Ala #3), 3.77 (1H, t, J = 6.3 Hz, αCH Lys), 2.75 (2H, 
m, εCH2 Lys), 2.26 (6H, m, γCH2 Glu #1-3), 1.92 (3H, m, βCH2 Glu #3, βCHa Glu 
#2), 1.74 (5H, m, βCH2 Glu #1, βCHb Glu #2, βCH2 Lys), 1.53 (2H, quin, J = 7.5 
Hz, γCH2 Lys), 1.36 (2H, m, δCH2 Lys), 1.24 (3H, d, J = 7.1 Hz, CH3 Ala #1), 1.20 
(6H, m, CH3 Ala #2-3); 
13C NMR (125 MHz, DMSO-d6): δ = 174.02, 174.00 173.7, 
173.1, 172.1, 171.8, 171.5, 171.1, 170.8, 168.1, 51.8, 51.7, 51.6, 51.3, 48.2, 48.0, 
38.5, 30.5, 30.1, 29.9, 27.5, 27.4, 26.5, 26.2, 21.0, 18.13, 18.08; HRMS (ESI+) m/z: 
Calculated for C30H51N8O14 [M+H]
+ 747.3519, found 747.3501, Calculated for 
C30H52N8O14 [M+2H]
+2 374.1796, found 374.1797, Calculated for C30H50N8NaO14 
[M+Na]+ 769.3339, found 769.3301. 
 
Perylene-3,4-anhydride-9,10-isopropylimide (Q4). Synthesis and purification 
were accomplished by analogous procedure for perylene-3,4-anhydride-9,10-
hexylimide Q1 as previously reported.88 
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N-yl-N'-isopropyl-perylene-3,4,9,10-diimide) – Lys(N-yl-N'-isopropyl-perylene-
3,4,9,10-diimide) – (Ala)3 – (Glu)3 – OH   (10) 
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Figure 8.12    Reaction to form compound 10 
Condensation of perylene-3,4-anhydride-9,10-isopropylimide Q4 (0.022 g, 0.051 
mmol) and peptide P10 (0.017 g, 0.023 mmol) performed according to the general 
perylene imide synthesis procedures afforded title compound 10 as dark purple solid 
(0.037 g, 67%). 1H NMR (500 MHz, CDCl3/CF3COOH, 2:1): δ = 8.86 (8H, m, Ar-
H #1), 8.75 (8H, m, Ar-H #2), 8.39-7.33 (NH exchange traces), 6.15 (1H, m, αCH 
Lys), 6.02 (2H, m, NCH isopropyl #1,2), 5.52 (2H, m, NCH2 Lys), 4.70 (3H, m, 
Ala #1-3), 4.30 (3H, m, Glu #1-3), 2.77-2.21 (6H, m, γCH2 Glu #1-3), 1.94 (6H, m, 
βCH2 Glu #1-3), 1.83-1.31 (27H, m, CH3 Ala#1-3, CH3 isopropyl, βCH2 Lys, γCH2 
Lys, δCH2 Lys);
 MS (MALDI) m/z: Calculated for C84H76N10NaO22 [M+Na]
+ 
1599.50, found 1599.37; IR (KBr): ν = 3427, 2982, 1700, 1653, 1593, 1507, 1440, 
1404, 1340, 1317, 1254, 1146, 1122, 1084, 1017, 856, 809, 738, 626 cm−1. 
[N-yl-perylene-3,4-imide-9,10-bis(n-butyl) ester] – Lys[N-yl-perylene-3,4-imide-
9,10-bis(n-butyl) ester] – (Ala)3 – (Glu)3 – OH   (11) 
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Figure 8.13    Reaction to form compound 11 
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Condensation of perylene-3,4-monoanhydride-9,10-bis(n-butyl ester) Q2 (0.13 g, 
0.25 mmol) and peptide P10 (0.090 g, 0.12 mmol) performed according to the 
general perylene imide synthesis procedures afforded title compound 11 as dark 
purple solid (0.070 g, 77%). 1H NMR: Data unavailable due to poor compound 
solubility and the presence of the acid-labile ester groups preventing the use of TFA; 
MS (MALDI) m/z: Calculated for C94H98N8NaO26 [M+Na]
+ 1777.65, found 
1777.60; IR (KBr): ν = 3324, 3070, 2960, 2936, 2873, 1770, 1699, 1653, 1594, 1531, 
1450, 1416, 1404, 1360, 1298, 1261, 1214, 1202, 1170, 1102, 1078, 1025, 956, 853, 
827, 808, 748, 652 cm−1. 
N,N′-di[Ac-Ile-Lys(-yl)-His-Leu-Ser-Val-Asn-NH2]perylene-3,4,9,10-
tetracarboxylic acid diimide   (12) 
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Figure 8.14    Reaction to form compound 12 
Condensation of PTCDA (0.015 g, 0.038 mmol) and terminal-protected peptide 
Ac-IKHLSVN-NH2 (Mimotops) (0.061 g, 0.072 mmol) performed according to the 
general perylene imide synthesis procedures afforded title compound 12 as dark 
purple solid (0.051 g, 66%). 1H NMR (500 MHz, CF3COOD): δ = 8.99 (8H, m, Ar-
H), 8.83 (2H, s, CH=N His), 8.80-7.55 (NH exchange traces), 7.57 (4H, s, NH2 
Asn-terminus), 7.52 (4H, s, NH2 Asn side-chain), 7.33 (2H, s, CH=C His), 5.21 (2H, 
m, αCH Asn), 4.84 (2H, m, αCH His), 4.61 (6H, m, αCH Ser, αCH Leu, αCH Lys), 
4.44 (4H, m, NCH2 Lys), 4.29 (2H, m, αCH Val), 4.21 (2H, m, αCH Ile), 3.58 (4H, 
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m, βCH2 Ser), 3.43 (4H, m, βCH2 His), 3.18 (4H, m, βCH2 Asn), 2.36 (8H, m, CH3 
Ac-Ile, βCH Val), 2.03 (6H, m, βCH2 Lys, βCH Ile), 1.75 (10H, m, βCH2 Leu, 
δCH2 Lys, γCH Leu), 1.40 (8H, m, γCH2 Lys, γCH2 Ile), 1.04 (36H, m, γCH3 Val, 
γCH3 Ile, δCH3 Ile, δCH3 Leu); MS (MALDI) m/z: Calculated for C104H145N24O24 
[M+H]+ 2114.09, found 2114.10, Calculated for C104H144N24NaO24 [M+Na]
+ 
2136.07, found 2136.08; IR (KBr): ν = 3433, 2966, 2876, 1695, 1635, 1595, 1540, 
1440, 1402, 1384, 1346, 1279, 1203, 1166, 1080, 1066, 850, 810, 794, 748, 700, 624 
cm−1. 
Ac-Ile-Lys(N-yl-N′-hexyl-perylene-3,4,9,10-tetracarboxylic acid diimide)-His-
Leu-Ser-Val-Asn-NH2   (12H) 
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Figure 8.15    Reaction to form compound 12H 
Condensation of perylene-3,4-anhydride-9,10-hexylimide Q1 (0.014 g, 0.029 mmol) 
and terminal-protected peptide Ac-IKHLSVN-NH2 (Mimotops) (0.026 g, 0.030 
mmol) performed according to the general perylene imide synthesis procedures 
afforded title compound 12H as dark purple solid (0.031 g, 80%).1H NMR (500 MHz, 
CF3COOD): δ = 8.97 (8H, m, Ar-H), 8.72 (1H, s, CH=N His), 8.66-7.57 (NH 
exchange traces), 7.59 (2H, m, NH2 Asn-terminus), 7.52 (2H, s, NH2 Asn side-
chain), 7.32 (1H, s, CH=C His), 5.23 (1H, m, αCH Asn), 4.85 (1H, m, αCH His), 
4.68 (1H, m, αCH Ser), 4.59 (2H, m, αCH Leu, αCH Lys), 4.43 (4H, m, NCH2 Lys, 
NCH2 hexyl), 4.31 (1H, m, αCH Val), 4.22 (1H, m, αCH Ile), 3.59 (2H, m, βCH2 
Ser), 3.44 (2H, m, βCH2 His), 3.20 (2H, m, βCH2 Asn), 2.38 (4H, m, CH3 Ac-Ile, 
βCH Val), 2.05 (4H, m, βCH2 Lys, βCH2 Leu), 1.94 (3H, m, βCH Ile, δCH2 Lys), 
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1.78 (2H, m, βCH2 hexyl), 1.71 (2H, m, γCH2 Lys), 1.62 (3H, m, γCH Leu, γCH2 
hexyl), 1.49 (4H, m, δCH2, εCH2 hexyl), 1.40 (2H, m, γCH2 Ile), 1.07 (21H, m, 
δCH3 Leu, γCH3 Ile, γCH3 Val, CH3 hexyl, δCH3 Ile); MS (MALDI) m/z: 
Calculated for C70H89N13NaO14 [M+Na]
+ 1358.65, found 1358.67, Calculated for 
C70H89N13KO14 [M+K]
+ 1374.63, found 1374.65, Calculated for C70H89N13Na2O14 
[M+2Na]+ 1381.64, found 1381.64; IR (KBr): ν = 3433, 3061, 2957, 2869, 1694, 
1648, 1635, 1595, 1540, 1440, 1403, 1374, 1344, 1279, 1249, 1169, 1122, 1088, 853, 
810, 794, 747, 655, 623 cm−1. 
NH2 – Gly – Ile – Arg – His – Leu – Ser – Val – Asn – Glu – Glu – Glu – OH (P13)    
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Figure 8.16    Chemical structure of peptide P13 
Synthesis was performed using Fmoc-Glu(OtBu)-Wang resin (0.50 g, loading 0.48 
mmol/g, 0.24 mmol) according to the general SPPS procedure with a modified 
resin cleavage solution consisting of TFA (8.8 mL), water (0.5 mL), toluene (0.5 
mL), and triisopropylsilane (0.2 mL). The dried peptide was successively soaked in 
acetonitrile and toluene and decanted to remove trace scavengers. Final drying of 
the soaked peptide afforded the title compound P13 as a pale, off-white solid (0.29 g, 
95%). 1H NMR (500 MHz, DMSO-d6): δ = 8.91 (1H, m, CH=N His), 8.44 (1H, d,  
J = 7.8 Hz, NH Arg), 8.34 (1H, d,  J = 6.3 Hz, NH Ile), 8.19 (3H, m, NH Ser, NH 
His, NH Asn), 8.06 (2H, m, NH Glu #1, NH Leu), 7.97 (3H, m, NH2 Gly, NH Glu 
#2), 7.74 (1H, m, NH Glu #3), 7.68 (1H, d,  J = 8.3 Hz, NH Val), 7.42 (2H, br. s, 
NH2 Asn), 7.34 (1H, m, NH His ring), 7.30 (1H, m, NH Arg guanidine), 7.06 (2H, 
br. s, C=NH, NH2 Arg guanidine), 6.93 (1H, br. s, CH=C His), 4.55 (2H, m, αCH 
Asn, αCH His), 4.36 (2H, m, αCH Ser, αCH Glu #1), 4.21 (6H, m, αCH Glu #2-3, 
αCH Leu, αCH Arg, αCH Val, αCH Ile), 3.61 (4H, m, CH2 Gly, βCH2 Ser), 3.02 
(2H, m, βCHa His, δCH2 Arg), 2.94 (1H, m, βCHb His), 2.56 (1H, dd,  J = 15.3 Hz, 
J = 6.2 Hz, βCHa Asn), 2.39 (1H, dd,  J = 15.5 Hz, J = 7.2 Hz, βCHb Asn), 2.24 
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(6H, m, γCH2 Glu #1-3), 1.95 (4H, m, βCH2 Glu #1, βCH2 Glu #2), 1.79 (3H, m, 
βCH Val, βCH2 Arg), 1.70 (1H, m, βCH Ile), 1.61 (2H, m, βCH2 Glu #3), 1.43 (5H, 
m, βCH2 Leu, γCH2 Arg, γCH Leu), 1.07 (2H, m, γCH2 Ile), 0.82 (18H, m, δCH3 
Leu, γCH3 Ile, γCH3 Val, δCH3 Ile); 
13C NMR (125 MHz, DMSO-d6): δ = 174.0, 
173.8, 173.1, 172.5, 172.1, 171.7, 171.6, 171.2, 171.0, 170.8, 170.7, 170.6, 169.9, 
169.6, 165.8, 156.8, 133.8, 129.0, 117.0, 65.0, 61.4, 57.2, 56.8, 55.0, 52.6, 51.8, 51.4, 
51.3, 49.7, 40.9, 40.5, 40.2, 37.0, 36.9, 30.9, 30.1, 30.0, 28.7, 27.3, 27.2, 26.2, 25.1, 
24.3, 24.2, 23.1, 21.4, 19.2, 17.8, 17.7, 15.2, 11.0; HRMS (ESI+) m/z: Calculated 
for C53H88N17O20 [M+H]
+ 1282.6386, found 1282.6367, Calculated for C53H89N17O20 
[M+2H]+2 641.8229, found 641.8244, Calculated for C53H87N17Na2O20 [M+2Na]
+2 
663.8049, found 663.8058. 
 
N,N′-di[-Gly-Ile-Arg-His-Leu-Ser-Val-Asn-Glu-Glu-Glu-OH]perylene-3,4,9,10-
tetracarboxylic acid diimide (13). Condensation of PTCDA (0.020 g, 0.051 mmol) 
and peptide P13 (0.13 g, 0.10 mmol) in imidazole (1.0 g) at 130-135 °C under N2 
produced a solidifying dark black mixture after 20 minutes. The mixture was then 
cooled to 95 °C and dissolved in 3 mL of water prior to fully hardening. After 
cooling to room temperature, purification on HP20ss resin as outlined in the 
general perylene imide synthesis procedures afforded title compound 13 as dark 
purple solid (0.13 g, 84%).  1H NMR (600 MHz, CF3COOD): δ = 8.94 (8H, m, Ar-
H), 8.69 (2H, m, CH=N His), 7.51 (2H, m, CH=C His), 5.34 (4H, m, CH2 Gly), 
5.18 (4H, m, αCH Asn, αCH His), 4.94 (6H, m, αCH Ser, αCH Glu #1-2), 4.80 (6H, 
m, αCH Glu #3, αCH Leu, αCH Arg), 4.57 (4H, m, αCH Val, αCH Ile), 3.53 (2H, 
m, βCHa His), 3.39 (6H, m, βCHb His, βCH2 Ser), 3.19 (4H, m, δCH2 Arg), 2.76 
(12H, m, γCH2 Glu #1-3), 2.57 (2H, m, Asn βCHa), 2.42 (2H, m, Asn βCHb), 2.26 
(8H, m, βCH2 Glu #1, βCH2 Glu #2), 2.01 (8H, m, βCH Val, βCH2 Arg, βCH Ile), 
1.81 (12H, m, βCH2 Glu #3, βCH2 Leu, γCH2 Arg), 1.37 (6H, m, γCH Leu, γCH2 
Ile), 1.05 (36H, m, δCH3 Leu, γCH3 Ile, γCH3 Val, δCH3 Ile); MS (MALDI) m/z: 
Calculated for C130H179N34O44 [M+H]
+ 2920.28, found 2920.22, Calculated for 
C130H178N34NaO44 [M+Na]
+ 2942.26, found 2942.24; IR (KBr): ν = 3424, 3280, 
3073, 2963, 2931, 2870, 1658, 1634, 1594, 1543, 1437, 1399, 1363, 1337, 1302, 
1276, 1237, 1174, 1025, 859, 810, 794, 733, 657, 630 cm−1. 
 
 
191 
 
Ac – (Glu)3 – Ile – Arg – His – Leu – Ser – Val – Asn – NH – CH2CH2 – NH2 (P14)    
H3C C N
O
CH C N
OH H
CH2
CH2
C
OH
O
CH C N
O H
CH2
CH2
C
OH
O
CH C N
O
CH2
CH2
C
OH
O
CH C N CH C N CH C N CH C N CH C N CH C N CH C N
OO O O O O OH H H H H H
CH
CH3H2C
CH3
CH2
CH2
CH2
NH
CH2 CH2 CH2CH2 CH
CH
CH3H3C
H3C CH3 C O
NH2
OHC
N
CH
HC
N
H
C
NH2
NH
H
CH2
H
NH2
CH2
 
Figure 8.17    Chemical structure of peptide P14 
Synthesis was performed according to the general SPPS procedure with a sample of 
1,2-diaminoethane-trityl resin (0.31 g, loading 0.96 mmol/g, 0.30 mmol) according 
to the general SPPS procedure with a modified resin cleavage solution consisting of 
TFA (8.8 mL), water (0.5 mL), toluene (0.5 mL), and triisopropylsilane (0.2 mL), 
affording title compound P14 as a pale, off-white solid (0.35 g, 92%). 1H NMR (500 
MHz, DMSO-d6): δ = 8.95 (1H, m, CH=N His), 8.26 (1H, d,  J = 7.3 Hz, NH Arg), 
8.11 (5H, m,  NH Ile, NH Ser, NH His, NH Asn, NH Glu #1), 7.97 (2H, m,  NH 
Glu #2-3) 7.78 (3H, m, NH2 ethyl, NH ethyl),  7.72 (1H, d,  J = 8.13 Hz, NH Leu), 
7.63 (1H, m, NH Val), 7.49 (2H, br. s, NH2 Asn), 7.34 (1H, m, NH His ring), 7.31-
7.05 (NH Arg guanidine exchange traces), 7.01 (1H, br. s, CH=C His), 4.60 (1H, m, 
αCH Asn), 4.45 (1H, m, αCH His), 4.36 (2H, m, αCH Ser, αCH Glu #3), 4.22 (3H, 
m, αCH Glu #1-2, αCH Leu), 4.14 (2H, m, αCH Arg, αCH Ile), 4.01 (1H, m, αCH 
Val), 3.60 (2H, m, βCH2 Ser), 3.37 (2H, m, αCH2 Asn-ethyl), 3.23 (2H, m, βCH2 
Asn-ethyl), 3.06 (3H, m, βCHa His, βCH2 Arg), 2.95 (1H, m, βCHb His), 2.55 (1H, 
dd,  J = 15.3 Hz, J = 6.5 Hz, βCHa Asn), 2.44 (1H, dd,  J = 15.3 Hz, J = 7.0 Hz, 
βCHb Asn), 2.23 (6H, m, γCH2 Glu #1-3), 1.97 (1H, m, βCH Val), 1.85 (7H, m, 
βCH2 Glu #2-3, CH3 Ac-Glu #1), 1.67 (5H, m, βCH Ile, βCH2 Arg, βCH2 Glu #1), 
1.45 (5H, m, βCH2 Leu, γCH2 Arg, γCH Leu), 1.07 (2H, m, γCH2 Ile), 0.80 (18H, 
m, δCH3 Leu, γCH3 Ile, γCH3 Val, δCH3 Ile); 
13C NMR (125 MHz, DMSO-d6): δ = 
174.1, 174.02, 173.96, 172.4, 171.8, 171.7, 171.5, 171.3, 171.1, 170.7, 170.5, 170.2, 
169.9, 169.7, 169.6, 156.8, 133.8, 129.0, 117.0, 65.0, 61.4, 57.7, 56.8, 54.9, 52.4, 
52.0, 51.4, 51.1, 50.0, 40.8, 40.4, 38.7, 37.0, 36.5, 36.4, 30.5, 30.4, 30.2, 30.1, 28.7, 
27.1, 25.0, 24.3, 24.2, 23.1, 22.5, 21.4, 19.1, 19.0, 17.9, 17.8, 15.2, 10.9; HRMS 
(ESI+) m/z: Calculated for C55H93N18O19 [M+H]
+ 1309.6859, found 1309.6825, 
Calculated for C55H94N18O19 [M+2H]
+2 655.8480, found 655.8490, Calculated for 
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C55H95N18O19 [M+3H]
+3 437.2335, found 437.2349, Calculated for C55H92N18NaO19 
[M+Na]+ 1331.6678, found 1331.6699. 
 
N,N′-di[Ac-Glu-Glu-Glu-Ile-Arg-His-Leu-Ser-Val-Asn-NH-CH2CH2-]perylene-
3,4,9,10-tetra-carboxylic acid diimide (14). Condensation of PTCDA (0.020 g, 
0.051 mmol) and peptide P14 (0.14 g, 0.11 mmol) performed according to the 
general perylene imide synthesis procedures afforded title compound 14 as dark 
purple solid (0.11 g, 71%). 1H NMR (600 MHz, CF3COOD): δ = 8.89 (8H, m, Ar-
H), 8.62 (2H, m, CH=N His), 7.50 (2H, m, CH=C His), 5.13 (4H, m, αCH Asn, 
αCH His), 5.00 (2H, m, αCH Ser), 4.86 (4H, m, αCH Glu #3, αCH Glu #2), 4.72 
(10H, m, αCH Glu #1, αCH Leu, αCH Arg, αCH Ile, αCH Val), 4.47 (4H, m, CH2 
ethylimide), 4.25 (4H, m, CH2 Asn-ethylamide), 3.86 (4H, m, βCH2 Ser), 3.53 (2H, 
m, βCHa His), 3.36 (6H, m, βCHb His, βCH2 Arg), 3.11 (4H, m, Asn βCH2), 2.76 
(12H, m, γCH2 Glu #1-3), 2.33 (6H, m, Val βCH, Glu #1 βCH2), 2.23 (10H, m, 
βCH2 Glu #2-3, CH3 Ac-Glu #1), 1.95 (8H, m, βCH2 Glu #1, βCH2 Arg), 1.72 
(10H, m, βCH Ile, βCH2 Leu, γCH2 Arg), 1.31 (6H, m, γCH Leu, γCH2 Ile), 1.01 
(36H, m, δCH3 Leu, γCH3 Ile, γCH3 Val, δCH3 Ile); IR (KBr): ν = 3478, 3308, 3060, 
2961, 2928, 2870, 1692, 1658, 1594, 1539, 1442, 1402, 1363, 1344, 1247, 1180, 
1104, 1026, 852, 810, 747, 697 cm−1. 
 
N-[-Gly-Ile-Arg-His-Leu-Ser-Val-Asn-Glu-Glu-Glu-OH]perylene-3,4-imide-
9,10-bis(n-butyl)ester (15). Condensation of perylene-3,4-monoanhydride-9,10-
bis(n-butyl ester) Q2 (0.020 g, 0.038 mmol) and peptide P13 (0.061 g, 0.048 mmol) 
was performed according to the general perylene imide synthesis procedures. The 
reaction mixture was cooled to 95 °C, diluted with 3 mL of water, and cooled to 
room temperature. The reaction mixture was then loaded onto HP20ss resin and 
the resin was successively flushed with ten 100 mL aqueous acetone solutions, 
forming a gradient series beginning at 10% (v/v) acetone/water increasing by 10% 
acetone with each 100 mL. Removal of the desired product using pyridine followed 
by 20% (v/v) pyridine/water followed by removal of the solvent under reduced 
pressure afforded title compound 15 as small dark purple needles (0.037 g, 76%). 1H 
NMR (500 MHz, D2O/pyridine-d5, 4:1): δ = 7.55 (8H, br. m, Ar-H), 6.76 (2H, m, 
CH=N His, CH=C His), 4.08 (3H, m, αCH Asn, αCH His, αCH Ser), 3.89 (4H, m, 
OCH2 esters), 3.49 (1H, m, αCHa Gly), 3.29 (1H, m, αCHb Gly), 2.77 (3H, m, αCH 
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Arg, αCH Leu, αCH Glu #1), 2.59 (2H, m, αCH Glu #2-3), 2.48 (2H, m, αCH Val, 
αCH Ile), 2.32 (2H, m, βCH2 Ser), 1.99 (6H, m, βCH2 His, βCH2 Asn, δCH2 Arg), 
1.85 (4H, m, βCH2 esters), 1.67 (6H, m, βCH2 Glu #1-3), 1.24 (8H, m, γCH2 esters, 
βCH Ile, βCH Val, γCH2 Glu #1), 0.98 (9H, m, γCH2 Glu #2-3, βCH2 Arg, βCH2 
Leu, γCH Leu), 0.48 (28H, m, γCH2 Arg, δCH3 esters, γCH2 Ile, γCH3 Val, γCH3 
Ile, δCH3 Leu, δCH3 Ile); MS (MALDI) m/z: Calculated for C85H112N17O26 [M+H]
+ 
1786.80, found 1786.72; IR (KBr): ν = 3357, 3056, 2956, 2930, 2860, 1690, 1658, 
1594, 1577, 1545, 1438, 1400, 1363, 1346, 1275, 1243, 1174, 1084, 987, 852, 810, 
795, 743, 700, 656, 628 cm−1. 
 
N-[Ac-Glu-Glu-Glu-Ile-Arg-His-Leu-Ser-Val-Asn-NH-CH2CH2-]perylene-3,4-
imide-9,10-bis(n-butyl)ester (16). Condensation of perylene-3,4-monoanhydride-
9,10-bis(n-butyl ester) Q2 (0.020 g, 0.038 mmol) and peptide P14 (0.061 g, 0.046 
mmol) was performed according to the general perylene imide synthesis procedures. 
The reaction mixture was cooled to 95 °C, diluted with 3 mL of water, and cooled 
to room temperature. The reaction mixture was then loaded onto HP20ss resin and 
the resin was successively flushed with ten 100 mL aqueous acetone solutions, 
forming a gradient series beginning at 10% (v/v) acetone/water increasing by 10% 
acetone with each 100 mL. Removal of the desired product using pyridine followed 
by 20% (v/v) pyridine/water followed by removal of the solvent under reduced 
pressure afforded title compound 16 as a dark purple solid (0.031 g, 64%). 1H NMR 
(500 MHz, D2O/pyridine-d5, 4:1): δ = 7.51 (8H, br. m, Ar-H), 6.77 (2H, m, CH=N 
His, CH=C His), 3.92 (7H, m, αCH Asn, αCH His, αCH Ser, OCH2 esters), 3.25 
(2H, m, CH2 ethylimide), 2.95 (2H, m, CH2 ethylamide), 2.72 (3H, m, αCH Arg, 
αCH Leu, αCH Glu #1), 2.39 (6H, m, αCH Glu #2-3, αCH Val, αCH Ile, βCH2 
Ser), 1.99 (6H, m, βCH2 His, βCH2 Asn, δCH2 Arg), 1.76 (7H, m, CH3 Ac-Glu #1, 
βCH2 esters), 1.61 (6H, m, βCH2 Glu #1-3), 1.08 (12H, m, γCH2 esters, βCH Ile, 
βCH Val, γCH2 Glu #1-3), 0.90 (5H, m, βCH2 Arg, βCH2 Leu, γCH Leu), 0.44 
(28H, m, γCH2 Arg, δCH3 esters, γCH2 Ile, γCH3 Val, γCH3 Ile, δCH3 Leu, δCH3 
Ile); MS (MALDI) m/z: Calculated for C87H110N18Na2O22 [M+2Na −3H2O]
+ 
1804.75, found 1804.39;  IR (KBr): ν = 3420, 3163, 2957, 2870, 1699, 1657, 1594, 
1539, 1509, 1437, 1400, 1362, 1344, 1294, 1262, 1241, 1165, 1099, 1079, 1017, 953, 
849, 809, 748, 652, 624 cm−1. 
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Figure 8.18    Chemical structure of peptide P15 
Synthesis was performed using Fmoc-Asn(Trt)-Wang resin (0.50 g, loading 0.51 
mmol/g, 0.26 mmol) according to the general SPPS procedure with a modified 
resin cleavage solution consisting of TFA (8.8 mL), water (0.5 mL), phenol (0.5 g), 
and triisopropylsilane (0.2 mL). The dried peptide was successively soaked in 
acetonitrile and toluene (followed by centrifugation and decanting the solvent) to 
remove trace scavengers. Drying of the rinsed peptide afforded the title compound 
P15 as a pale, off-white solid (0.21 g, 92%). 1H NMR (500 MHz, DMSO-d6): δ = 
8.96 (1H, s, CH=N His), 8.42 (1H, d,  J = 8.5 Hz, NH Arg), 8.31 (2H, m, NH Ile, 
NH Ser), 8.23 (1H, d,  J = 7.6 Hz, NH His), 8.19 (1H, d,  J = 7.8 Hz, NH Asn), 
8.12 (1H, d,  J = 7.8 Hz, NH Leu), 8.01 (2H, br s, NH2 Gly), 7.71 (1H, s, NH Arg 
guanidine), 7.58 (1H, d,  J = 9.0 Hz, NH Val), 7.39 (1H, s, NH His ring), 7.36 (2H, 
s, NH2 Asn), 7.29-6.98 (2H, NH2 exchange traces, Arg guanidine), 6.92 (1H, br. s, 
CH=C His), 4.61 (1H, m, αCH Asn), 4.50 (1H, m, αCH His), 4.36 (2H, m, αCH 
Ser, αCH Leu), 4.24 (3H, m, αCH Arg, αCH Val, αCH Ile), 3.60 (4H, m, CH2 Gly, 
βCH2 Ser), 3.06 (3H, m, βCH2 His, δCHa Arg), 2.95 (1H, m, δCHb Arg), 2.55 (1H, 
dd,  J = 15.6 Hz, J = 5.6 Hz, βCHa Asn), 2.43 (1H, dd,  J = 15.6 Hz, J = 7.3 Hz, 
βCHb Asn), 1.99 (1H, dq,  J = 12.9 Hz, J = 6.7 Hz, βCH Val), 1.64 (3H, m, βCH2 
Arg, βCH Ile), 1.44 (5H, m, βCH2 Leu, γCH2 Arg, γCH Leu), 1.06 (2H, m, γCH2 
Ile), 0.83 (18H, m, CH3 Leu, γCH3 Ile, CH3 Val, δCH3 Ile); 
13C NMR (125 MHz, 
DMSO-d6): δ = 172.8, 172.6, 171.2, 170.9, 170.5, 169.7, 169.6, 165.9, 156.9, 144.5, 
117.8, 117.1, 115.3, 61.4, 57.0, 56.9, 55.1, 52.6, 51.4, 51.2, 48.8, 40.9, 40.5, 40.2, 
37.0, 36.6, 31.0, 28.8, 25.1, 24.2, 23.1, 21.5, 19.2, 17.5, 15.3, 11.0; HRMS (ESI+) 
m/z: Calculated for C38H66N14O11 [M+2H]
+2 448.2591, found 448.2588; Calculated 
for C38H66N14O11 [M+H]
+ 895.5108, found 895.5089. 
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Figure 8.19    Chemical structure of peptide P16 
Synthesis was performed using Fmoc-Asn(Trt)-Wang resin Fmoc-Asn(Trt)-Wang 
resin (0.51 g, loading 0.51 mmol/g, 0.26 mmol) according to the general SPPS 
procedure with a modified resin cleavage solution consisting of TFA (8.8 mL), 
water (0.5 mL), phenol (0.5 g), and triisopropylsilane (0.2 mL). The dried peptide 
was successively soaked in acetonitrile and toluene and decanted to remove trace 
scavengers. Final drying of the soaked peptide afforded the title compound P16 as a 
pale, off-white solid (0.19 g, 85%). 1H NMR (500 MHz, DMSO-d6): δ = 8.83 (1H, 
br s, CH=N His), 8.57 (1H, m, AcNH Ile), 8.28 (1H, d,  J = 7.3 Hz, NH Arg), 8.21 
(1H, m, NH Ile), 8.15 (1H, m,  NH Ser), 8.10 (2H, m, NH His, NH Asn), 7.96 (1H, 
d,  J = 8.2 Hz, NH Leu), 7.62 (1H, br s, NH Arg guanidine), 7.58 (1H, d,  J = 8.8 
Hz, NH Val), 7.39 (2H, s, NH2 Asn), 7.30 (1H, s, NH His ring), 7.29-6.98 (2H, 
NH2 exchange traces, Arg guanidine), 6.92 (1H, br. s, CH=C His), 4.58 (1H, m, 
αCH Asn), 4.49 (1H, m, αCH His), 4.35 (2H, m, αCH Ser, αCH Leu), 4.22 (2H, m, 
αCH Arg, αCH Val), 4.10 (1H, t, J = 7.9 Hz, αCH Ile), 3.59 (2H, m, βCH2 Ser), 
3.07 (3H, m, βCHa His, δCH2 Arg), 2.96 (1H, dd, J = 15.1 Hz, J = 7.5 Hz, βCHb 
His), 2.54 (1H, dd,  J = 15.6 Hz, J = 5.9 Hz, βCHa Asn), 2.43 (1H, dd,  J = 15.7 Hz, 
J = 7.2 Hz, βCHb Asn), 1.99 (1H, dd,  J = 12.9 Hz, J = 6.5 Hz, βCH Val), 1.86 (3H, 
s, CH3 Ile acetamide), 1.62 (3H, m, βCH2 Arg, βCH Ile), 1.45 (5H, m, βCH2 Leu, 
γCH2 Arg, γCH Leu), 1.08 (2H, m, γCH2 Ile), 0.81 (18H, m, δCH3 Leu, γCH3 Ile, 
γCH3 Val, δCH3 Ile); 
13C NMR (150 MHz, DMSO-d6): δ = 172.7, 172.5, 171.7, 
171.3, 171.2, 170.5, 169.7, 169.6, 156.8, 149.5, 133.8, 124.1, 117.1, 61.4, 57.2, 57.0, 
55.1, 52.4, 51.2, 48.8, 40.8, 40.5, 36.6, 36.2, 31.0, 28.6, 25.1, 24.6, 24.2, 23.1, 22.5, 
21.4, 19.1, 17.5, 15.4, 11.0; HRMS (ESI+) m/z: Calculated for C38H65N13O11 
[M+2H]+2 441.2550, found 441.2559. 
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A.1     1H and 13C NMR Spectra of Synthesized Peptides  
  
 
 
Figure A.1 1H NMR spectrum of P1, NH2-Gly-(Gly)3-(Glu)3, in DMSO-d6. 
                   
 
 
 
 
Figure A.2 13C NMR spectrum of P1, NH2-Gly-(Gly)3-(Glu)3, in DMSO-d6. 
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A.1     1H and 13C NMR Spectra of Synthesized Peptides  
  
 
 
Figure A.3 1H NMR spectrum of P2, NH2-Gly-(Ala)3-Glu, in DMSO-d6. 
                   
 
 
 
 
Figure A.4 13C NMR spectrum of P2, NH2-Gly-(Ala)3-Glu, in DMSO-d6. 
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A.1     1H and 13C NMR Spectra of Synthesized Peptides  
  
 
Figure A.5 1H NMR spectrum of P3, NH2-Gly-(Ala)3-(Glu)3, in DMSO-d6. 
 
 
Figure A.6 13C NMR spectrum of P3, NH2-Gly-(Ala)3-(Glu)3, in DMSO-d6. 
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Figure A.7 1H NMR spectrum of P3E, NH2-Gly-(D-Ala)3-( D-Glu)3, in DMSO-d6. 
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Figure A.8 13C NMR spectrum of P3E, NH2-Gly-( D-Ala)3-( D-Glu)3,  
  in DMSO-d6. 
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Figure A.9 1H NMR spectrum of P4, NH2-Gly-(D-Ala)3-(Glu)3, in DMSO-d6. 
 
 
Figure A.10 13C NMR spectrum of P4, NH2-Gly-(D-Ala)3-(Glu)3, in DMSO-d6. 
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Figure A.11 1H NMR spectrum of P5, NH2-Gly-(Glu)3, in DMSO-d6. 
 
 
Figure A.12 13C NMR spectrum of P5, NH2-Gly-(Glu)3, in DMSO-d6. 
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Figure A.13 1H NMR spectrum of P6, NH2-Gly-(Phe)3-(Glu)3, in DMSO-d6. 
 
 
Figure A.14 13C NMR spectrum of P6, NH2-Gly-(Phe)3-(Glu)3, in DMSO-d6. 
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Figure A.15 1H NMR spectrum of P7, NH2-Gly-(Leu)3-(Glu)3, in DMSO-d6. 
 
 
Figure A.16 13C NMR spectrum of P7, NH2-Gly-(Leu)3-(Glu)3, in DMSO-d6. 
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Figure A.17 1H NMR spectrum of P8, NH2-Gly-(D-Leu)3-(Glu)3, in DMSO-d6. 
 
 
Figure A.18 13C NMR spectrum of P8, NH2-Gly-( D-Leu)3-(Glu)3, in DMSO-d6. 
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Figure A.19 1H NMR spectrum of P9, NH2-Gly-(Ala)3-[Lys(Boc)]3, in DMSO-d6. 
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Figure A.20 1H NMR spectrum of P9, NH2-Gly-(Ala)3-[Lys(Boc)]3, in CDCl3. 
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Figure A.21 1H NMR spectrum of P10, NH2-Lys-(Ala)3-(Glu)3, in DMSO-d6. 
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Figure A.22 13C NMR spectrum of P10, NH2-Lys-(Ala)3-(Glu)3, in DMSO-d6. 
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Figure A.23 1H NMR spectrum of P13, NH2-Gly-Ile-Arg-His-Leu-Ser-Val-Asn- 
Glu-Glu-Glu-OH, in DMSO-d6. 
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Figure A.24 13C NMR spectrum of P13, NH2-Gly-Ile-Arg-His-Leu-Ser-Val-Asn- 
Glu-Glu-Glu-OH, in DMSO-d6. 
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Figure A.25 1H NMR spectrum of P14, Ac-Glu-Glu-Glu-Ile-Arg-His-Leu-Ser-
Val-Asn-NH-CH2CH2-NH2, in DMSO-d6. 
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Figure A.26 13C NMR spectrum of P14, Ac-Glu-Glu-Glu-Ile-Arg-His-Leu-Ser-
Val-Asn-NH-CH2CH2-NH2, in DMSO-d6. 
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Figure A.27 1H NMR spectral comparison of: (A) NH2-Gly-(Gly)3-(Glu)3 peptide 
(P1) in DMSO-d6 and (B) N,N'-di[-Gly-(Gly)3-(Glu)3]perylene-3,4,9,10- 
tetracarboxylic acid diimide  (1) in 2:1 CDCl3/TFA. 
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Figure A.28 1H NMR spectral comparison of: (A) NH2-Gly-(Gly)3-(Glu)3 peptide 
(P1) in DMSO-d6 and (B) N-hexyl-N'-[-Gly-(Gly)3-(Glu)3]perylene-3,4,9,10- 
tetracarboxylic acid diimide  (1H) in 2:1 CDCl3/TFA. 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
ze
d
 In
te
n
si
ty
1
.7
13
1
.7
59
1
.7
69
1
.8
82
1
.8
94
2
.2
21
2
.2
36
2
.2
50
2
.2
65
2
.2
83
2
.3
01
3
.6
09
3
.7
45
3
.7
56
3
.8
42
3
.8
53
4
.1
63
4
.1
74
4
.2
31
4
.2
43
4
.2
80
4
.2
91
8
.0
06
8
.0
20
8
.0
29
8
.0
45
8
.1
27
8
.1
60
8
.1
75
8
.2
98
8
.6
19
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.005
0.010
0.015
0.020
0.025
0.030
0.035
N
o
rm
a
li
ze
d
 In
te
n
si
ty
0
.9
04
0
.9
15
0
.9
27
1
.2
92
1
.3
68
1
.3
73
1
.3
79
1
.4
08
1
.4
20
1
.4
76
1
.7
83
1
.7
95
1
.8
21
4
.2
69
4
.2
83
4
.2
96
4
.3
23
4
.3
32
4
.4
55
4
.4
66
4
.4
78
4
.4
91
5
.2
02
5
.2
27
8
.0
98
8
.1
09
8
.1
21
8
.6
30
8
.6
43
8
.8
04
8
.8
12
8
.8
39
8
.8
48
(A) 
(B) 
213 
 
A.2 1H NMR Spectra of Synthesized PDIs  
 (with Peptide 1H NMR Spectral Comparisons)  
  
     
 
 
Figure A.29 1H NMR spectral comparison of: (A) NH2-Gly-(Ala)3-Glu peptide 
(P2) in DMSO-d6 and (B) N,N'-di[-Gly-(Ala)3-Glu]perylene-3,4,9,10- 
tetracarboxylic acid diimide  (2) in 2:1 CDCl3/TFA. 
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Figure A.30 1H NMR spectral comparison of: (A) NH2-Gly-(Ala)3-Glu peptide 
(P2) in DMSO-d6 and (B) N-hexyl-N'-[-Gly-(Ala)3-Glu]perylene-3,4,9,10- 
tetracarboxylic acid diimide  (2H) in 2:1 CDCl3/TFA. 
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Figure A.31 1H NMR spectral comparison of: (A) NH2-Gly-(Ala)3-(Glu)3 peptide 
(P3) in DMSO-d6 and (B) N,N'-di[-Gly-(Ala)3-(Glu)3]perylene-3,4,9,10- 
tetracarboxylic acid diimide  (3) in 2:1 CDCl3/TFA. 
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Figure A.32 1H NMR spectral comparison of: (A) NH2-Gly-(Ala)3-(Glu)3 peptide 
(P3) in DMSO-d6 and (B) N-hexyl-N'-[-Gly-(Ala)3-(Glu)3]perylene-3,4,9,10- 
tetracarboxylic acid diimide (3H) in 2:1 CDCl3/TFA. 
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Figure A.33 1H NMR spectral comparison of: (A) NH2-Gly-(D-Ala)3-(D-Glu)3 
peptide (P3E) in DMSO-d6 and (B) N,N'-di[-Gly-(D-Ala)3-(D-Glu)3]perylene-
3,4,9,10- tetracarboxylic acid diimide (3E) in 2:1 CDCl3/TFA. 
(A) 
(B) 
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Figure A.34 1H NMR spectral comparison of: (A) NH2-Gly-(D-Ala)3-(D-Glu)3 
peptide (P3E) in DMSO-d6 and (B) N-hexyl-N'-[-Gly-(D-Ala)3-(D-Glu)3]perylene-
3,4,9,10- tetracarboxylic acid diimide (3HE) in 2:1 CDCl3/TFA. 
(A) 
(B) 
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Figure A.35 1H NMR spectral comparison of: (A) NH2-Gly-(Ala)3-(Glu)3 peptide 
(P3) in DMSO-d6 and (B) N-[-Gly-(L-Ala)3-(L-Glu)3]-N'-[-Gly-(D-Ala)3-(D-Glu)3]-
perylene-3,4,9,10- tetracarboxylic acid diimide (3M) in 2:1 CDCl3/TFA. 
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Figure A.36 1H NMR spectral comparison of: (A) NH2-Gly-(D-Ala)3-(Glu)3 
peptide (P4) in DMSO-d6 and (B) N,N'-di[-Gly-(D-Ala)3-(Glu)3]perylene-3,4,9,10- 
tetracarboxylic acid diimide (4) in 2:1 CDCl3/TFA. 
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Figure A.37 1H NMR spectral comparison of: (A) NH2-Gly-(D-Ala)3-(Glu)3 
peptide (P4) in DMSO-d6 and (B) N-hexyl-N'-[-Gly-(D-Ala)3-(Glu)3]perylene-
3,4,9,10- tetracarboxylic acid diimide (4H) in 2:1 CDCl3/TFA. 
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
ze
d
 In
te
n
si
ty
1
.1
97
1
.2
07
1
.2
19
1
.7
26
1
.7
71
1
.7
86
1
.8
99
1
.9
13
2
.1
87
2
.2
03
2
.2
19
2
.2
46
2
.2
64
2
.2
80
3
.5
58
3
.5
68
4
.1
53
4
.1
64
4
.2
31
4
.2
58
4
.2
67
4
.2
81
4
.3
75
4
.3
90
4
.4
04
7
.9
57
7
.9
71
7
.9
99
8
.0
17
8
.0
31
8
.1
82
8
.2
10
8
.2
24
8
.5
45
8
.5
60
9 8 7 6 5 4 3 2 1 0
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
N
o
rm
a
li
ze
d
 In
te
n
si
ty
0
.9
06
0
.9
17
0
.9
29
0
.9
51
1
.3
70
1
.3
76
1
.3
82
1
.4
65
1
.4
76
1
.4
91
1
.5
04
1
.7
99
1
.8
12
2
.6
33
4
.2
74
4
.2
87
4
.3
00
4
.3
20
4
.3
31
4
.3
42
4
.6
50
4
.6
62
4
.6
73
4
.7
12
5
.2
08
5
.2
37
5
.2
59
7
.6
64
8
.7
81
8
.7
94
8
.8
21
8
.8
32
8
.8
44
(A) 
(B) 
222 
 
A.2 1H NMR Spectra of Synthesized PDIs  
 (with Peptide 1H NMR Spectral Comparisons)  
  
 
 
 
Figure A.38 1H NMR spectral comparison of: (A) NH2-Gly-(Glu)3 peptide (P5) 
in DMSO-d6 and (B) N,N'-di[-Gly-(Glu)3]perylene-3,4,9,10- tetracarboxylic acid 
diimide (5) in 2:1 CDCl3/TFA. 
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Figure A.39 1H NMR spectral comparison of: (A) NH2-Gly-(Glu)3 peptide (P5) 
in DMSO-d6 and (B) N-hexyl-N'-[-Gly-(Glu)3]perylene-3,4,9,10- tetracarboxylic 
acid diimide (5H) in 2:1 CDCl3/TFA. 
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Figure A.40 1H NMR spectral comparison of: (A) NH2-Gly-(Phe)3-(Glu)3 peptide 
(P6) in DMSO-d6 and (B) N,N'-di[-Gly-(Phe)3-(Glu)3]perylene-3,4,9,10- 
tetracarboxylic acid diimide (6) in 2:1 CDCl3/TFA. 
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Figure A.41 1H NMR spectral comparison of: (A) NH2-Gly-(Leu)3-(Glu)3 peptide 
(P7) in DMSO-d6 and (B) N,N'-di[-Gly-(Leu)3-(Glu)3]perylene-3,4,9,10- 
tetracarboxylic acid diimide (7) in 2:1 CDCl3/TFA. 
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Figure A.42 1H NMR spectral comparison of: (A) NH2-Gly-(D-Leu)3-(Glu)3 
peptide (P8) in DMSO-d6 and (B) N,N'-di[-Gly-(D-Leu)3-(Glu)3]perylene-3,4,9,10- 
tetracarboxylic acid diimide (8) in 2:1 CDCl3/TFA. 
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Figure A.43 1H NMR spectral comparison of: (A) NH2-Gly-(Ala)3-[Lys(Boc)]3 
peptide (P9) in CDCl3 and (B) N,N'-di[-Gly-(Ala)3-(Lys)3]perylene-3,4,9,10- 
tetracarboxylic acid diimide (9) in CF3COOD. 
(A) 
(B) 
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Figure A.44 1H NMR spectral comparison of: (A) NH2-Lys-(Ala)3-(Glu)3 peptide 
(P10) in DMSO-d6 and (B) (N-yl-N'-isopropyl-perylene-3,4,9,10-diimide)2-Lys-
(Ala)3-(Glu)3-OH   (10) in 2:1 CDCl3/TFA. 
(A) 
(B) 
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Figure A.45 1H NMR spectral comparison of: (A) Ac-Ile-Lys-His-Leu-Ser-Val-
Asn-NH2 peptide in DMSO-d6 and (B) N,N'-di[Ac-Ile-Lys(-yl)-His-Leu-Ser-Val-
Asn-NH2]perylene-3,4,9,10-tetracarboxylic acid diimide (12) in CF3COOD. 
(A) 
(B) 
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Figure A.46 1H NMR spectral comparison of: (A) Ac-Ile-Lys-His-Leu-Ser-Val-
Asn-NH2 peptide in DMSO-d6 and (B) N-hexyl-N'-[Ac-Ile-Lys(-yl)-His-Leu-Ser-Val-
Asn-NH2]perylene-3,4,9,10-tetracarboxylic acid diimide (12H) in CF3COOD. 
(A) 
(B) 
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Figure A.47 1H NMR spectral comparison of: (A) GIRHLSVNEEE peptide (P13) 
in DMSO-d6 and (B) N,N'-di[-GIRHLSVNEEE]perylene-3,4,9,10-tetracarboxylic 
acid diimide (13) in CF3COOD. 
(A) 
(B) 
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Figure A.48 1H NMR spectral comparison of: (A) Ac-EEEIRHLSVN-
amidoethylamine peptide (P14) in DMSO-d6 and (B) N,N'-di[Ac-EEEIRHLSVN-
amidoethyl]perylene-3,4,9,10-tetracarboxylic acid diimide (14) in CF3COOD. 
(A) 
(B) 
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Figure A.49 1H NMR spectral comparison of: (A) GIRHLSVNEEE peptide (P13) 
in DMSO-d6 and (B) N-[-GIRHLSVNEEE]perylene-3,4-imide-9,10-bis(n-butyl) 
ester (15) in 4:1 D2O/pyridine-d5. 
(A) 
(B) 
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Figure A.50 1H NMR spectral comparison of: (A) Ac-EEEIRHLSVN-
amidoethylamine peptide (P14) in DMSO-d6 and (B) N-[Ac-EEEIRHLSVN-
amidoethyl]perylene-3,4-imide-9,10-bis(n-butyl) ester (16) in 4:1 D2O/pyridine-d5. 
(A) 
(B) 
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Appendix - B 
MALDI Mass Spectra of 
Synthesized Perylene Imides 
B.1 Primary Ion Spectra with 
 Selected Ion Fragmentation Spectra  
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.1 MALDI mass spectra of PDI 1: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.2 MALDI mass spectra of PDI 1H: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.3 MALDI mass spectra of PDI 2: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.4 MALDI mass spectra of PDI 2H: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.5 MALDI mass spectra of PDI 3: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.6 MALDI mass spectra of PDI 3H: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.7 MALDI mass spectra of PDI 3E: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.8 MALDI mass spectra of PDI 3HE: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.9 MALDI mass spectra of perylene imide bisester Q2: (A) Primary ion 
spectrum; (B) [M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.10 MALDI mass spectra of PDI 3M: (A) Primary ion spectrum; (B) 
[M+H]+ ion fragmentation spectrum. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.11 MALDI mass spectra of PDI 4: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.12 MALDI mass spectra of PDI 4H: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.13 MALDI mass spectra of PDI 5: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.14 MALDI mass spectra of PDI 5H: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.15 MALDI mass spectra of PDI 6: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.16 MALDI mass spectra of PDI 7: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.17 MALDI mass spectra of PDI 8: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.18 MALDI mass spectra of NH2-Gly-(Ala)3-[Lys(Boc)]3 peptide P9:          
(A) Primary ion spectrum; (B) [M+Na]+ ion fragmentation spectrum. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.19 MALDI mass spectra of PDI 9: (A) Primary ion spectrum; (B) 
[M+H]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.20 MALDI mass spectra of PDI 9: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.21 MALDI mass spectra of compound 10: (A) Primary ion spectrum;   
(B) [M+Na]+ ion fragmentation spectrum. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.22  MALDI mass spectra of compound 11: (A) Primary ion spectrum; 
(B) [M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.23 MALDI mass spectra of PDI 12: (A) Primary ion spectrum; (B) 
[M+H]+ ion fragmentation spectrum. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.24 MALDI mass spectra of PDI 12H: (A) Primary ion spectrum; (B) 
[M+Na]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.25 MALDI mass spectra of compound 15: (A) Primary ion spectrum; (B) 
[M+H]+ ion fragmentation spectrum with assigned ion fragments. 
(A) 
(B) 
261 
 
B.1 MALDI Mass Spectra 
 
 
 
 
Figure B.26 MALDI mass spectra of compound 16: (A) Primary ion spectrum; (B) 
[M+H]+ ion fragmentation spectrum. 
(A) 
(B) 
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B.1 MALDI Mass Spectra 
 
 
Figure B.27 Primary ion MALDI mass spectrum of compound 13. 
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Appendix - C 
FT-IR Spectra of Synthesized 
Perylene Imides 
C.1 FT-IR Spectra with 
 Fingerprint Region Spectral Comparisons 
C.2 Amide I and II Band Analysis  
 
 
 
 
 
 
 
 
 
 
 
 
 
264 
 
C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.1 FT-IR spectra of compound 1: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.2 FT-IR spectra of compound 1H: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.3 FT-IR spectra of compound 2: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.4 FT-IR spectra of compound 2H: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.5 FT-IR spectra of compound 3: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.6 FT-IR spectra of compound 3H: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.7 FT-IR spectra of compound 3E: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.8 FT-IR spectra of compound 3HE: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.9 FT-IR spectra of compound 3M: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
273 
 
C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.10 FT-IR spectra of compound 4: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.11 FT-IR spectra of compound 4H: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.12 FT-IR spectra of compound 5: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.13 FT-IR spectra of compound 5H: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.14 FT-IR spectra of compound 6: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.15 FT-IR spectra of compound 7: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.16 FT-IR spectra of compound 8: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.17 FT-IR spectra of compound 9: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.18 FT-IR spectra of compound 10: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.19 FT-IR spectra of compound 11: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.20 FT-IR spectra of compound 12: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.21 FT-IR spectra of compound 12H: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.22 FT-IR spectra of compound 13: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.23 FT-IR spectra of compound 14: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.24 FT-IR spectra of compound 15: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.1 FT-IR Spectra of Synthesized Perylene Imides 
 
 
 
 
 
Figure C.25 FT-IR spectra of compound 16: (A) Spectral range 4000-500 cm−1;     
(B) Fingerprint region spectral comparison showing anhydride to imide conversion. 
(A) 
(B) 
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C.2 Amide I and II Band Analysis 
 
 
Figure C.26 FT-IR spectral analysis of the amide I and II bands of peptide P13. 
 
 
Figure C.27 FT-IR spectral analysis of the amide I and II bands of peptide P14. 
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C.2 Amide I and II Band Analysis 
 
 
Figure C.28 FT-IR spectral analysis of the amide I and II bands of compound 13. 
 
 
Figure C.29 FT-IR spectral analysis of the amide I and II bands of compound 14. 
13 
14 
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C.2 Amide I and II Band Analysis 
 
 
Figure C.30 FT-IR spectral analysis of the amide I and II bands of compound 15. 
 
 
Figure C.31 FT-IR spectral analysis of the amide I and II bands of compound 16. 
15 
16 
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D.3 Spectral Data Fitting of Selected Organic  
 PDI Solutions  
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D.1 Temperature-Dependent Spectra of Aqueous 
 PDI Solutions 
 
 
 
Figure D.1 Temperature-dependent spectra of aqueous solutions of PDIs 1-8 and 
1H-5H from the thermodynamic study discussed in Chapter 3. 
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D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
 
Figure D.2 Spectral data fitting for PDI 1 in water with increasing temperature. 
 
 
Figure S50. Spectral data fitting 















 


2
908.0exp1
1
m
m
T
RT
TT
H

ΔH = -53811.2 
 Tm =  385.625 
300 K 
302 K 
307 K 
312 K 
326 K 
331 K 
335 K 
340 K 
354 K 
359 K 
364 K 
367 K 
316 K 
321 K 
345 K 
350 K 
296 
 
D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.3 Spectral data fitting for PDI 2 in water with increasing temperature. 
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D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.4 Spectral data fitting for PDI 3 in water with increasing temperature. 
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D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.5 Spectral data fitting for PDI 4 in water with increasing temperature. 
 















 


2
908.0exp1
1
m
m
T
RT
TT
H

ΔH = -29796.9 
 Tm =  357.279 
298 K 
302 K 
307 K 
312 K 
326 K 
331 K 
335 K 
340 K 
354 K 
359 K 
364 K 
367 K 
316 K 
321 K 
345 K 
350 K 
299 
 
D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.6 Spectral data fitting for PDI 5 in water with increasing temperature. 
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D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.7 Spectral data fitting for PDI 6 in water with increasing temperature. 
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D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.8 Spectral data fitting for PDI 7 in water with increasing temperature. 
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D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.9 Spectral data fitting for PDI 8 in water with increasing temperature. 
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D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.10 Spectral data fitting for PDI 1H in water with increasing temperature. 
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D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.11 Spectral data fitting for PDI 2H in water with increasing temperature. 
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D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.12 Spectral data fitting for PDI 3H in water with increasing temperature. 
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D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.13 Spectral data fitting for PDI 4H in water with increasing temperature. 
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D.2 Spectral Data Fitting of Aqueous PDI Solutions 
 
 
Figure D.14 Spectral data fitting for PDI 5H in water with increasing temperature. 
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D.3 Spectral Data Fitting of Selected Organic PDI Solutions 
 
Figure D.15 Spectral data fitting for PDI 1 in selected organic solvents (water 
comparison included). 
 
 
 
Figure D.16 Spectral data fitting for PDI 2 in selected organic solvents (water 
comparison included). 
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D.3 Spectral Data Fitting of Selected Organic PDI Solutions 
 
Figure D.17 Spectral data fitting for PDI 3 in selected organic solvents (water 
comparison included). 
 
 
Figure D.18 Spectral data fitting for PDI 4 in selected organic solvents (water 
comparison included). 
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D.3 Spectral Data Fitting of Selected Organic PDI Solutions 
 
Figure D.19 Spectral data fitting for PDI 5 in selected organic solvents (water 
comparison included). 
 
 
Figure D.20 Spectral data fitting for PDI 7 in selected organic solvents (water 
comparison included). 
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D.3 Spectral Data Fitting of Selected Organic PDI Solutions 
 
Figure D.21 Spectral data fitting for PDI 6 in selected organic solvents (water 
comparison included). 
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D.3 Spectral Data Fitting of Selected Organic PDI Solutions 
 
Figure D.22 Spectral data fitting for PDI 8 in selected organic solvents (water 
comparison included). 
 
 
Figure D.23 Spectral data fitting for PDI 2H in selected organic solvents (water 
comparison included). 
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D.3 Spectral Data Fitting of Selected Organic PDI Solutions 
 
Figure D.24 Spectral data fitting for PDI 1H in selected organic solvents (water 
comparison included). 
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D.3 Spectral Data Fitting of Selected Organic PDI Solutions 
 
Figure D.25 Spectral data fitting for PDI 3H in selected organic solvents (water 
comparison included). 
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D.3 Spectral Data Fitting of Selected Organic PDI Solutions 
 
Figure D.26 Spectral data fitting for PDI 4H in selected organic solvents (water 
comparison included). 
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D.3 Spectral Data Fitting of Selected Organic PDI Solutions 
 
Figure D.27 Spectral data fitting for PDI 5H in selected organic solvents (water 
comparison included). 
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